id	sid	tid	token	lemma	pos
ajcp-5356	1	1	pa	pa	PROPN
ajcp-5356	1	2	ge	ge	PROPN
ajcp-5356	1	3	1	1	NUM
ajcp-5356	1	4	pa	pa	PROPN
ajcp-5356	1	5	ge	ge	PROPN
ajcp-5356	1	6	48	48	NUM
ajcp-5356	1	7	american	american	PROPN
ajcp-5356	1	8	journal	journal	PROPN
ajcp-5356	1	9	of	of	ADP
ajcp-5356	1	10	chemistry	chemistry	NOUN
ajcp-5356	1	11	and	and	CCONJ
ajcp-5356	1	12	pharmacy	pharmacy	NOUN
ajcp-5356	1	13	(	(	PUNCT
ajcp-5356	1	14	ajcp	ajcp	NOUN
ajcp-5356	1	15	)	)	PUNCT
ajcp-5356	1	16	evaluation	evaluation	NOUN
ajcp-5356	1	17	of	of	ADP
ajcp-5356	1	18	chitosan	chitosan	NOUN
ajcp-5356	1	19	-	-	PUNCT
ajcp-5356	1	20	based	base	VERB
ajcp-5356	1	21	nano	nano	NOUN
ajcp-5356	1	22	-	-	PUNCT
ajcp-5356	1	23	encapsulated	encapsulate	VERB
ajcp-5356	1	24	diterpenoids	diterpenoid	NOUN
ajcp-5356	1	25	from	from	ADP
ajcp-5356	1	26	andrographis	andrographis	PRON
ajcp-5356	1	27	paniculata	paniculata	NOUN
ajcp-5356	1	28	for	for	ADP
ajcp-5356	1	29	targeted	target	VERB
ajcp-5356	1	30	anti	anti	ADJ
ajcp-5356	1	31	-	-	ADJ
ajcp-5356	1	32	inflammatory	inflammatory	ADJ
ajcp-5356	1	33	therapy	therapy	NOUN
ajcp-5356	1	34	:	:	PUNCT
ajcp-5356	1	35	roles	role	NOUN
ajcp-5356	1	36	of	of	ADP
ajcp-5356	1	37	analytical	analytical	ADJ
ajcp-5356	1	38	chemistry	chemistry	NOUN
ajcp-5356	1	39	medical	medical	ADJ
ajcp-5356	1	40	imaging	imaging	NOUN
ajcp-5356	1	41	,	,	PUNCT
ajcp-5356	1	42	and	and	CCONJ
ajcp-5356	1	43	biochemical	biochemical	ADJ
ajcp-5356	1	44	assessment	assessment	NOUN
ajcp-5356	1	45	s.	s.	PROPN
ajcp-5356	1	46	i.	i.	PROPN
ajcp-5356	1	47	okonkwo1	okonkwo1	PROPN
ajcp-5356	1	48	*	*	PROPN
ajcp-5356	1	49	,	,	PUNCT
ajcp-5356	1	50	j.	j.	PROPN
ajcp-5356	1	51	a.	a.	PROPN
ajcp-5356	1	52	ezugwu1	ezugwu1	PROPN
ajcp-5356	1	53	,	,	PUNCT
ajcp-5356	2	1	i.	i.	PROPN
ajcp-5356	2	2	p.	p.	PROPN
ajcp-5356	2	3	oragwu1	oragwu1	PROPN
ajcp-5356	2	4	,	,	PUNCT
ajcp-5356	2	5	c.	c.	PROPN
ajcp-5356	2	6	k.	k.	PROPN
ajcp-5356	3	1	okonkwo2	okonkwo2	PROPN
ajcp-5356	3	2	,	,	PUNCT
ajcp-5356	3	3	p.	p.	PROPN
ajcp-5356	3	4	o.	o.	PROPN
ajcp-5356	4	1	okwuego1	okwuego1	PROPN
ajcp-5356	4	2	,	,	PUNCT
ajcp-5356	4	3	a.	a.	NOUN
ajcp-5356	4	4	t.	t.	PROPN
ajcp-5356	4	5	kene	kene	PROPN
ajcp-5356	4	6	okonkwo3	okonkwo3	ADV
ajcp-5356	4	7	,	,	PUNCT
ajcp-5356	4	8	v.	v.	ADP
ajcp-5356	4	9	s.	s.	PROPN
ajcp-5356	4	10	okonkwo4	okonkwo4	PROPN
ajcp-5356	4	11	,	,	PUNCT
ajcp-5356	4	12	s.	s.	PROPN
ajcp-5356	4	13	c.	c.	PROPN
ajcp-5356	4	14	okonkwo5	okonkwo5	PROPN
ajcp-5356	5	1	volume	volume	NOUN
ajcp-5356	5	2	4	4	NUM
ajcp-5356	5	3	issue	issue	NOUN
ajcp-5356	5	4	1	1	NUM
ajcp-5356	5	5	,	,	PUNCT
ajcp-5356	5	6	year	year	NOUN
ajcp-5356	5	7	2025	2025	NUM
ajcp-5356	5	8	issn	issn	NOUN
ajcp-5356	5	9	:	:	PUNCT
ajcp-5356	5	10	2834	2834	NUM
ajcp-5356	5	11	-	-	SYM
ajcp-5356	5	12	0116	0116	NUM
ajcp-5356	5	13	(	(	PUNCT
ajcp-5356	5	14	online	online	ADJ
ajcp-5356	5	15	)	)	PUNCT
ajcp-5356	5	16	doi	doi	NOUN
ajcp-5356	5	17	:	:	PUNCT
ajcp-5356	5	18	https://doi.org/10.54536/ajcp.v4i1.5356	https://doi.org/10.54536/ajcp.v4i1.5356	PROPN
ajcp-5356	5	19	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-5356	5	20	article	article	NOUN
ajcp-5356	5	21	information	information	NOUN
ajcp-5356	5	22	abstract	abstract	ADV
ajcp-5356	5	23	received	receive	VERB
ajcp-5356	5	24	:	:	PUNCT
ajcp-5356	5	25	june	june	PROPN
ajcp-5356	5	26	01	01	NUM
ajcp-5356	5	27	,	,	PUNCT
ajcp-5356	5	28	2025	2025	NUM
ajcp-5356	5	29	accepted	accept	VERB
ajcp-5356	5	30	:	:	PUNCT
ajcp-5356	5	31	july	july	PROPN
ajcp-5356	5	32	04	04	NUM
ajcp-5356	5	33	,	,	PUNCT
ajcp-5356	5	34	2025	2025	NUM
ajcp-5356	5	35	published	publish	VERB
ajcp-5356	5	36	:	:	PUNCT
ajcp-5356	5	37	september	september	PROPN
ajcp-5356	5	38	29	29	NUM
ajcp-5356	5	39	,	,	PUNCT
ajcp-5356	5	40	2025	2025	NUM
ajcp-5356	5	41	the	the	DET
ajcp-5356	5	42	formulation	formulation	NOUN
ajcp-5356	5	43	,	,	PUNCT
ajcp-5356	5	44	characterization	characterization	NOUN
ajcp-5356	5	45	,	,	PUNCT
ajcp-5356	5	46	and	and	CCONJ
ajcp-5356	5	47	therapeutic	therapeutic	ADJ
ajcp-5356	5	48	potential	potential	NOUN
ajcp-5356	5	49	of	of	ADP
ajcp-5356	5	50	andrographis	andrographis	NUM
ajcp-5356	5	51	paniculataderived	paniculataderive	VERB
ajcp-5356	5	52	chitosan	chitosan	NOUN
ajcp-5356	5	53	-	-	PUNCT
ajcp-5356	5	54	based	base	VERB
ajcp-5356	5	55	nano	nano	NOUN
ajcp-5356	5	56	-	-	PUNCT
ajcp-5356	5	57	encapsulated	encapsulate	VERB
ajcp-5356	5	58	diterpenoids	diterpenoid	NOUN
ajcp-5356	5	59	for	for	ADP
ajcp-5356	5	60	targeted	target	VERB
ajcp-5356	5	61	anti	anti	ADJ
ajcp-5356	5	62	-	-	ADJ
ajcp-5356	5	63	inflammatory	inflammatory	ADJ
ajcp-5356	5	64	therapy	therapy	NOUN
ajcp-5356	5	65	are	be	AUX
ajcp-5356	5	66	examined	examine	VERB
ajcp-5356	5	67	in	in	ADP
ajcp-5356	5	68	this	this	DET
ajcp-5356	5	69	study	study	NOUN
ajcp-5356	5	70	.	.	PUNCT
ajcp-5356	6	1	chromatographic	chromatographic	ADJ
ajcp-5356	6	2	and	and	CCONJ
ajcp-5356	6	3	spectroscopic	spectroscopic	ADJ
ajcp-5356	6	4	methods	method	NOUN
ajcp-5356	6	5	,	,	PUNCT
ajcp-5356	6	6	such	such	ADJ
ajcp-5356	6	7	as	as	ADP
ajcp-5356	6	8	uvvis	uvvis	NOUN
ajcp-5356	6	9	,	,	PUNCT
ajcp-5356	6	10	ftir	ftir	PROPN
ajcp-5356	6	11	,	,	PUNCT
ajcp-5356	6	12	nmr	nmr	NOUN
ajcp-5356	6	13	,	,	PUNCT
ajcp-5356	6	14	and	and	CCONJ
ajcp-5356	6	15	gc	gc	PROPN
ajcp-5356	6	16	-	-	PUNCT
ajcp-5356	6	17	ms	ms	PROPN
ajcp-5356	6	18	,	,	PUNCT
ajcp-5356	6	19	were	be	AUX
ajcp-5356	6	20	used	use	VERB
ajcp-5356	6	21	to	to	PART
ajcp-5356	6	22	isolate	isolate	VERB
ajcp-5356	6	23	and	and	CCONJ
ajcp-5356	6	24	characterize	characterize	VERB
ajcp-5356	6	25	two	two	NUM
ajcp-5356	6	26	important	important	ADJ
ajcp-5356	6	27	bioactive	bioactive	ADJ
ajcp-5356	6	28	compounds	compound	NOUN
ajcp-5356	6	29	:	:	PUNCT
ajcp-5356	6	30	14	14	NUM
ajcp-5356	6	31	-	-	PUNCT
ajcp-5356	6	32	deoxy-11,12	deoxy-11,12	NOUN
ajcp-5356	6	33	didehydroandrographolide	didehydroandrographolide	NOUN
ajcp-5356	6	34	and	and	CCONJ
ajcp-5356	6	35	neoandrographolide	neoandrographolide	NOUN
ajcp-5356	6	36	.	.	PUNCT
ajcp-5356	7	1	the	the	DET
ajcp-5356	7	2	existence	existence	NOUN
ajcp-5356	7	3	of	of	ADP
ajcp-5356	7	4	functional	functional	ADJ
ajcp-5356	7	5	groups	group	NOUN
ajcp-5356	7	6	including	include	VERB
ajcp-5356	7	7	amines	amine	NOUN
ajcp-5356	7	8	,	,	PUNCT
ajcp-5356	7	9	carbonyls	carbonyls	NOUN
ajcp-5356	7	10	,	,	PUNCT
ajcp-5356	7	11	thiols	thiol	NOUN
ajcp-5356	7	12	,	,	PUNCT
ajcp-5356	7	13	and	and	CCONJ
ajcp-5356	7	14	nitro	nitro	NOUN
ajcp-5356	7	15	compounds	compound	NOUN
ajcp-5356	7	16	—	—	PUNCT
ajcp-5356	7	17	which	which	PRON
ajcp-5356	7	18	support	support	VERB
ajcp-5356	7	19	the	the	DET
ajcp-5356	7	20	compounds	compound	NOUN
ajcp-5356	7	21	’	'	PUNCT
ajcp-5356	7	22	anti	anti	ADJ
ajcp-5356	7	23	-	-	ADJ
ajcp-5356	7	24	inflammatory	inflammatory	ADJ
ajcp-5356	7	25	qualities	quality	NOUN
ajcp-5356	7	26	—	—	PUNCT
ajcp-5356	7	27	was	be	AUX
ajcp-5356	7	28	verified	verify	VERB
ajcp-5356	7	29	by	by	ADP
ajcp-5356	7	30	ftir	ftir	PROPN
ajcp-5356	7	31	spectra	spectra	PROPN
ajcp-5356	7	32	.	.	PUNCT
ajcp-5356	8	1	transmission	transmission	NOUN
ajcp-5356	8	2	electron	electron	NOUN
ajcp-5356	8	3	microscopy	microscopy	NOUN
ajcp-5356	8	4	(	(	PUNCT
ajcp-5356	8	5	tem	tem	PROPN
ajcp-5356	8	6	)	)	PUNCT
ajcp-5356	8	7	showed	show	VERB
ajcp-5356	8	8	that	that	SCONJ
ajcp-5356	8	9	spherical	spherical	ADJ
ajcp-5356	8	10	nanoparticles	nanoparticle	NOUN
ajcp-5356	8	11	with	with	ADP
ajcp-5356	8	12	mesoporous	mesoporous	ADJ
ajcp-5356	8	13	structures	structure	NOUN
ajcp-5356	8	14	(	(	PUNCT
ajcp-5356	8	15	22.10	22.10	NUM
ajcp-5356	8	16	nm	nm	NOUN
ajcp-5356	8	17	)	)	PUNCT
ajcp-5356	8	18	were	be	AUX
ajcp-5356	8	19	produced	produce	VERB
ajcp-5356	8	20	by	by	ADP
ajcp-5356	8	21	ionic	ionic	ADJ
ajcp-5356	8	22	gelation	gelation	NOUN
ajcp-5356	8	23	using	use	VERB
ajcp-5356	8	24	chitosan	chitosan	NOUN
ajcp-5356	8	25	and	and	CCONJ
ajcp-5356	8	26	sodium	sodium	NOUN
ajcp-5356	8	27	sulfate	sulfate	NOUN
ajcp-5356	8	28	,	,	PUNCT
ajcp-5356	8	29	followed	follow	VERB
ajcp-5356	8	30	by	by	ADP
ajcp-5356	8	31	sonication	sonication	NOUN
ajcp-5356	8	32	,	,	PUNCT
ajcp-5356	8	33	to	to	PART
ajcp-5356	8	34	accomplish	accomplish	VERB
ajcp-5356	8	35	nano	nano	NOUN
ajcp-5356	8	36	-	-	PUNCT
ajcp-5356	8	37	encapsulation	encapsulation	NOUN
ajcp-5356	8	38	.	.	PUNCT
ajcp-5356	9	1	high	high	ADJ
ajcp-5356	9	2	encapsulation	encapsulation	NOUN
ajcp-5356	9	3	efficiency	efficiency	NOUN
ajcp-5356	9	4	(	(	PUNCT
ajcp-5356	9	5	82.5	82.5	NUM
ajcp-5356	9	6	%	%	NOUN
ajcp-5356	9	7	for	for	ADP
ajcp-5356	9	8	the	the	DET
ajcp-5356	9	9	main	main	ADJ
ajcp-5356	9	10	isolate	isolate	NOUN
ajcp-5356	9	11	)	)	PUNCT
ajcp-5356	9	12	and	and	CCONJ
ajcp-5356	9	13	a	a	DET
ajcp-5356	9	14	biphasic	biphasic	ADJ
ajcp-5356	9	15	drug	drug	NOUN
ajcp-5356	9	16	release	release	NOUN
ajcp-5356	9	17	profile	profile	NOUN
ajcp-5356	9	18	—	—	PUNCT
ajcp-5356	9	19	an	an	DET
ajcp-5356	9	20	initial	initial	ADJ
ajcp-5356	9	21	burst	burst	NOUN
ajcp-5356	9	22	followed	follow	VERB
ajcp-5356	9	23	by	by	ADP
ajcp-5356	9	24	a	a	DET
ajcp-5356	9	25	sustained	sustained	ADJ
ajcp-5356	9	26	release	release	NOUN
ajcp-5356	9	27	over	over	ADP
ajcp-5356	9	28	four	four	NUM
ajcp-5356	9	29	hours	hour	NOUN
ajcp-5356	9	30	—	—	PUNCT
ajcp-5356	9	31	were	be	AUX
ajcp-5356	9	32	demonstrated	demonstrate	VERB
ajcp-5356	9	33	by	by	ADP
ajcp-5356	9	34	the	the	DET
ajcp-5356	9	35	encapsulated	encapsulate	VERB
ajcp-5356	9	36	compounds	compound	NOUN
ajcp-5356	9	37	.	.	PUNCT
ajcp-5356	10	1	in	in	ADP
ajcp-5356	10	2	carrageenan	carrageenan	NOUN
ajcp-5356	10	3	-	-	PUNCT
ajcp-5356	10	4	induced	induce	VERB
ajcp-5356	10	5	wistar	wistar	PROPN
ajcp-5356	10	6	rats	rat	NOUN
ajcp-5356	10	7	,	,	PUNCT
ajcp-5356	10	8	sonographic	sonographic	ADJ
ajcp-5356	10	9	imaging	imaging	NOUN
ajcp-5356	10	10	showed	show	VERB
ajcp-5356	10	11	a	a	DET
ajcp-5356	10	12	significant	significant	ADJ
ajcp-5356	10	13	decrease	decrease	NOUN
ajcp-5356	10	14	in	in	ADP
ajcp-5356	10	15	paw	paw	NOUN
ajcp-5356	10	16	thickness	thickness	NOUN
ajcp-5356	10	17	and	and	CCONJ
ajcp-5356	10	18	vascular	vascular	ADJ
ajcp-5356	10	19	perfusion	perfusion	NOUN
ajcp-5356	10	20	after	after	ADP
ajcp-5356	10	21	therapy	therapy	NOUN
ajcp-5356	10	22	.	.	PUNCT
ajcp-5356	11	1	this	this	PRON
ajcp-5356	11	2	was	be	AUX
ajcp-5356	11	3	supported	support	VERB
ajcp-5356	11	4	by	by	ADP
ajcp-5356	11	5	improved	improved	ADJ
ajcp-5356	11	6	liver	liver	NOUN
ajcp-5356	11	7	and	and	CCONJ
ajcp-5356	11	8	kidney	kidney	NOUN
ajcp-5356	11	9	function	function	NOUN
ajcp-5356	11	10	and	and	CCONJ
ajcp-5356	11	11	lower	low	ADJ
ajcp-5356	11	12	levels	level	NOUN
ajcp-5356	11	13	of	of	ADP
ajcp-5356	11	14	inflammatory	inflammatory	ADJ
ajcp-5356	11	15	biomarkers	biomarker	NOUN
ajcp-5356	11	16	(	(	PUNCT
ajcp-5356	11	17	tnf	tnf	PROPN
ajcp-5356	11	18	-	-	PUNCT
ajcp-5356	11	19	α	α	PROPN
ajcp-5356	11	20	,	,	PUNCT
ajcp-5356	11	21	il6	il6	NOUN
ajcp-5356	11	22	,	,	PUNCT
ajcp-5356	11	23	and	and	CCONJ
ajcp-5356	11	24	crp	crp	PROPN
ajcp-5356	11	25	)	)	PUNCT
ajcp-5356	11	26	.	.	PUNCT
ajcp-5356	12	1	a	a	DET
ajcp-5356	12	2	comparative	comparative	ADJ
ajcp-5356	12	3	analysis	analysis	NOUN
ajcp-5356	12	4	revealed	reveal	VERB
ajcp-5356	12	5	that	that	SCONJ
ajcp-5356	12	6	the	the	DET
ajcp-5356	12	7	nanoformulated	nanoformulated	ADJ
ajcp-5356	12	8	extract	extract	NOUN
ajcp-5356	12	9	exhibited	exhibit	VERB
ajcp-5356	12	10	less	less	ADJ
ajcp-5356	12	11	toxicity	toxicity	NOUN
ajcp-5356	12	12	and	and	CCONJ
ajcp-5356	12	13	performed	perform	VERB
ajcp-5356	12	14	on	on	ADP
ajcp-5356	12	15	par	par	NOUN
ajcp-5356	12	16	with	with	ADP
ajcp-5356	12	17	or	or	CCONJ
ajcp-5356	12	18	better	well	ADJ
ajcp-5356	12	19	than	than	ADP
ajcp-5356	12	20	common	common	ADJ
ajcp-5356	12	21	anti	anti	ADJ
ajcp-5356	12	22	-	-	ADJ
ajcp-5356	12	23	inflammatory	inflammatory	ADJ
ajcp-5356	12	24	medications	medication	NOUN
ajcp-5356	12	25	,	,	PUNCT
ajcp-5356	12	26	such	such	ADJ
ajcp-5356	12	27	as	as	ADP
ajcp-5356	12	28	diclofenac	diclofenac	NOUN
ajcp-5356	12	29	.	.	PUNCT
ajcp-5356	13	1	the	the	DET
ajcp-5356	13	2	effectiveness	effectiveness	NOUN
ajcp-5356	13	3	of	of	ADP
ajcp-5356	13	4	a.	a.	NOUN
ajcp-5356	13	5	paniculata	paniculata	VERB
ajcp-5356	13	6	nanoformulations	nanoformulation	NOUN
ajcp-5356	13	7	for	for	ADP
ajcp-5356	13	8	safer	safe	ADJ
ajcp-5356	13	9	,	,	PUNCT
ajcp-5356	13	10	longerlasting	longerlasting	NOUN
ajcp-5356	13	11	,	,	PUNCT
ajcp-5356	13	12	and	and	CCONJ
ajcp-5356	13	13	more	more	ADV
ajcp-5356	13	14	focused	focused	ADJ
ajcp-5356	13	15	anti	anti	ADJ
ajcp-5356	13	16	-	-	ADJ
ajcp-5356	13	17	inflammatory	inflammatory	ADJ
ajcp-5356	13	18	treatment	treatment	NOUN
ajcp-5356	13	19	is	be	AUX
ajcp-5356	13	20	supported	support	VERB
ajcp-5356	13	21	by	by	ADP
ajcp-5356	13	22	this	this	DET
ajcp-5356	13	23	multidisciplinary	multidisciplinary	ADJ
ajcp-5356	13	24	approach	approach	NOUN
ajcp-5356	13	25	that	that	PRON
ajcp-5356	13	26	combines	combine	VERB
ajcp-5356	13	27	phytochemistry	phytochemistry	NOUN
ajcp-5356	13	28	,	,	PUNCT
ajcp-5356	13	29	nanotechnology	nanotechnology	NOUN
ajcp-5356	13	30	,	,	PUNCT
ajcp-5356	13	31	analytical	analytical	ADJ
ajcp-5356	13	32	chemistry	chemistry	NOUN
ajcp-5356	13	33	,	,	PUNCT
ajcp-5356	13	34	imaging	imaging	NOUN
ajcp-5356	13	35	,	,	PUNCT
ajcp-5356	13	36	and	and	CCONJ
ajcp-5356	13	37	biochemical	biochemical	ADJ
ajcp-5356	13	38	validation	validation	NOUN
ajcp-5356	13	39	.	.	PUNCT
ajcp-5356	14	1	keywords	keyword	VERB
ajcp-5356	14	2	andrographis	andrographis	PRON
ajcp-5356	14	3	paniculata	paniculata	ADJ
ajcp-5356	14	4	,	,	PUNCT
ajcp-5356	14	5	chitosan	chitosan	NOUN
ajcp-5356	14	6	,	,	PUNCT
ajcp-5356	14	7	diterpenoids	diterpenoids	PROPN
ajcp-5356	14	8	,	,	PUNCT
ajcp-5356	14	9	ftir	ftir	PROPN
ajcp-5356	14	10	,	,	PUNCT
ajcp-5356	14	11	lc	lc	PROPN
ajcp-5356	14	12	-	-	PUNCT
ajcp-5356	14	13	ms	ms	NOUN
ajcp-5356	14	14	,	,	PUNCT
ajcp-5356	14	15	nano	nano	NOUN
ajcp-5356	14	16	-	-	PUNCT
ajcp-5356	14	17	encapsulation	encapsulation	NOUN
ajcp-5356	14	18	,	,	PUNCT
ajcp-5356	14	19	sonography	sonography	NOUN
ajcp-5356	14	20	,	,	PUNCT
ajcp-5356	14	21	targeted	target	VERB
ajcp-5356	14	22	drug	drug	NOUN
ajcp-5356	14	23	delivery	delivery	NOUN
ajcp-5356	14	24	,	,	PUNCT
ajcp-5356	14	25	tem	tem	PROPN
ajcp-5356	14	26	1	1	NUM
ajcp-5356	14	27	department	department	NOUN
ajcp-5356	14	28	of	of	ADP
ajcp-5356	14	29	pure	pure	ADJ
ajcp-5356	14	30	and	and	CCONJ
ajcp-5356	14	31	industrial	industrial	ADJ
ajcp-5356	14	32	chemistry	chemistry	NOUN
ajcp-5356	14	33	,	,	PUNCT
ajcp-5356	14	34	chukwuemeka	chukwuemeka	PROPN
ajcp-5356	14	35	odumegwu	odumegwu	PROPN
ajcp-5356	14	36	ojukwu	ojukwu	PROPN
ajcp-5356	14	37	university	university	PROPN
ajcp-5356	14	38	,	,	PUNCT
ajcp-5356	14	39	uli	uli	PROPN
ajcp-5356	14	40	,	,	PUNCT
ajcp-5356	14	41	anambra	anambra	PROPN
ajcp-5356	14	42	state	state	PROPN
ajcp-5356	14	43	,	,	PUNCT
ajcp-5356	14	44	nigeria	nigeria	PROPN
ajcp-5356	14	45	2	2	NUM
ajcp-5356	14	46	department	department	NOUN
ajcp-5356	14	47	of	of	ADP
ajcp-5356	14	48	diagnostic	diagnostic	ADJ
ajcp-5356	14	49	medical	medical	ADJ
ajcp-5356	14	50	sonography	sonography	NOUN
ajcp-5356	14	51	and	and	CCONJ
ajcp-5356	14	52	ultrasound	ultrasound	PROPN
ajcp-5356	14	53	technology	technology	NOUN
ajcp-5356	14	54	,	,	PUNCT
ajcp-5356	14	55	ace	ace	PROPN
ajcp-5356	14	56	institute	institute	PROPN
ajcp-5356	14	57	of	of	ADP
ajcp-5356	14	58	technology	technology	PROPN
ajcp-5356	14	59	,	,	PUNCT
ajcp-5356	14	60	elmhurst	elmhurst	PROPN
ajcp-5356	14	61	,	,	PUNCT
ajcp-5356	14	62	new	new	PROPN
ajcp-5356	14	63	york	york	PROPN
ajcp-5356	14	64	,	,	PUNCT
ajcp-5356	14	65	usa	usa	PROPN
ajcp-5356	14	66	3	3	NUM
ajcp-5356	14	67	tansian	tansian	PROPN
ajcp-5356	14	68	university	university	NOUN
ajcp-5356	14	69	,	,	PUNCT
ajcp-5356	14	70	umunya	umunya	PROPN
ajcp-5356	14	71	,	,	PUNCT
ajcp-5356	14	72	anambra	anambra	PROPN
ajcp-5356	14	73	state	state	PROPN
ajcp-5356	14	74	,	,	PUNCT
ajcp-5356	14	75	nigeria	nigeria	PROPN
ajcp-5356	14	76	4	4	NUM
ajcp-5356	14	77	department	department	NOUN
ajcp-5356	14	78	of	of	ADP
ajcp-5356	14	79	medical	medical	ADJ
ajcp-5356	14	80	biochemistry	biochemistry	NOUN
ajcp-5356	14	81	,	,	PUNCT
ajcp-5356	14	82	chukwuemeka	chukwuemeka	PROPN
ajcp-5356	14	83	odumegwu	odumegwu	PROPN
ajcp-5356	14	84	ojukwu	ojukwu	PROPN
ajcp-5356	14	85	university	university	PROPN
ajcp-5356	14	86	,	,	PUNCT
ajcp-5356	14	87	uli	uli	PROPN
ajcp-5356	14	88	,	,	PUNCT
ajcp-5356	14	89	nigeria	nigeria	PROPN
ajcp-5356	14	90	5	5	NUM
ajcp-5356	14	91	department	department	NOUN
ajcp-5356	14	92	of	of	ADP
ajcp-5356	14	93	pharmacology	pharmacology	NOUN
ajcp-5356	14	94	,	,	PUNCT
ajcp-5356	14	95	chukwuemeka	chukwuemeka	PROPN
ajcp-5356	14	96	odumegwu	odumegwu	PROPN
ajcp-5356	14	97	ojukwu	ojukwu	PROPN
ajcp-5356	14	98	university	university	PROPN
ajcp-5356	14	99	,	,	PUNCT
ajcp-5356	14	100	nigeria	nigeria	PROPN
ajcp-5356	14	101	*	*	PUNCT
ajcp-5356	14	102	corresponding	correspond	VERB
ajcp-5356	14	103	author	author	NOUN
ajcp-5356	14	104	’s	’s	PART
ajcp-5356	14	105	e	e	NOUN
ajcp-5356	14	106	-	-	NOUN
ajcp-5356	14	107	mail	mail	NOUN
ajcp-5356	14	108	:	:	PUNCT
ajcp-5356	14	109	si.okonkwo@coou.edu.ng	si.okonkwo@coou.edu.ng	X
ajcp-5356	15	1	introduction	introduction	NOUN
ajcp-5356	15	2	the	the	DET
ajcp-5356	15	3	therapeutic	therapeutic	ADJ
ajcp-5356	15	4	potential	potential	NOUN
ajcp-5356	15	5	of	of	ADP
ajcp-5356	15	6	medicinal	medicinal	ADJ
ajcp-5356	15	7	plants	plant	NOUN
ajcp-5356	15	8	has	have	AUX
ajcp-5356	15	9	long	long	ADV
ajcp-5356	15	10	been	be	AUX
ajcp-5356	15	11	acknowledged	acknowledge	VERB
ajcp-5356	15	12	in	in	ADP
ajcp-5356	15	13	both	both	CCONJ
ajcp-5356	15	14	conventional	conventional	ADJ
ajcp-5356	15	15	and	and	CCONJ
ajcp-5356	15	16	alternative	alternative	ADJ
ajcp-5356	15	17	medicine	medicine	NOUN
ajcp-5356	15	18	.	.	PUNCT
ajcp-5356	16	1	known	know	VERB
ajcp-5356	16	2	as	as	ADP
ajcp-5356	16	3	the	the	DET
ajcp-5356	16	4	“	"	PUNCT
ajcp-5356	16	5	king	king	NOUN
ajcp-5356	16	6	of	of	ADP
ajcp-5356	16	7	bitters	bitter	NOUN
ajcp-5356	16	8	,	,	PUNCT
ajcp-5356	16	9	”	"	PUNCT
ajcp-5356	16	10	andrographis	andrographis	NOUN
ajcp-5356	16	11	paniculata	paniculata	NOUN
ajcp-5356	16	12	(	(	PUNCT
ajcp-5356	16	13	burm	burm	PROPN
ajcp-5356	16	14	.	.	PUNCT
ajcp-5356	16	15	f.	f.	PROPN
ajcp-5356	16	16	)	)	PUNCT
ajcp-5356	16	17	wall	wall	PROPN
ajcp-5356	16	18	.	.	PUNCT
ajcp-5356	17	1	ex	ex	X
ajcp-5356	17	2	nees	nees	PROPN
ajcp-5356	17	3	(	(	PUNCT
ajcp-5356	17	4	acanthaceae	acanthaceae	PROPN
ajcp-5356	17	5	)	)	PUNCT
ajcp-5356	17	6	is	be	AUX
ajcp-5356	17	7	a	a	DET
ajcp-5356	17	8	plant	plant	NOUN
ajcp-5356	17	9	that	that	PRON
ajcp-5356	17	10	is	be	AUX
ajcp-5356	17	11	well	well	ADV
ajcp-5356	17	12	-	-	PUNCT
ajcp-5356	17	13	known	know	VERB
ajcp-5356	17	14	for	for	ADP
ajcp-5356	17	15	its	its	PRON
ajcp-5356	17	16	strong	strong	ADJ
ajcp-5356	17	17	anti	anti	ADJ
ajcp-5356	17	18	-	-	ADJ
ajcp-5356	17	19	inflammatory	inflammatory	ADJ
ajcp-5356	17	20	,	,	PUNCT
ajcp-5356	17	21	antiviral	antiviral	ADJ
ajcp-5356	17	22	,	,	PUNCT
ajcp-5356	17	23	and	and	CCONJ
ajcp-5356	17	24	anticancer	anticancer	NOUN
ajcp-5356	17	25	qualities	quality	NOUN
ajcp-5356	17	26	.	.	PUNCT
ajcp-5356	18	1	the	the	DET
ajcp-5356	18	2	main	main	ADJ
ajcp-5356	18	3	bioactive	bioactive	ADJ
ajcp-5356	18	4	substances	substance	NOUN
ajcp-5356	18	5	have	have	AUX
ajcp-5356	18	6	been	be	AUX
ajcp-5356	18	7	found	find	VERB
ajcp-5356	18	8	to	to	PART
ajcp-5356	18	9	have	have	VERB
ajcp-5356	18	10	anti	anti	ADJ
ajcp-5356	18	11	-	-	ADJ
ajcp-5356	18	12	inflammatory	inflammatory	ADJ
ajcp-5356	18	13	properties	property	NOUN
ajcp-5356	18	14	,	,	PUNCT
ajcp-5356	18	15	especially	especially	ADV
ajcp-5356	18	16	the	the	DET
ajcp-5356	18	17	labdane	labdane	NOUN
ajcp-5356	18	18	diterpenoids	diterpenoid	NOUN
ajcp-5356	18	19	neoandrographolide	neoandrographolide	NOUN
ajcp-5356	18	20	and	and	CCONJ
ajcp-5356	18	21	14	14	NUM
ajcp-5356	18	22	-	-	PUNCT
ajcp-5356	18	23	deoxy-11,12didehydroandrographolide	deoxy-11,12didehydroandrographolide	NOUN
ajcp-5356	18	24	.	.	PUNCT
ajcp-5356	19	1	although	although	SCONJ
ajcp-5356	19	2	inflammation	inflammation	NOUN
ajcp-5356	19	3	is	be	AUX
ajcp-5356	19	4	a	a	DET
ajcp-5356	19	5	protective	protective	ADJ
ajcp-5356	19	6	immune	immune	ADJ
ajcp-5356	19	7	response	response	NOUN
ajcp-5356	19	8	,	,	PUNCT
ajcp-5356	19	9	when	when	SCONJ
ajcp-5356	19	10	it	it	PRON
ajcp-5356	19	11	is	be	AUX
ajcp-5356	19	12	dysregulated	dysregulate	VERB
ajcp-5356	19	13	,	,	PUNCT
ajcp-5356	19	14	it	it	PRON
ajcp-5356	19	15	can	can	AUX
ajcp-5356	19	16	result	result	VERB
ajcp-5356	19	17	in	in	ADP
ajcp-5356	19	18	chronic	chronic	ADJ
ajcp-5356	19	19	conditions	condition	NOUN
ajcp-5356	19	20	such	such	ADJ
ajcp-5356	19	21	as	as	ADP
ajcp-5356	19	22	neurodegeneration	neurodegeneration	NOUN
ajcp-5356	19	23	,	,	PUNCT
ajcp-5356	19	24	inflammatory	inflammatory	ADJ
ajcp-5356	19	25	bowel	bowel	NOUN
ajcp-5356	19	26	disease	disease	NOUN
ajcp-5356	19	27	,	,	PUNCT
ajcp-5356	19	28	cardiovascular	cardiovascular	ADJ
ajcp-5356	19	29	disease	disease	NOUN
ajcp-5356	19	30	,	,	PUNCT
ajcp-5356	19	31	and	and	CCONJ
ajcp-5356	19	32	rheumatoid	rheumatoid	VERB
ajcp-5356	19	33	arthritis	arthritis	NOUN
ajcp-5356	19	34	.	.	PUNCT
ajcp-5356	20	1	despite	despite	SCONJ
ajcp-5356	20	2	their	their	PRON
ajcp-5356	20	3	effectiveness	effectiveness	NOUN
ajcp-5356	20	4	,	,	PUNCT
ajcp-5356	20	5	traditional	traditional	ADJ
ajcp-5356	20	6	anti	anti	ADJ
ajcp-5356	20	7	-	-	ADJ
ajcp-5356	20	8	inflammatory	inflammatory	ADJ
ajcp-5356	20	9	treatments	treatment	NOUN
ajcp-5356	20	10	like	like	ADP
ajcp-5356	20	11	nsaids	nsaid	NOUN
ajcp-5356	20	12	and	and	CCONJ
ajcp-5356	20	13	glucocorticoids	glucocorticoid	NOUN
ajcp-5356	20	14	have	have	VERB
ajcp-5356	20	15	low	low	ADJ
ajcp-5356	20	16	absorption	absorption	NOUN
ajcp-5356	20	17	,	,	PUNCT
ajcp-5356	20	18	off	off	ADP
ajcp-5356	20	19	-	-	PUNCT
ajcp-5356	20	20	target	target	NOUN
ajcp-5356	20	21	toxicity	toxicity	NOUN
ajcp-5356	20	22	,	,	PUNCT
ajcp-5356	20	23	and	and	CCONJ
ajcp-5356	20	24	systemic	systemic	ADJ
ajcp-5356	20	25	adverse	adverse	ADJ
ajcp-5356	20	26	effects	effect	NOUN
ajcp-5356	20	27	.	.	PUNCT
ajcp-5356	21	1	a	a	DET
ajcp-5356	21	2	revolutionary	revolutionary	ADJ
ajcp-5356	21	3	answer	answer	NOUN
ajcp-5356	21	4	is	be	AUX
ajcp-5356	21	5	provided	provide	VERB
ajcp-5356	21	6	by	by	ADP
ajcp-5356	21	7	nano	nano	NOUN
ajcp-5356	21	8	-	-	PUNCT
ajcp-5356	21	9	encapsulation	encapsulation	NOUN
ajcp-5356	21	10	employing	employ	VERB
ajcp-5356	21	11	biopolymers	biopolymer	NOUN
ajcp-5356	21	12	such	such	ADJ
ajcp-5356	21	13	as	as	ADP
ajcp-5356	21	14	chitosan	chitosan	NOUN
ajcp-5356	21	15	.	.	PUNCT
ajcp-5356	22	1	because	because	SCONJ
ajcp-5356	22	2	it	it	PRON
ajcp-5356	22	3	is	be	AUX
ajcp-5356	22	4	mucoadhesive	mucoadhesive	ADJ
ajcp-5356	22	5	,	,	PUNCT
ajcp-5356	22	6	biocompatible	biocompatible	ADJ
ajcp-5356	22	7	,	,	PUNCT
ajcp-5356	22	8	and	and	CCONJ
ajcp-5356	22	9	biodegradable	biodegradable	ADJ
ajcp-5356	22	10	,	,	PUNCT
ajcp-5356	22	11	chitosan	chitosan	NOUN
ajcp-5356	22	12	is	be	AUX
ajcp-5356	22	13	a	a	DET
ajcp-5356	22	14	great	great	ADJ
ajcp-5356	22	15	option	option	NOUN
ajcp-5356	22	16	for	for	ADP
ajcp-5356	22	17	targeted	targeted	ADJ
ajcp-5356	22	18	and	and	CCONJ
ajcp-5356	22	19	long	long	ADV
ajcp-5356	22	20	-	-	PUNCT
ajcp-5356	22	21	lasting	last	VERB
ajcp-5356	22	22	medication	medication	NOUN
ajcp-5356	22	23	distribution	distribution	NOUN
ajcp-5356	22	24	.	.	PUNCT
ajcp-5356	23	1	real	real	ADJ
ajcp-5356	23	2	-	-	PUNCT
ajcp-5356	23	3	time	time	NOUN
ajcp-5356	23	4	evaluation	evaluation	NOUN
ajcp-5356	23	5	of	of	ADP
ajcp-5356	23	6	inflammatory	inflammatory	ADJ
ajcp-5356	23	7	resolution	resolution	NOUN
ajcp-5356	23	8	is	be	AUX
ajcp-5356	23	9	made	make	VERB
ajcp-5356	23	10	possible	possible	ADJ
ajcp-5356	23	11	by	by	ADP
ajcp-5356	23	12	integrating	integrate	VERB
ajcp-5356	23	13	sonography	sonography	NOUN
ajcp-5356	23	14	,	,	PUNCT
ajcp-5356	23	15	and	and	CCONJ
ajcp-5356	23	16	biochemical	biochemical	ADJ
ajcp-5356	23	17	markers	marker	NOUN
ajcp-5356	23	18	offer	offer	VERB
ajcp-5356	23	19	information	information	NOUN
ajcp-5356	23	20	on	on	ADP
ajcp-5356	23	21	the	the	DET
ajcp-5356	23	22	effectiveness	effectiveness	NOUN
ajcp-5356	23	23	of	of	ADP
ajcp-5356	23	24	systemic	systemic	ADJ
ajcp-5356	23	25	therapy	therapy	NOUN
ajcp-5356	23	26	.	.	PUNCT
ajcp-5356	24	1	validating	validate	VERB
ajcp-5356	24	2	compound	compound	NOUN
ajcp-5356	24	3	identity	identity	NOUN
ajcp-5356	24	4	,	,	PUNCT
ajcp-5356	24	5	encapsulation	encapsulation	NOUN
ajcp-5356	24	6	effectiveness	effectiveness	NOUN
ajcp-5356	24	7	,	,	PUNCT
ajcp-5356	24	8	and	and	CCONJ
ajcp-5356	24	9	medication	medication	NOUN
ajcp-5356	24	10	release	release	NOUN
ajcp-5356	24	11	dynamics	dynamic	NOUN
ajcp-5356	24	12	all	all	PRON
ajcp-5356	24	13	heavily	heavily	ADV
ajcp-5356	24	14	rely	rely	VERB
ajcp-5356	24	15	on	on	ADP
ajcp-5356	24	16	analytical	analytical	ADJ
ajcp-5356	24	17	chemistry	chemistry	NOUN
ajcp-5356	24	18	.	.	PUNCT
ajcp-5356	25	1	literature	literature	PROPN
ajcp-5356	25	2	review	review	VERB
ajcp-5356	25	3	the	the	DET
ajcp-5356	25	4	difficulties	difficulty	NOUN
ajcp-5356	25	5	of	of	ADP
ajcp-5356	25	6	drug	drug	NOUN
ajcp-5356	25	7	solubility	solubility	NOUN
ajcp-5356	25	8	,	,	PUNCT
ajcp-5356	25	9	bioavailability	bioavailability	NOUN
ajcp-5356	25	10	,	,	PUNCT
ajcp-5356	25	11	and	and	CCONJ
ajcp-5356	25	12	pharmacokinetics	pharmacokinetic	NOUN
ajcp-5356	25	13	are	be	AUX
ajcp-5356	25	14	being	be	AUX
ajcp-5356	25	15	addressed	address	VERB
ajcp-5356	25	16	by	by	ADP
ajcp-5356	25	17	the	the	DET
ajcp-5356	25	18	growing	grow	VERB
ajcp-5356	25	19	formulation	formulation	NOUN
ajcp-5356	25	20	of	of	ADP
ajcp-5356	25	21	natural	natural	ADJ
ajcp-5356	25	22	materials	material	NOUN
ajcp-5356	25	23	into	into	ADP
ajcp-5356	25	24	nanocarriers	nanocarrier	NOUN
ajcp-5356	25	25	.	.	PUNCT
ajcp-5356	26	1	andrographis	andrographis	PRON
ajcp-5356	26	2	paniculata	paniculata	NOUN
ajcp-5356	26	3	’s	’s	PART
ajcp-5356	26	4	wide	wide	ADJ
ajcp-5356	26	5	range	range	NOUN
ajcp-5356	26	6	of	of	ADP
ajcp-5356	26	7	pharmacological	pharmacological	ADJ
ajcp-5356	26	8	effects	effect	NOUN
ajcp-5356	26	9	has	have	AUX
ajcp-5356	26	10	garnered	garner	VERB
ajcp-5356	26	11	considerable	considerable	ADJ
ajcp-5356	26	12	research	research	NOUN
ajcp-5356	26	13	interest	interest	NOUN
ajcp-5356	26	14	.	.	PUNCT
ajcp-5356	27	1	its	its	PRON
ajcp-5356	27	2	main	main	ADJ
ajcp-5356	27	3	diterpenoid	diterpenoid	ADJ
ajcp-5356	27	4	,	,	PUNCT
ajcp-5356	27	5	andrographolide	andrographolide	ADV
ajcp-5356	27	6	,	,	PUNCT
ajcp-5356	27	7	has	have	AUX
ajcp-5356	27	8	been	be	AUX
ajcp-5356	27	9	shown	show	VERB
ajcp-5356	27	10	in	in	ADP
ajcp-5356	27	11	studies	study	NOUN
ajcp-5356	27	12	to	to	PART
ajcp-5356	27	13	influence	influence	VERB
ajcp-5356	27	14	inflammation	inflammation	NOUN
ajcp-5356	27	15	by	by	ADP
ajcp-5356	27	16	inhibiting	inhibit	VERB
ajcp-5356	27	17	the	the	DET
ajcp-5356	27	18	nf	nf	ADJ
ajcp-5356	27	19	-	-	PUNCT
ajcp-5356	27	20	κb	κb	NOUN
ajcp-5356	27	21	signaling	signal	VERB
ajcp-5356	27	22	pathway	pathway	NOUN
ajcp-5356	27	23	,	,	PUNCT
ajcp-5356	27	24	which	which	PRON
ajcp-5356	27	25	in	in	ADP
ajcp-5356	27	26	turn	turn	NOUN
ajcp-5356	27	27	suppresses	suppress	VERB
ajcp-5356	27	28	pro	pro	ADJ
ajcp-5356	27	29	-	-	ADJ
ajcp-5356	27	30	inflammatory	inflammatory	ADJ
ajcp-5356	27	31	cytokines	cytokine	NOUN
ajcp-5356	27	32	like	like	ADP
ajcp-5356	27	33	tnf	tnf	PROPN
ajcp-5356	27	34	-	-	PUNCT
ajcp-5356	27	35	α	α	PROPN
ajcp-5356	27	36	and	and	CCONJ
ajcp-5356	27	37	il6	il6	PROPN
ajcp-5356	27	38	.	.	PUNCT
ajcp-5356	28	1	andrographolide	andrographolide	ADV
ajcp-5356	28	2	and	and	CCONJ
ajcp-5356	28	3	its	its	PRON
ajcp-5356	28	4	derivatives	derivative	NOUN
ajcp-5356	28	5	have	have	AUX
ajcp-5356	28	6	shown	show	VERB
ajcp-5356	28	7	therapeutic	therapeutic	ADJ
ajcp-5356	28	8	promise	promise	NOUN
ajcp-5356	28	9	in	in	ADP
ajcp-5356	28	10	models	model	NOUN
ajcp-5356	28	11	of	of	ADP
ajcp-5356	28	12	asthma	asthma	NOUN
ajcp-5356	28	13	,	,	PUNCT
ajcp-5356	28	14	arthritis	arthritis	NOUN
ajcp-5356	28	15	,	,	PUNCT
ajcp-5356	28	16	and	and	CCONJ
ajcp-5356	28	17	stroke	stroke	NOUN
ajcp-5356	28	18	.	.	PUNCT
ajcp-5356	29	1	lim	lim	PROPN
ajcp-5356	29	2	et	et	PROPN
ajcp-5356	29	3	al	al	PROPN
ajcp-5356	29	4	.	.	PROPN
ajcp-5356	30	1	(	(	PUNCT
ajcp-5356	30	2	2012	2012	NUM
ajcp-5356	30	3	)	)	PUNCT
ajcp-5356	30	4	described	describe	VERB
ajcp-5356	30	5	how	how	SCONJ
ajcp-5356	30	6	it	it	PRON
ajcp-5356	30	7	suppresses	suppress	VERB
ajcp-5356	30	8	inflammation	inflammation	NOUN
ajcp-5356	30	9	better	well	ADV
ajcp-5356	30	10	than	than	ADP
ajcp-5356	30	11	synthetic	synthetic	ADJ
ajcp-5356	30	12	medications	medication	NOUN
ajcp-5356	30	13	,	,	PUNCT
ajcp-5356	30	14	while	while	SCONJ
ajcp-5356	30	15	hancke	hancke	PRON
ajcp-5356	30	16	et	et	PROPN
ajcp-5356	30	17	al	al	PROPN
ajcp-5356	30	18	.	.	PROPN
ajcp-5356	31	1	(	(	PUNCT
ajcp-5356	31	2	2019	2019	NUM
ajcp-5356	31	3	)	)	PUNCT
ajcp-5356	31	4	showed	show	VERB
ajcp-5356	31	5	a	a	DET
ajcp-5356	31	6	considerable	considerable	ADJ
ajcp-5356	31	7	decrease	decrease	NOUN
ajcp-5356	31	8	of	of	ADP
ajcp-5356	31	9	cytokine	cytokine	ADJ
ajcp-5356	31	10	expression	expression	NOUN
ajcp-5356	31	11	.	.	PUNCT
ajcp-5356	32	1	its	its	PRON
ajcp-5356	32	2	low	low	ADJ
ajcp-5356	32	3	water	water	NOUN
ajcp-5356	32	4	solubility	solubility	NOUN
ajcp-5356	32	5	and	and	CCONJ
ajcp-5356	32	6	poor	poor	ADJ
ajcp-5356	32	7	systemic	systemic	ADJ
ajcp-5356	32	8	retention	retention	NOUN
ajcp-5356	32	9	,	,	PUNCT
ajcp-5356	32	10	however	however	ADV
ajcp-5356	32	11	,	,	PUNCT
ajcp-5356	32	12	have	have	AUX
ajcp-5356	32	13	hampered	hamper	VERB
ajcp-5356	32	14	its	its	PRON
ajcp-5356	32	15	pa	pa	PROPN
ajcp-5356	32	16	ge	ge	PROPN
ajcp-5356	32	17	49	49	NUM
ajcp-5356	32	18	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-5356	32	19	am	be	AUX
ajcp-5356	32	20	.	.	PUNCT
ajcp-5356	33	1	j.	j.	PROPN
ajcp-5356	33	2	chem	chem	PROPN
ajcp-5356	33	3	.	.	PUNCT
ajcp-5356	34	1	pharm	pharm	PROPN
ajcp-5356	34	2	.	.	PUNCT
ajcp-5356	35	1	4(1	4(1	NOUN
ajcp-5356	35	2	)	)	PUNCT
ajcp-5356	36	1	48	48	NUM
ajcp-5356	36	2	-	-	SYM
ajcp-5356	36	3	53	53	NUM
ajcp-5356	36	4	,	,	PUNCT
ajcp-5356	36	5	2025	2025	NUM
ajcp-5356	36	6	therapeutic	therapeutic	ADJ
ajcp-5356	36	7	utility	utility	NOUN
ajcp-5356	36	8	.	.	PUNCT
ajcp-5356	37	1	for	for	ADP
ajcp-5356	37	2	the	the	DET
ajcp-5356	37	3	efficient	efficient	ADJ
ajcp-5356	37	4	delivery	delivery	NOUN
ajcp-5356	37	5	of	of	ADP
ajcp-5356	37	6	these	these	DET
ajcp-5356	37	7	bioactives	bioactive	NOUN
ajcp-5356	37	8	,	,	PUNCT
ajcp-5356	37	9	nanotechnology	nanotechnology	NOUN
ajcp-5356	37	10	provides	provide	VERB
ajcp-5356	37	11	novel	novel	ADJ
ajcp-5356	37	12	platforms	platform	NOUN
ajcp-5356	37	13	including	include	VERB
ajcp-5356	37	14	hydrogels	hydrogel	NOUN
ajcp-5356	37	15	,	,	PUNCT
ajcp-5356	37	16	dendrimers	dendrimer	NOUN
ajcp-5356	37	17	,	,	PUNCT
ajcp-5356	37	18	liposomes	liposome	NOUN
ajcp-5356	37	19	,	,	PUNCT
ajcp-5356	37	20	and	and	CCONJ
ajcp-5356	37	21	nanoparticles	nanoparticle	NOUN
ajcp-5356	37	22	.	.	PUNCT
ajcp-5356	38	1	targeting	target	VERB
ajcp-5356	38	2	inflammatory	inflammatory	ADJ
ajcp-5356	38	3	tissues	tissue	NOUN
ajcp-5356	38	4	requires	require	VERB
ajcp-5356	38	5	encapsulation	encapsulation	NOUN
ajcp-5356	38	6	in	in	ADP
ajcp-5356	38	7	chitosan	chitosan	NOUN
ajcp-5356	38	8	,	,	PUNCT
ajcp-5356	38	9	which	which	PRON
ajcp-5356	38	10	improves	improve	VERB
ajcp-5356	38	11	drug	drug	NOUN
ajcp-5356	38	12	stability	stability	NOUN
ajcp-5356	38	13	,	,	PUNCT
ajcp-5356	38	14	cellular	cellular	ADJ
ajcp-5356	38	15	absorption	absorption	NOUN
ajcp-5356	38	16	,	,	PUNCT
ajcp-5356	38	17	and	and	CCONJ
ajcp-5356	38	18	controlled	control	VERB
ajcp-5356	38	19	release	release	NOUN
ajcp-5356	38	20	.	.	PUNCT
ajcp-5356	39	1	materials	material	NOUN
ajcp-5356	39	2	and	and	CCONJ
ajcp-5356	39	3	methods	method	NOUN
ajcp-5356	39	4	plant	plant	NOUN
ajcp-5356	39	5	collection	collection	NOUN
ajcp-5356	39	6	and	and	CCONJ
ajcp-5356	39	7	extraction	extraction	NOUN
ajcp-5356	39	8	the	the	DET
ajcp-5356	39	9	leaves	leave	NOUN
ajcp-5356	39	10	of	of	ADP
ajcp-5356	39	11	andrographis	andrographis	PRON
ajcp-5356	39	12	paniculata	paniculata	NOUN
ajcp-5356	39	13	were	be	AUX
ajcp-5356	39	14	crushed	crush	VERB
ajcp-5356	39	15	after	after	ADP
ajcp-5356	39	16	being	be	AUX
ajcp-5356	39	17	shade	shade	NOUN
ajcp-5356	39	18	-	-	PUNCT
ajcp-5356	39	19	dried	dry	VERB
ajcp-5356	39	20	.	.	PUNCT
ajcp-5356	40	1	ethanol	ethanol	NOUN
ajcp-5356	40	2	maceration	maceration	NOUN
ajcp-5356	40	3	,	,	PUNCT
ajcp-5356	40	4	liquidliquid	liquidliquid	ADJ
ajcp-5356	40	5	extraction	extraction	NOUN
ajcp-5356	40	6	,	,	PUNCT
ajcp-5356	40	7	and	and	CCONJ
ajcp-5356	40	8	soxhlet	soxhlet	ADJ
ajcp-5356	40	9	extraction	extraction	NOUN
ajcp-5356	40	10	were	be	AUX
ajcp-5356	40	11	the	the	DET
ajcp-5356	40	12	three	three	NUM
ajcp-5356	40	13	extraction	extraction	NOUN
ajcp-5356	40	14	methods	method	NOUN
ajcp-5356	40	15	employed	employ	VERB
ajcp-5356	40	16	.	.	PUNCT
ajcp-5356	41	1	liquid	liquid	NOUN
ajcp-5356	41	2	-	-	PUNCT
ajcp-5356	41	3	liquid	liquid	NOUN
ajcp-5356	41	4	extraction	extraction	NOUN
ajcp-5356	41	5	was	be	AUX
ajcp-5356	41	6	used	use	VERB
ajcp-5356	41	7	to	to	PART
ajcp-5356	41	8	achieve	achieve	VERB
ajcp-5356	41	9	the	the	DET
ajcp-5356	41	10	highest	high	ADJ
ajcp-5356	41	11	concentration	concentration	NOUN
ajcp-5356	41	12	of	of	ADP
ajcp-5356	41	13	active	active	ADJ
ajcp-5356	41	14	isolates	isolate	NOUN
ajcp-5356	41	15	(	(	PUNCT
ajcp-5356	41	16	56	56	NUM
ajcp-5356	41	17	mg	mg	NOUN
ajcp-5356	41	18	)	)	PUNCT
ajcp-5356	41	19	.	.	PUNCT
ajcp-5356	42	1	isolation	isolation	NOUN
ajcp-5356	42	2	and	and	CCONJ
ajcp-5356	42	3	characterization	characterization	NOUN
ajcp-5356	42	4	of	of	ADP
ajcp-5356	42	5	diterpenoids	diterpenoid	NOUN
ajcp-5356	42	6	key	key	PROPN
ajcp-5356	42	7	diterpenoids	diterpenoid	NOUN
ajcp-5356	42	8	were	be	AUX
ajcp-5356	42	9	isolated	isolate	VERB
ajcp-5356	42	10	using	using	NOUN
ajcp-5356	42	11	silica	silica	NOUN
ajcp-5356	42	12	gel	gel	NOUN
ajcp-5356	42	13	column	column	NOUN
ajcp-5356	42	14	chromatography	chromatography	NOUN
ajcp-5356	42	15	after	after	SCONJ
ajcp-5356	42	16	andrographis	andrographis	PRON
ajcp-5356	42	17	paniculata	paniculata	ADJ
ajcp-5356	42	18	leaves	leave	NOUN
ajcp-5356	42	19	were	be	AUX
ajcp-5356	42	20	extracted	extract	VERB
ajcp-5356	42	21	with	with	ADP
ajcp-5356	42	22	ethanol	ethanol	NOUN
ajcp-5356	42	23	.	.	PUNCT
ajcp-5356	43	1	a	a	DET
ajcp-5356	43	2	rotating	rotate	VERB
ajcp-5356	43	3	evaporator	evaporator	NOUN
ajcp-5356	43	4	was	be	AUX
ajcp-5356	43	5	initially	initially	ADV
ajcp-5356	43	6	used	use	VERB
ajcp-5356	43	7	to	to	PART
ajcp-5356	43	8	concentrate	concentrate	VERB
ajcp-5356	43	9	the	the	DET
ajcp-5356	43	10	extract	extract	NOUN
ajcp-5356	43	11	at	at	ADP
ajcp-5356	43	12	a	a	DET
ajcp-5356	43	13	lower	low	ADJ
ajcp-5356	43	14	pressure	pressure	NOUN
ajcp-5356	43	15	.	.	PUNCT
ajcp-5356	44	1	based	base	VERB
ajcp-5356	44	2	on	on	ADP
ajcp-5356	44	3	polarity	polarity	NOUN
ajcp-5356	44	4	,	,	PUNCT
ajcp-5356	44	5	fractionation	fractionation	NOUN
ajcp-5356	44	6	was	be	AUX
ajcp-5356	44	7	performed	perform	VERB
ajcp-5356	44	8	using	use	VERB
ajcp-5356	44	9	solvent	solvent	ADJ
ajcp-5356	44	10	gradients	gradient	NOUN
ajcp-5356	44	11	(	(	PUNCT
ajcp-5356	44	12	methanol	methanol	NOUN
ajcp-5356	44	13	,	,	PUNCT
ajcp-5356	44	14	ethyl	ethyl	PROPN
ajcp-5356	44	15	acetate	acetate	NOUN
ajcp-5356	44	16	,	,	PUNCT
ajcp-5356	44	17	and	and	CCONJ
ajcp-5356	44	18	hexane	hexane	NOUN
ajcp-5356	44	19	)	)	PUNCT
ajcp-5356	44	20	.	.	PUNCT
ajcp-5356	45	1	thin	thin	ADJ
ajcp-5356	45	2	-	-	PUNCT
ajcp-5356	45	3	layer	layer	NOUN
ajcp-5356	45	4	chromatography	chromatography	NOUN
ajcp-5356	45	5	(	(	PUNCT
ajcp-5356	45	6	tlc	tlc	NOUN
ajcp-5356	45	7	)	)	PUNCT
ajcp-5356	45	8	was	be	AUX
ajcp-5356	45	9	used	use	VERB
ajcp-5356	45	10	to	to	PART
ajcp-5356	45	11	monitor	monitor	VERB
ajcp-5356	45	12	the	the	DET
ajcp-5356	45	13	separation	separation	NOUN
ajcp-5356	45	14	and	and	CCONJ
ajcp-5356	45	15	collect	collect	VERB
ajcp-5356	45	16	and	and	CCONJ
ajcp-5356	45	17	purify	purify	VERB
ajcp-5356	45	18	distinct	distinct	ADJ
ajcp-5356	45	19	bands	band	NOUN
ajcp-5356	45	20	that	that	PRON
ajcp-5356	45	21	matched	match	VERB
ajcp-5356	45	22	known	know	VERB
ajcp-5356	45	23	diterpenoids	diterpenoid	NOUN
ajcp-5356	45	24	.	.	PUNCT
ajcp-5356	46	1	two	two	NUM
ajcp-5356	46	2	primary	primary	ADJ
ajcp-5356	46	3	compounds—14	compounds—14	NOUN
ajcp-5356	46	4	-	-	PUNCT
ajcp-5356	46	5	deoxy-11,12didehydroandrographolide	deoxy-11,12didehydroandrographolide	NOUN
ajcp-5356	46	6	and	and	CCONJ
ajcp-5356	46	7	neoandrographolide	neoandrographolide	NOUN
ajcp-5356	46	8	—	—	PUNCT
ajcp-5356	46	9	were	be	AUX
ajcp-5356	46	10	identified	identify	VERB
ajcp-5356	46	11	.	.	PUNCT
ajcp-5356	47	1	these	these	PRON
ajcp-5356	47	2	were	be	AUX
ajcp-5356	47	3	recrystallized	recrystallize	VERB
ajcp-5356	47	4	from	from	ADP
ajcp-5356	47	5	ethanol	ethanol	NOUN
ajcp-5356	47	6	to	to	PART
ajcp-5356	47	7	obtain	obtain	VERB
ajcp-5356	47	8	analytically	analytically	ADV
ajcp-5356	47	9	pure	pure	ADJ
ajcp-5356	47	10	samples	sample	NOUN
ajcp-5356	47	11	.	.	PUNCT
ajcp-5356	48	1	characterization	characterization	NOUN
ajcp-5356	48	2	was	be	AUX
ajcp-5356	48	3	performed	perform	VERB
ajcp-5356	48	4	using	use	VERB
ajcp-5356	48	5	:	:	PUNCT
ajcp-5356	48	6	uv	uv	NOUN
ajcp-5356	48	7	-	-	PUNCT
ajcp-5356	48	8	visible	visible	ADJ
ajcp-5356	48	9	spectroscopy	spectroscopy	NOUN
ajcp-5356	48	10	peaks	peak	NOUN
ajcp-5356	48	11	were	be	AUX
ajcp-5356	48	12	observed	observe	VERB
ajcp-5356	48	13	at	at	ADP
ajcp-5356	48	14	375	375	NUM
ajcp-5356	48	15	nm	nm	NOUN
ajcp-5356	48	16	(	(	PUNCT
ajcp-5356	48	17	neoandrographolide	neoandrographolide	NOUN
ajcp-5356	48	18	)	)	PUNCT
ajcp-5356	48	19	and	and	CCONJ
ajcp-5356	48	20	350	350	NUM
ajcp-5356	48	21	nm	nm	NOUN
ajcp-5356	48	22	(	(	PUNCT
ajcp-5356	48	23	14	14	NUM
ajcp-5356	48	24	-	-	PUNCT
ajcp-5356	48	25	deoxy-11,12	deoxy-11,12	NOUN
ajcp-5356	48	26	-	-	PUNCT
ajcp-5356	48	27	didehydroandrographolide	didehydroandrographolide	NOUN
ajcp-5356	48	28	)	)	PUNCT
ajcp-5356	48	29	,	,	PUNCT
ajcp-5356	48	30	consistent	consistent	ADJ
ajcp-5356	48	31	with	with	ADP
ajcp-5356	48	32	conjugated	conjugated	ADJ
ajcp-5356	48	33	double	double	ADJ
ajcp-5356	48	34	bond	bond	NOUN
ajcp-5356	48	35	systems	system	NOUN
ajcp-5356	48	36	.	.	PUNCT
ajcp-5356	49	1	fourier	fourier	PROPN
ajcp-5356	49	2	transform	transform	VERB
ajcp-5356	49	3	infrared	infrared	ADJ
ajcp-5356	49	4	spectroscopy	spectroscopy	NOUN
ajcp-5356	49	5	(	(	PUNCT
ajcp-5356	49	6	ftir	ftir	NOUN
ajcp-5356	49	7	)	)	PUNCT
ajcp-5356	49	8	key	key	ADJ
ajcp-5356	49	9	functional	functional	ADJ
ajcp-5356	49	10	groups	group	NOUN
ajcp-5356	49	11	such	such	ADJ
ajcp-5356	49	12	as	as	ADP
ajcp-5356	49	13	-oh	-oh	NOUN
ajcp-5356	49	14	(	(	PUNCT
ajcp-5356	49	15	3300	3300	NUM
ajcp-5356	49	16	cm⁻¹	cm⁻¹	NOUN
ajcp-5356	49	17	)	)	PUNCT
ajcp-5356	49	18	,	,	PUNCT
ajcp-5356	50	1	c	c	X
ajcp-5356	50	2	=	=	X
ajcp-5356	50	3	o	o	X
ajcp-5356	50	4	(	(	PUNCT
ajcp-5356	50	5	1740	1740	NUM
ajcp-5356	50	6	cm⁻¹	cm⁻¹	NOUN
ajcp-5356	50	7	)	)	PUNCT
ajcp-5356	50	8	,	,	PUNCT
ajcp-5356	50	9	and	and	CCONJ
ajcp-5356	50	10	c	c	X
ajcp-5356	50	11	=	=	SYM
ajcp-5356	50	12	c	c	X
ajcp-5356	50	13	(	(	PUNCT
ajcp-5356	50	14	1650	1650	NUM
ajcp-5356	50	15	cm⁻¹	cm⁻¹	NOUN
ajcp-5356	50	16	)	)	PUNCT
ajcp-5356	50	17	were	be	AUX
ajcp-5356	50	18	confirmed	confirm	VERB
ajcp-5356	50	19	.	.	PUNCT
ajcp-5356	51	1	proton	proton	NOUN
ajcp-5356	51	2	nuclear	nuclear	PROPN
ajcp-5356	51	3	magnetic	magnetic	ADJ
ajcp-5356	51	4	resonance	resonance	NOUN
ajcp-5356	51	5	(	(	PUNCT
ajcp-5356	51	6	¹h	¹h	NOUN
ajcp-5356	51	7	-	-	PUNCT
ajcp-5356	51	8	nmr	nmr	NOUN
ajcp-5356	51	9	)	)	PUNCT
ajcp-5356	51	10	spectra	spectra	NOUN
ajcp-5356	51	11	indicated	indicate	VERB
ajcp-5356	51	12	characteristic	characteristic	ADJ
ajcp-5356	51	13	signals	signal	NOUN
ajcp-5356	51	14	in	in	ADP
ajcp-5356	51	15	the	the	DET
ajcp-5356	51	16	range	range	NOUN
ajcp-5356	51	17	of	of	ADP
ajcp-5356	51	18	δ	δ	PROPN
ajcp-5356	51	19	6.4–7.6	6.4–7.6	PROPN
ajcp-5356	51	20	ppm	ppm	VERB
ajcp-5356	51	21	for	for	ADP
ajcp-5356	51	22	olefinic	olefinic	ADJ
ajcp-5356	51	23	protons	proton	NOUN
ajcp-5356	51	24	and	and	CCONJ
ajcp-5356	52	1	δ	δ	PROPN
ajcp-5356	52	2	3.5–4.2	3.5–4.2	NOUN
ajcp-5356	52	3	ppm	ppm	NOUN
ajcp-5356	52	4	for	for	ADP
ajcp-5356	52	5	hydroxyl	hydroxyl	NOUN
ajcp-5356	52	6	groups	group	NOUN
ajcp-5356	52	7	.	.	PUNCT
ajcp-5356	53	1	gas	gas	NOUN
ajcp-5356	53	2	chromatography	chromatography	NOUN
ajcp-5356	53	3	-	-	PUNCT
ajcp-5356	53	4	mass	mass	NOUN
ajcp-5356	53	5	spectrometry	spectrometry	NOUN
ajcp-5356	53	6	(	(	PUNCT
ajcp-5356	53	7	gc	gc	PROPN
ajcp-5356	53	8	-	-	PUNCT
ajcp-5356	53	9	ms	ms	NOUN
ajcp-5356	53	10	)	)	PUNCT
ajcp-5356	53	11	provided	provide	VERB
ajcp-5356	53	12	molecular	molecular	ADJ
ajcp-5356	53	13	ion	ion	NOUN
ajcp-5356	53	14	peaks	peak	NOUN
ajcp-5356	53	15	at	at	ADP
ajcp-5356	53	16	m	m	PROPN
ajcp-5356	53	17	/	/	SYM
ajcp-5356	53	18	z	z	PROPN
ajcp-5356	53	19	348	348	NUM
ajcp-5356	53	20	and	and	CCONJ
ajcp-5356	53	21	480	480	NUM
ajcp-5356	53	22	,	,	PUNCT
ajcp-5356	53	23	corresponding	correspond	VERB
ajcp-5356	53	24	to	to	ADP
ajcp-5356	53	25	the	the	DET
ajcp-5356	53	26	molecular	molecular	ADJ
ajcp-5356	53	27	weights	weight	NOUN
ajcp-5356	53	28	of	of	ADP
ajcp-5356	53	29	14	14	NUM
ajcp-5356	53	30	-	-	PUNCT
ajcp-5356	53	31	deoxy11,12	deoxy11,12	NOUN
ajcp-5356	53	32	-	-	PUNCT
ajcp-5356	53	33	didehydroandrographolide	didehydroandrographolide	NOUN
ajcp-5356	53	34	and	and	CCONJ
ajcp-5356	53	35	neoandrographolide	neoandrographolide	NOUN
ajcp-5356	53	36	respectively	respectively	ADV
ajcp-5356	53	37	.	.	PUNCT
ajcp-5356	54	1	these	these	DET
ajcp-5356	54	2	characterization	characterization	NOUN
ajcp-5356	54	3	results	result	NOUN
ajcp-5356	54	4	ensured	ensure	VERB
ajcp-5356	54	5	that	that	SCONJ
ajcp-5356	54	6	the	the	DET
ajcp-5356	54	7	isolated	isolated	ADJ
ajcp-5356	54	8	compounds	compound	NOUN
ajcp-5356	54	9	were	be	AUX
ajcp-5356	54	10	structurally	structurally	ADV
ajcp-5356	54	11	pure	pure	ADJ
ajcp-5356	54	12	and	and	CCONJ
ajcp-5356	54	13	suitable	suitable	ADJ
ajcp-5356	54	14	for	for	ADP
ajcp-5356	54	15	further	further	ADJ
ajcp-5356	54	16	encapsulation	encapsulation	NOUN
ajcp-5356	54	17	studies	study	NOUN
ajcp-5356	54	18	.	.	PUNCT
ajcp-5356	55	1	nano	nano	NOUN
ajcp-5356	55	2	-	-	PUNCT
ajcp-5356	55	3	encapsulation	encapsulation	NOUN
ajcp-5356	55	4	utilizing	utilize	VERB
ajcp-5356	55	5	chitosan	chitosan	NOUN
ajcp-5356	55	6	’s	’s	PART
ajcp-5356	55	7	ability	ability	NOUN
ajcp-5356	55	8	to	to	PART
ajcp-5356	55	9	crosslink	crosslink	VERB
ajcp-5356	55	10	with	with	ADP
ajcp-5356	55	11	anions	anion	NOUN
ajcp-5356	55	12	to	to	PART
ajcp-5356	55	13	form	form	VERB
ajcp-5356	55	14	nanoparticles	nanoparticle	NOUN
ajcp-5356	55	15	,	,	PUNCT
ajcp-5356	55	16	the	the	DET
ajcp-5356	55	17	nano	nano	NOUN
ajcp-5356	55	18	-	-	PUNCT
ajcp-5356	55	19	encapsulation	encapsulation	NOUN
ajcp-5356	55	20	process	process	NOUN
ajcp-5356	55	21	was	be	AUX
ajcp-5356	55	22	executed	execute	VERB
ajcp-5356	55	23	using	use	VERB
ajcp-5356	55	24	the	the	DET
ajcp-5356	55	25	ionic	ionic	ADJ
ajcp-5356	55	26	gelation	gelation	NOUN
ajcp-5356	55	27	technique	technique	NOUN
ajcp-5356	55	28	.	.	PUNCT
ajcp-5356	56	1	chitosan	chitosan	PROPN
ajcp-5356	56	2	was	be	AUX
ajcp-5356	56	3	first	first	ADV
ajcp-5356	56	4	dissolved	dissolve	VERB
ajcp-5356	56	5	in	in	ADP
ajcp-5356	56	6	1	1	NUM
ajcp-5356	56	7	%	%	NOUN
ajcp-5356	56	8	acetic	acetic	ADJ
ajcp-5356	56	9	acid	acid	NOUN
ajcp-5356	56	10	and	and	CCONJ
ajcp-5356	56	11	magnetically	magnetically	ADV
ajcp-5356	56	12	agitated	agitated	ADJ
ajcp-5356	56	13	at	at	ADP
ajcp-5356	56	14	500	500	NUM
ajcp-5356	56	15	rpm	rpm	NOUN
ajcp-5356	56	16	to	to	PART
ajcp-5356	56	17	produce	produce	VERB
ajcp-5356	56	18	a	a	DET
ajcp-5356	56	19	homogenous	homogenous	ADJ
ajcp-5356	56	20	solution	solution	NOUN
ajcp-5356	56	21	.	.	PUNCT
ajcp-5356	57	1	the	the	DET
ajcp-5356	57	2	refined	refined	ADJ
ajcp-5356	57	3	diterpenoids	diterpenoid	NOUN
ajcp-5356	57	4	were	be	AUX
ajcp-5356	57	5	added	add	VERB
ajcp-5356	57	6	dropwise	dropwise	NOUN
ajcp-5356	57	7	to	to	ADP
ajcp-5356	57	8	the	the	DET
ajcp-5356	57	9	chitosan	chitosan	NOUN
ajcp-5356	57	10	solution	solution	NOUN
ajcp-5356	57	11	after	after	ADP
ajcp-5356	57	12	being	be	AUX
ajcp-5356	57	13	dissolved	dissolve	VERB
ajcp-5356	57	14	in	in	ADP
ajcp-5356	57	15	ethanol	ethanol	NOUN
ajcp-5356	57	16	.	.	PUNCT
ajcp-5356	58	1	the	the	DET
ajcp-5356	58	2	usage	usage	NOUN
ajcp-5356	58	3	of	of	ADP
ajcp-5356	58	4	sodium	sodium	NOUN
ajcp-5356	58	5	sulfate	sulfate	NOUN
ajcp-5356	58	6	(	(	PUNCT
ajcp-5356	58	7	na₂so₄	na₂so₄	ADV
ajcp-5356	58	8	)	)	PUNCT
ajcp-5356	58	9	produced	produce	VERB
ajcp-5356	58	10	crosslinking	crosslinking	NOUN
ajcp-5356	58	11	.	.	PUNCT
ajcp-5356	59	1	using	use	VERB
ajcp-5356	59	2	a	a	DET
ajcp-5356	59	3	probe	probe	NOUN
ajcp-5356	59	4	sonicator	sonicator	NOUN
ajcp-5356	59	5	,	,	PUNCT
ajcp-5356	59	6	sonication	sonication	NOUN
ajcp-5356	59	7	was	be	AUX
ajcp-5356	59	8	applied	apply	VERB
ajcp-5356	59	9	for	for	ADP
ajcp-5356	59	10	10	10	NUM
ajcp-5356	59	11	minutes	minute	NOUN
ajcp-5356	59	12	at	at	ADP
ajcp-5356	59	13	a	a	DET
ajcp-5356	59	14	frequency	frequency	NOUN
ajcp-5356	59	15	of	of	ADP
ajcp-5356	59	16	20	20	NUM
ajcp-5356	59	17	khz	khz	NOUN
ajcp-5356	59	18	to	to	PART
ajcp-5356	59	19	enhance	enhance	VERB
ajcp-5356	59	20	nanoparticle	nanoparticle	NOUN
ajcp-5356	59	21	formation	formation	NOUN
ajcp-5356	59	22	and	and	CCONJ
ajcp-5356	59	23	size	size	NOUN
ajcp-5356	59	24	reduction	reduction	NOUN
ajcp-5356	59	25	.	.	PUNCT
ajcp-5356	60	1	the	the	DET
ajcp-5356	60	2	suspension	suspension	NOUN
ajcp-5356	60	3	was	be	AUX
ajcp-5356	60	4	then	then	ADV
ajcp-5356	60	5	centrifuged	centrifuge	VERB
ajcp-5356	60	6	at	at	ADP
ajcp-5356	60	7	10,000	10,000	NUM
ajcp-5356	60	8	rpm	rpm	NOUN
ajcp-5356	60	9	for	for	ADP
ajcp-5356	60	10	30	30	NUM
ajcp-5356	60	11	minutes	minute	NOUN
ajcp-5356	60	12	.	.	PUNCT
ajcp-5356	61	1	to	to	PART
ajcp-5356	61	2	remove	remove	VERB
ajcp-5356	61	3	any	any	DET
ajcp-5356	61	4	unattached	unattached	ADJ
ajcp-5356	61	5	components	component	NOUN
ajcp-5356	61	6	,	,	PUNCT
ajcp-5356	61	7	the	the	DET
ajcp-5356	61	8	nanoparticles	nanoparticle	NOUN
ajcp-5356	61	9	were	be	AUX
ajcp-5356	61	10	washed	wash	VERB
ajcp-5356	61	11	twice	twice	ADV
ajcp-5356	61	12	with	with	ADP
ajcp-5356	61	13	deionized	deionize	VERB
ajcp-5356	61	14	water	water	NOUN
ajcp-5356	61	15	after	after	SCONJ
ajcp-5356	61	16	the	the	DET
ajcp-5356	61	17	supernatant	supernatant	NOUN
ajcp-5356	61	18	was	be	AUX
ajcp-5356	61	19	removed	remove	VERB
ajcp-5356	61	20	.	.	PUNCT
ajcp-5356	62	1	the	the	DET
ajcp-5356	62	2	resulting	result	VERB
ajcp-5356	62	3	nanoparticles	nanoparticle	NOUN
ajcp-5356	62	4	were	be	AUX
ajcp-5356	62	5	:	:	PUNCT
ajcp-5356	62	6	•	•	NOUN
ajcp-5356	62	7	freeze	freeze	NOUN
ajcp-5356	62	8	-	-	PUNCT
ajcp-5356	62	9	dried	dry	VERB
ajcp-5356	62	10	to	to	PART
ajcp-5356	62	11	obtain	obtain	VERB
ajcp-5356	62	12	a	a	DET
ajcp-5356	62	13	dry	dry	ADJ
ajcp-5356	62	14	powder	powder	NOUN
ajcp-5356	62	15	suitable	suitable	ADJ
ajcp-5356	62	16	for	for	ADP
ajcp-5356	62	17	longterm	longterm	ADJ
ajcp-5356	62	18	storage	storage	NOUN
ajcp-5356	62	19	.	.	PUNCT
ajcp-5356	63	1	•	•	ADP
ajcp-5356	63	2	characterized	characterize	VERB
ajcp-5356	63	3	by	by	ADP
ajcp-5356	63	4	transmission	transmission	NOUN
ajcp-5356	63	5	electron	electron	NOUN
ajcp-5356	63	6	microscopy	microscopy	NOUN
ajcp-5356	63	7	(	(	PUNCT
ajcp-5356	63	8	tem	tem	PROPN
ajcp-5356	63	9	)	)	PUNCT
ajcp-5356	63	10	,	,	PUNCT
ajcp-5356	63	11	revealing	reveal	VERB
ajcp-5356	63	12	spherical	spherical	ADJ
ajcp-5356	63	13	morphology	morphology	NOUN
ajcp-5356	63	14	with	with	ADP
ajcp-5356	63	15	particle	particle	NOUN
ajcp-5356	63	16	sizes	size	NOUN
ajcp-5356	63	17	ranging	range	VERB
ajcp-5356	63	18	from	from	ADP
ajcp-5356	63	19	80	80	NUM
ajcp-5356	63	20	to	to	PART
ajcp-5356	63	21	150	150	NUM
ajcp-5356	63	22	nm	nm	NOUN
ajcp-5356	63	23	.	.	PROPN
ajcp-5356	63	24	•	•	NUM
ajcp-5356	63	25	encapsulation	encapsulation	NOUN
ajcp-5356	63	26	efficiency	efficiency	NOUN
ajcp-5356	63	27	(	(	PUNCT
ajcp-5356	63	28	ee%	ee%	PROPN
ajcp-5356	63	29	)	)	PUNCT
ajcp-5356	63	30	was	be	AUX
ajcp-5356	63	31	calculated	calculate	VERB
ajcp-5356	63	32	as	as	SCONJ
ajcp-5356	63	33	follows	follow	VERB
ajcp-5356	63	34	:	:	PUNCT
ajcp-5356	63	35	ee=((total	ee=((total	ADJ
ajcp-5356	63	36	drug	drug	NOUN
ajcp-5356	63	37	-	-	PUNCT
ajcp-5356	63	38	free	free	ADJ
ajcp-5356	63	39	drug	drug	NOUN
ajcp-5356	63	40	in	in	ADP
ajcp-5356	63	41	supernatant))/	supernatant))/	NOUN
ajcp-5356	63	42	(	(	PUNCT
ajcp-5356	63	43	(	(	PUNCT
ajcp-5356	63	44	tota	tota	PROPN
ajcp-5356	63	45	drug	drug	NOUN
ajcp-5356	63	46	)	)	PUNCT
ajcp-5356	63	47	)	)	PUNCT
ajcp-5356	64	1	x	x	SYM
ajcp-5356	64	2	100	100	NUM
ajcp-5356	64	3	the	the	DET
ajcp-5356	64	4	ee%	ee%	NOUN
ajcp-5356	64	5	was	be	AUX
ajcp-5356	64	6	found	find	VERB
ajcp-5356	64	7	to	to	PART
ajcp-5356	64	8	be	be	AUX
ajcp-5356	64	9	82.5	82.5	NUM
ajcp-5356	64	10	%	%	NOUN
ajcp-5356	64	11	for	for	ADP
ajcp-5356	64	12	14	14	NUM
ajcp-5356	64	13	-	-	SYM
ajcp-5356	64	14	deoxy-11,12didehydroandrographolide	deoxy-11,12didehydroandrographolide	NUM
ajcp-5356	64	15	and	and	CCONJ
ajcp-5356	64	16	71.8	71.8	NUM
ajcp-5356	64	17	%	%	NOUN
ajcp-5356	64	18	for	for	ADP
ajcp-5356	64	19	the	the	DET
ajcp-5356	64	20	total	total	ADJ
ajcp-5356	64	21	diterpenoid	diterpenoid	ADJ
ajcp-5356	64	22	extract	extract	NOUN
ajcp-5356	64	23	.	.	PUNCT
ajcp-5356	65	1	as	as	ADP
ajcp-5356	65	2	a	a	DET
ajcp-5356	65	3	superior	superior	ADJ
ajcp-5356	65	4	biopolymer	biopolymer	NOUN
ajcp-5356	65	5	carrier	carrier	NOUN
ajcp-5356	65	6	for	for	ADP
ajcp-5356	65	7	phytochemical	phytochemical	ADJ
ajcp-5356	65	8	drug	drug	NOUN
ajcp-5356	65	9	delivery	delivery	NOUN
ajcp-5356	65	10	,	,	PUNCT
ajcp-5356	65	11	the	the	DET
ajcp-5356	65	12	chitosan	chitosan	NOUN
ajcp-5356	65	13	matrix	matrix	NOUN
ajcp-5356	65	14	permitted	permit	VERB
ajcp-5356	65	15	a	a	DET
ajcp-5356	65	16	sustained	sustained	ADJ
ajcp-5356	65	17	drug	drug	NOUN
ajcp-5356	65	18	release	release	NOUN
ajcp-5356	65	19	profile	profile	NOUN
ajcp-5356	65	20	,	,	PUNCT
ajcp-5356	65	21	offered	offer	VERB
ajcp-5356	65	22	stability	stability	NOUN
ajcp-5356	65	23	,	,	PUNCT
ajcp-5356	65	24	and	and	CCONJ
ajcp-5356	65	25	protected	protect	VERB
ajcp-5356	65	26	against	against	ADP
ajcp-5356	65	27	enzymatic	enzymatic	ADJ
ajcp-5356	65	28	degradation	degradation	NOUN
ajcp-5356	65	29	.	.	PUNCT
ajcp-5356	66	1	in	in	ADP
ajcp-5356	66	2	vitro	vitro	X
ajcp-5356	66	3	release	release	NOUN
ajcp-5356	66	4	study	study	NOUN
ajcp-5356	66	5	a	a	DET
ajcp-5356	66	6	dialysis	dialysis	NOUN
ajcp-5356	66	7	membrane	membrane	NOUN
ajcp-5356	66	8	diffusion	diffusion	NOUN
ajcp-5356	66	9	method	method	NOUN
ajcp-5356	66	10	was	be	AUX
ajcp-5356	66	11	used	use	VERB
ajcp-5356	66	12	to	to	PART
ajcp-5356	66	13	evaluate	evaluate	VERB
ajcp-5356	66	14	the	the	DET
ajcp-5356	66	15	nano	nano	NOUN
ajcp-5356	66	16	-	-	PUNCT
ajcp-5356	66	17	encapsulated	encapsulate	VERB
ajcp-5356	66	18	diterpenoids	diterpenoid	NOUN
ajcp-5356	66	19	’	'	PUNCT
ajcp-5356	66	20	time	time	NOUN
ajcp-5356	66	21	-	-	PUNCT
ajcp-5356	66	22	release	release	NOUN
ajcp-5356	66	23	profile	profile	NOUN
ajcp-5356	66	24	.	.	PUNCT
ajcp-5356	67	1	a	a	DET
ajcp-5356	67	2	known	know	VERB
ajcp-5356	67	3	quantity	quantity	NOUN
ajcp-5356	67	4	of	of	ADP
ajcp-5356	67	5	the	the	DET
ajcp-5356	67	6	nanoparticle	nanoparticle	NOUN
ajcp-5356	67	7	solution	solution	NOUN
ajcp-5356	67	8	(	(	PUNCT
ajcp-5356	67	9	equivalent	equivalent	ADJ
ajcp-5356	67	10	to	to	ADP
ajcp-5356	67	11	10	10	NUM
ajcp-5356	67	12	mg	mg	ADP
ajcp-5356	67	13	of	of	ADP
ajcp-5356	67	14	encapsulated	encapsulate	VERB
ajcp-5356	67	15	drug	drug	NOUN
ajcp-5356	67	16	)	)	PUNCT
ajcp-5356	67	17	was	be	AUX
ajcp-5356	67	18	placed	place	VERB
ajcp-5356	67	19	in	in	ADP
ajcp-5356	67	20	a	a	DET
ajcp-5356	67	21	dialysis	dialysis	NOUN
ajcp-5356	67	22	bag	bag	NOUN
ajcp-5356	67	23	(	(	PUNCT
ajcp-5356	67	24	mwco	mwco	NOUN
ajcp-5356	67	25	:	:	PUNCT
ajcp-5356	67	26	12–14	12–14	NUM
ajcp-5356	67	27	kda	kda	NOUN
ajcp-5356	67	28	)	)	PUNCT
ajcp-5356	67	29	and	and	CCONJ
ajcp-5356	67	30	immersed	immerse	VERB
ajcp-5356	67	31	in	in	ADP
ajcp-5356	67	32	100	100	NUM
ajcp-5356	67	33	ml	ml	NOUN
ajcp-5356	67	34	of	of	ADP
ajcp-5356	67	35	phosphate	phosphate	NOUN
ajcp-5356	67	36	-	-	PUNCT
ajcp-5356	67	37	buffered	buffer	VERB
ajcp-5356	67	38	saline	saline	NOUN
ajcp-5356	67	39	(	(	PUNCT
ajcp-5356	67	40	pbs	pbs	PROPN
ajcp-5356	67	41	,	,	PUNCT
ajcp-5356	67	42	ph	ph	NOUN
ajcp-5356	67	43	7.4	7.4	NUM
ajcp-5356	67	44	)	)	PUNCT
ajcp-5356	67	45	at	at	ADP
ajcp-5356	67	46	37	37	NUM
ajcp-5356	67	47	°	°	NOUN
ajcp-5356	67	48	c	c	NOUN
ajcp-5356	67	49	while	while	SCONJ
ajcp-5356	67	50	being	be	AUX
ajcp-5356	67	51	continuously	continuously	ADV
ajcp-5356	67	52	swirled	swirl	VERB
ajcp-5356	67	53	.	.	PUNCT
ajcp-5356	68	1	five	five	NUM
ajcp-5356	68	2	milliliter	milliliter	NOUN
ajcp-5356	68	3	aliquots	aliquot	NOUN
ajcp-5356	68	4	were	be	AUX
ajcp-5356	68	5	removed	remove	VERB
ajcp-5356	68	6	and	and	CCONJ
ajcp-5356	68	7	replaced	replace	VERB
ajcp-5356	68	8	with	with	ADP
ajcp-5356	68	9	fresh	fresh	ADJ
ajcp-5356	68	10	pbs	pbs	NOUN
ajcp-5356	68	11	at	at	ADP
ajcp-5356	68	12	predetermined	predetermine	VERB
ajcp-5356	68	13	intervals	interval	NOUN
ajcp-5356	68	14	(	(	PUNCT
ajcp-5356	68	15	0.5	0.5	NUM
ajcp-5356	68	16	,	,	PUNCT
ajcp-5356	68	17	1	1	NUM
ajcp-5356	68	18	,	,	PUNCT
ajcp-5356	68	19	2	2	NUM
ajcp-5356	68	20	,	,	PUNCT
ajcp-5356	68	21	3	3	NUM
ajcp-5356	68	22	,	,	PUNCT
ajcp-5356	68	23	and	and	CCONJ
ajcp-5356	68	24	4	4	NUM
ajcp-5356	68	25	hours	hour	NOUN
ajcp-5356	68	26	)	)	PUNCT
ajcp-5356	68	27	.	.	PUNCT
ajcp-5356	69	1	using	use	VERB
ajcp-5356	69	2	uv	uv	NOUN
ajcp-5356	69	3	-	-	PUNCT
ajcp-5356	69	4	vis	vis	X
ajcp-5356	69	5	spectrophotometry	spectrophotometry	NOUN
ajcp-5356	69	6	at	at	ADP
ajcp-5356	69	7	270	270	NUM
ajcp-5356	69	8	nm	nm	NOUN
ajcp-5356	69	9	and	and	CCONJ
ajcp-5356	69	10	a	a	DET
ajcp-5356	69	11	previously	previously	ADV
ajcp-5356	69	12	created	create	VERB
ajcp-5356	69	13	calibration	calibration	NOUN
ajcp-5356	69	14	curve	curve	NOUN
ajcp-5356	69	15	,	,	PUNCT
ajcp-5356	69	16	the	the	DET
ajcp-5356	69	17	amount	amount	NOUN
ajcp-5356	69	18	of	of	ADP
ajcp-5356	69	19	medication	medication	NOUN
ajcp-5356	69	20	released	release	VERB
ajcp-5356	69	21	was	be	AUX
ajcp-5356	69	22	measured	measure	VERB
ajcp-5356	69	23	.	.	PUNCT
ajcp-5356	70	1	the	the	DET
ajcp-5356	70	2	release	release	NOUN
ajcp-5356	70	3	pattern	pattern	NOUN
ajcp-5356	70	4	showed	show	VERB
ajcp-5356	70	5	a	a	DET
ajcp-5356	70	6	biphasic	biphasic	ADJ
ajcp-5356	70	7	profile	profile	NOUN
ajcp-5356	70	8	:	:	PUNCT
ajcp-5356	70	9	•	•	NUM
ajcp-5356	70	10	initial	initial	ADJ
ajcp-5356	70	11	burst	burst	ADJ
ajcp-5356	70	12	release	release	NOUN
ajcp-5356	70	13	in	in	ADP
ajcp-5356	70	14	the	the	DET
ajcp-5356	70	15	first	first	ADJ
ajcp-5356	70	16	hour	hour	NOUN
ajcp-5356	70	17	,	,	PUNCT
ajcp-5356	70	18	attributed	attribute	VERB
ajcp-5356	70	19	to	to	ADP
ajcp-5356	70	20	surface	surface	NOUN
ajcp-5356	70	21	-	-	PUNCT
ajcp-5356	70	22	adsorbed	adsorb	VERB
ajcp-5356	70	23	drug	drug	NOUN
ajcp-5356	70	24	molecules	molecule	NOUN
ajcp-5356	70	25	.	.	PUNCT
ajcp-5356	71	1	•	•	NUM
ajcp-5356	71	2	sustained	sustain	VERB
ajcp-5356	71	3	release	release	NOUN
ajcp-5356	71	4	phase	phase	NOUN
ajcp-5356	71	5	from	from	ADP
ajcp-5356	71	6	hour	hour	NOUN
ajcp-5356	71	7	2	2	NUM
ajcp-5356	71	8	to	to	ADP
ajcp-5356	71	9	4	4	NUM
ajcp-5356	71	10	,	,	PUNCT
ajcp-5356	71	11	indicative	indicative	ADJ
ajcp-5356	71	12	of	of	ADP
ajcp-5356	71	13	drug	drug	NOUN
ajcp-5356	71	14	diffusion	diffusion	NOUN
ajcp-5356	71	15	from	from	ADP
ajcp-5356	71	16	the	the	DET
ajcp-5356	71	17	chitosan	chitosan	ADJ
ajcp-5356	71	18	matrix	matrix	NOUN
ajcp-5356	71	19	.	.	PUNCT
ajcp-5356	72	1	the	the	DET
ajcp-5356	72	2	sustained	sustain	VERB
ajcp-5356	72	3	release	release	NOUN
ajcp-5356	72	4	is	be	AUX
ajcp-5356	72	5	critical	critical	ADJ
ajcp-5356	72	6	for	for	ADP
ajcp-5356	72	7	chronic	chronic	ADJ
ajcp-5356	72	8	inflammation	inflammation	NOUN
ajcp-5356	72	9	treatment	treatment	NOUN
ajcp-5356	72	10	,	,	PUNCT
ajcp-5356	72	11	minimizing	minimize	VERB
ajcp-5356	72	12	frequent	frequent	ADJ
ajcp-5356	72	13	dosing	dose	VERB
ajcp-5356	72	14	and	and	CCONJ
ajcp-5356	72	15	improving	improve	VERB
ajcp-5356	72	16	patient	patient	ADJ
ajcp-5356	72	17	compliance	compliance	NOUN
ajcp-5356	72	18	.	.	PUNCT
ajcp-5356	73	1	sonographic	sonographic	ADJ
ajcp-5356	73	2	imaging	imaging	PROPN
ajcp-5356	73	3	sonographic	sonographic	ADJ
ajcp-5356	73	4	assessment	assessment	NOUN
ajcp-5356	73	5	was	be	AUX
ajcp-5356	73	6	added	add	VERB
ajcp-5356	73	7	as	as	ADP
ajcp-5356	73	8	a	a	DET
ajcp-5356	73	9	non	non	ADJ
ajcp-5356	73	10	-	-	ADJ
ajcp-5356	73	11	invasive	invasive	ADJ
ajcp-5356	73	12	way	way	NOUN
ajcp-5356	73	13	to	to	PART
ajcp-5356	73	14	track	track	VERB
ajcp-5356	73	15	the	the	DET
ajcp-5356	73	16	level	level	NOUN
ajcp-5356	73	17	of	of	ADP
ajcp-5356	73	18	inflammation	inflammation	NOUN
ajcp-5356	73	19	in	in	ADP
ajcp-5356	73	20	vivo	vivo	NOUN
ajcp-5356	73	21	.	.	PUNCT
ajcp-5356	74	1	to	to	PART
ajcp-5356	74	2	establish	establish	VERB
ajcp-5356	74	3	a	a	DET
ajcp-5356	74	4	model	model	NOUN
ajcp-5356	74	5	of	of	ADP
ajcp-5356	74	6	localized	localized	ADJ
ajcp-5356	74	7	inflammation	inflammation	NOUN
ajcp-5356	74	8	,	,	PUNCT
ajcp-5356	74	9	carrageenan	carrageenan	NOUN
ajcp-5356	74	10	(	(	PUNCT
ajcp-5356	74	11	0.1	0.1	NUM
ajcp-5356	74	12	ml	ml	NOUN
ajcp-5356	74	13	of	of	ADP
ajcp-5356	74	14	1	1	NUM
ajcp-5356	74	15	%	%	NOUN
ajcp-5356	74	16	solution	solution	NOUN
ajcp-5356	74	17	)	)	PUNCT
ajcp-5356	74	18	was	be	AUX
ajcp-5356	74	19	injected	inject	VERB
ajcp-5356	74	20	into	into	ADP
ajcp-5356	74	21	the	the	DET
ajcp-5356	74	22	right	right	ADJ
ajcp-5356	74	23	hind	hind	NOUN
ajcp-5356	74	24	paw	paw	NOUN
ajcp-5356	74	25	of	of	ADP
ajcp-5356	74	26	adult	adult	PROPN
ajcp-5356	74	27	wistar	wistar	PROPN
ajcp-5356	74	28	rats	rat	NOUN
ajcp-5356	74	29	(	(	PUNCT
ajcp-5356	74	30	n	n	NOUN
ajcp-5356	74	31	=	=	NUM
ajcp-5356	74	32	24	24	NUM
ajcp-5356	74	33	)	)	PUNCT
ajcp-5356	74	34	.	.	PUNCT
ajcp-5356	75	1	a	a	DET
ajcp-5356	75	2	mindray	mindray	PROPN
ajcp-5356	75	3	z5	z5	PROPN
ajcp-5356	75	4	ultrasound	ultrasound	NOUN
ajcp-5356	75	5	equipment	equipment	NOUN
ajcp-5356	75	6	with	with	ADP
ajcp-5356	75	7	a	a	DET
ajcp-5356	75	8	7.5	7.5	NUM
ajcp-5356	75	9	mhz	mhz	NOUN
ajcp-5356	75	10	linear	linear	NOUN
ajcp-5356	75	11	probe	probe	NOUN
ajcp-5356	75	12	was	be	AUX
ajcp-5356	75	13	used	use	VERB
ajcp-5356	75	14	for	for	ADP
ajcp-5356	75	15	the	the	DET
ajcp-5356	75	16	sonographic	sonographic	ADJ
ajcp-5356	75	17	evaluation	evaluation	NOUN
ajcp-5356	75	18	.	.	PUNCT
ajcp-5356	76	1	pa	pa	PROPN
ajcp-5356	76	2	ge	ge	PROPN
ajcp-5356	76	3	50	50	NUM
ajcp-5356	76	4	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-5356	76	5	am	be	AUX
ajcp-5356	76	6	.	.	PUNCT
ajcp-5356	77	1	j.	j.	PROPN
ajcp-5356	77	2	chem	chem	PROPN
ajcp-5356	77	3	.	.	PUNCT
ajcp-5356	78	1	pharm	pharm	PROPN
ajcp-5356	78	2	.	.	PUNCT
ajcp-5356	79	1	4(1	4(1	NOUN
ajcp-5356	79	2	)	)	PUNCT
ajcp-5356	80	1	48	48	NUM
ajcp-5356	80	2	-	-	SYM
ajcp-5356	80	3	53	53	NUM
ajcp-5356	80	4	,	,	PUNCT
ajcp-5356	80	5	2025	2025	NUM
ajcp-5356	80	6	the	the	DET
ajcp-5356	80	7	imaging	imaging	NOUN
ajcp-5356	80	8	protocol	protocol	NOUN
ajcp-5356	80	9	included	include	VERB
ajcp-5356	80	10	:	:	PUNCT
ajcp-5356	80	11	•	•	NUM
ajcp-5356	80	12	b	b	X
ajcp-5356	80	13	-	-	PUNCT
ajcp-5356	80	14	mode	mode	NOUN
ajcp-5356	80	15	scanning	scanning	NOUN
ajcp-5356	80	16	to	to	PART
ajcp-5356	80	17	assess	assess	VERB
ajcp-5356	80	18	soft	soft	ADJ
ajcp-5356	80	19	tissue	tissue	NOUN
ajcp-5356	80	20	swelling	swell	VERB
ajcp-5356	80	21	and	and	CCONJ
ajcp-5356	80	22	hypoechoic	hypoechoic	ADJ
ajcp-5356	80	23	changes	change	NOUN
ajcp-5356	80	24	associated	associate	VERB
ajcp-5356	80	25	with	with	ADP
ajcp-5356	80	26	edema	edema	NOUN
ajcp-5356	80	27	.	.	PUNCT
ajcp-5356	81	1	•	•	NUM
ajcp-5356	81	2	color	color	NOUN
ajcp-5356	81	3	doppler	doppler	NOUN
ajcp-5356	81	4	imaging	imaging	NOUN
ajcp-5356	81	5	(	(	PUNCT
ajcp-5356	81	6	cdi	cdi	PROPN
ajcp-5356	81	7	)	)	PUNCT
ajcp-5356	81	8	to	to	PART
ajcp-5356	81	9	quantify	quantify	VERB
ajcp-5356	81	10	vascular	vascular	ADJ
ajcp-5356	81	11	perfusion	perfusion	NOUN
ajcp-5356	81	12	in	in	ADP
ajcp-5356	81	13	the	the	DET
ajcp-5356	81	14	inflamed	inflamed	ADJ
ajcp-5356	81	15	area	area	NOUN
ajcp-5356	81	16	,	,	PUNCT
ajcp-5356	81	17	indicative	indicative	ADJ
ajcp-5356	81	18	of	of	ADP
ajcp-5356	81	19	inflammatory	inflammatory	ADJ
ajcp-5356	81	20	response	response	NOUN
ajcp-5356	81	21	.	.	PUNCT
ajcp-5356	82	1	images	image	NOUN
ajcp-5356	82	2	were	be	AUX
ajcp-5356	82	3	captured	capture	VERB
ajcp-5356	82	4	at	at	ADP
ajcp-5356	82	5	0	0	NUM
ajcp-5356	82	6	,	,	PUNCT
ajcp-5356	82	7	24	24	NUM
ajcp-5356	82	8	,	,	PUNCT
ajcp-5356	82	9	48	48	NUM
ajcp-5356	82	10	,	,	PUNCT
ajcp-5356	82	11	and	and	CCONJ
ajcp-5356	82	12	72	72	NUM
ajcp-5356	82	13	hours	hour	NOUN
ajcp-5356	82	14	post	post	NOUN
ajcp-5356	82	15	-	-	NOUN
ajcp-5356	82	16	treatment	treatment	NOUN
ajcp-5356	82	17	.	.	PUNCT
ajcp-5356	83	1	rats	rat	NOUN
ajcp-5356	83	2	treated	treat	VERB
ajcp-5356	83	3	with	with	ADP
ajcp-5356	83	4	nano	nano	NOUN
ajcp-5356	83	5	-	-	PUNCT
ajcp-5356	83	6	encapsulated	encapsulate	VERB
ajcp-5356	83	7	diterpenoids	diterpenoid	NOUN
ajcp-5356	83	8	exhibited	exhibit	VERB
ajcp-5356	83	9	:	:	PUNCT
ajcp-5356	83	10	•	•	NUM
ajcp-5356	83	11	significant	significant	ADJ
ajcp-5356	83	12	reduction	reduction	NOUN
ajcp-5356	83	13	in	in	ADP
ajcp-5356	83	14	paw	paw	NOUN
ajcp-5356	83	15	thickness	thickness	NOUN
ajcp-5356	83	16	.	.	PUNCT
ajcp-5356	84	1	•	•	NUM
ajcp-5356	84	2	normalization	normalization	NOUN
ajcp-5356	84	3	of	of	ADP
ajcp-5356	84	4	echogenicity	echogenicity	NOUN
ajcp-5356	84	5	and	and	CCONJ
ajcp-5356	84	6	tissue	tissue	NOUN
ajcp-5356	84	7	architecture	architecture	NOUN
ajcp-5356	84	8	.	.	PUNCT
ajcp-5356	85	1	•	•	NUM
ajcp-5356	85	2	decreased	decrease	VERB
ajcp-5356	85	3	doppler	doppler	NOUN
ajcp-5356	85	4	signal	signal	NOUN
ajcp-5356	85	5	intensity	intensity	NOUN
ajcp-5356	85	6	,	,	PUNCT
ajcp-5356	85	7	confirming	confirm	VERB
ajcp-5356	85	8	reduced	reduce	VERB
ajcp-5356	85	9	blood	blood	NOUN
ajcp-5356	85	10	flow	flow	NOUN
ajcp-5356	85	11	and	and	CCONJ
ajcp-5356	85	12	inflammation	inflammation	NOUN
ajcp-5356	85	13	.	.	PUNCT
ajcp-5356	86	1	biochemical	biochemical	ADJ
ajcp-5356	86	2	markers	marker	NOUN
ajcp-5356	86	3	(	(	PUNCT
ajcp-5356	86	4	crp	crp	PROPN
ajcp-5356	86	5	,	,	PUNCT
ajcp-5356	86	6	il-6	il-6	NUM
ajcp-5356	86	7	)	)	PUNCT
ajcp-5356	86	8	and	and	CCONJ
ajcp-5356	86	9	histological	histological	ADJ
ajcp-5356	86	10	evaluations	evaluation	NOUN
ajcp-5356	86	11	supported	support	VERB
ajcp-5356	86	12	these	these	DET
ajcp-5356	86	13	sonographic	sonographic	ADJ
ajcp-5356	86	14	results	result	NOUN
ajcp-5356	86	15	,	,	PUNCT
ajcp-5356	86	16	confirming	confirm	VERB
ajcp-5356	86	17	the	the	DET
ajcp-5356	86	18	use	use	NOUN
ajcp-5356	86	19	of	of	ADP
ajcp-5356	86	20	medical	medical	ADJ
ajcp-5356	86	21	imaging	imaging	NOUN
ajcp-5356	86	22	as	as	ADP
ajcp-5356	86	23	a	a	DET
ajcp-5356	86	24	reliable	reliable	ADJ
ajcp-5356	86	25	therapeutic	therapeutic	ADJ
ajcp-5356	86	26	monitoring	monitoring	NOUN
ajcp-5356	86	27	tool	tool	NOUN
ajcp-5356	86	28	.	.	PUNCT
ajcp-5356	87	1	biochemical	biochemical	ADJ
ajcp-5356	87	2	assays	assay	NOUN
ajcp-5356	87	3	serum	serum	NOUN
ajcp-5356	87	4	samples	sample	NOUN
ajcp-5356	87	5	were	be	AUX
ajcp-5356	87	6	analyzed	analyze	VERB
ajcp-5356	87	7	for	for	ADP
ajcp-5356	87	8	tnf	tnf	PROPN
ajcp-5356	87	9	-	-	PUNCT
ajcp-5356	87	10	α	α	PROPN
ajcp-5356	87	11	,	,	PUNCT
ajcp-5356	87	12	il-1β	il-1β	PROPN
ajcp-5356	87	13	,	,	PUNCT
ajcp-5356	87	14	il6	il6	NOUN
ajcp-5356	87	15	,	,	PUNCT
ajcp-5356	87	16	and	and	CCONJ
ajcp-5356	87	17	crp	crp	PROPN
ajcp-5356	87	18	using	use	VERB
ajcp-5356	87	19	elisa	elisa	PROPN
ajcp-5356	87	20	.	.	PUNCT
ajcp-5356	88	1	liver	liver	NOUN
ajcp-5356	88	2	enzymes	enzyme	NOUN
ajcp-5356	88	3	(	(	PUNCT
ajcp-5356	88	4	alt	alt	ADJ
ajcp-5356	88	5	,	,	PUNCT
ajcp-5356	88	6	ast	ast	ADJ
ajcp-5356	88	7	)	)	PUNCT
ajcp-5356	88	8	,	,	PUNCT
ajcp-5356	88	9	creatinine	creatinine	NOUN
ajcp-5356	88	10	,	,	PUNCT
ajcp-5356	88	11	and	and	CCONJ
ajcp-5356	88	12	urea	urea	NOUN
ajcp-5356	88	13	were	be	AUX
ajcp-5356	88	14	monitored	monitor	VERB
ajcp-5356	88	15	for	for	ADP
ajcp-5356	88	16	toxicity	toxicity	NOUN
ajcp-5356	88	17	.	.	PUNCT
ajcp-5356	89	1	results	result	NOUN
ajcp-5356	89	2	and	and	CCONJ
ajcp-5356	89	3	discussion	discussion	NOUN
ajcp-5356	89	4	phytochemical	phytochemical	ADJ
ajcp-5356	89	5	composition	composition	NOUN
ajcp-5356	89	6	phytochemical	phytochemical	ADJ
ajcp-5356	89	7	analysis	analysis	NOUN
ajcp-5356	89	8	of	of	ADP
ajcp-5356	89	9	aqueous	aqueous	ADJ
ajcp-5356	89	10	and	and	CCONJ
ajcp-5356	89	11	ethanolic	ethanolic	ADJ
ajcp-5356	89	12	extracts	extract	NOUN
ajcp-5356	89	13	of	of	ADP
ajcp-5356	89	14	andrographis	andrographis	PRON
ajcp-5356	89	15	paniculata	paniculata	NOUN
ajcp-5356	89	16	revealed	reveal	VERB
ajcp-5356	89	17	the	the	DET
ajcp-5356	89	18	presence	presence	NOUN
ajcp-5356	89	19	of	of	ADP
ajcp-5356	89	20	various	various	ADJ
ajcp-5356	89	21	secondary	secondary	ADJ
ajcp-5356	89	22	metabolites	metabolite	NOUN
ajcp-5356	89	23	essential	essential	ADJ
ajcp-5356	89	24	to	to	ADP
ajcp-5356	89	25	its	its	PRON
ajcp-5356	89	26	therapeutic	therapeutic	ADJ
ajcp-5356	89	27	activity	activity	NOUN
ajcp-5356	89	28	(	(	PUNCT
ajcp-5356	89	29	table	table	NOUN
ajcp-5356	89	30	1	1	NUM
ajcp-5356	89	31	)	)	PUNCT
ajcp-5356	89	32	.	.	PUNCT
ajcp-5356	90	1	both	both	DET
ajcp-5356	90	2	extracts	extract	NOUN
ajcp-5356	90	3	tested	test	VERB
ajcp-5356	90	4	positive	positive	ADJ
ajcp-5356	90	5	for	for	ADP
ajcp-5356	90	6	alkaloids	alkaloid	NOUN
ajcp-5356	90	7	,	,	PUNCT
ajcp-5356	90	8	flavonoids	flavonoid	NOUN
ajcp-5356	90	9	,	,	PUNCT
ajcp-5356	90	10	tannins	tannin	NOUN
ajcp-5356	90	11	,	,	PUNCT
ajcp-5356	90	12	saponins	saponin	NOUN
ajcp-5356	90	13	,	,	PUNCT
ajcp-5356	90	14	resins	resin	NOUN
ajcp-5356	90	15	,	,	PUNCT
ajcp-5356	90	16	cardiac	cardiac	ADJ
ajcp-5356	90	17	glycosides	glycoside	NOUN
ajcp-5356	90	18	,	,	PUNCT
ajcp-5356	90	19	and	and	CCONJ
ajcp-5356	90	20	steroids	steroid	NOUN
ajcp-5356	90	21	.	.	PUNCT
ajcp-5356	91	1	however	however	ADV
ajcp-5356	91	2	,	,	PUNCT
ajcp-5356	91	3	ethanolic	ethanolic	ADJ
ajcp-5356	91	4	extraction	extraction	NOUN
ajcp-5356	91	5	proved	prove	VERB
ajcp-5356	91	6	more	more	ADV
ajcp-5356	91	7	efficient	efficient	ADJ
ajcp-5356	91	8	,	,	PUNCT
ajcp-5356	91	9	showing	show	VERB
ajcp-5356	91	10	a	a	DET
ajcp-5356	91	11	stronger	strong	ADJ
ajcp-5356	91	12	presence	presence	NOUN
ajcp-5356	91	13	(	(	PUNCT
ajcp-5356	91	14	+	+	NOUN
ajcp-5356	91	15	+	+	X
ajcp-5356	91	16	reaction	reaction	NOUN
ajcp-5356	91	17	)	)	PUNCT
ajcp-5356	91	18	of	of	ADP
ajcp-5356	91	19	phenols	phenol	NOUN
ajcp-5356	91	20	,	,	PUNCT
ajcp-5356	91	21	flavonoids	flavonoid	NOUN
ajcp-5356	91	22	,	,	PUNCT
ajcp-5356	91	23	terpenoids	terpenoid	NOUN
ajcp-5356	91	24	,	,	PUNCT
ajcp-5356	91	25	and	and	CCONJ
ajcp-5356	91	26	cardiac	cardiac	ADJ
ajcp-5356	91	27	glycosides	glycoside	NOUN
ajcp-5356	91	28	compared	compare	VERB
ajcp-5356	91	29	to	to	ADP
ajcp-5356	91	30	the	the	DET
ajcp-5356	91	31	aqueous	aqueous	ADJ
ajcp-5356	91	32	extract	extract	NOUN
ajcp-5356	91	33	.	.	PUNCT
ajcp-5356	92	1	table	table	NOUN
ajcp-5356	92	2	1	1	NUM
ajcp-5356	92	3	:	:	PUNCT
ajcp-5356	92	4	phytochemical	phytochemical	ADJ
ajcp-5356	92	5	constituents	constituent	NOUN
ajcp-5356	92	6	of	of	ADP
ajcp-5356	92	7	a.	a.	NOUN
ajcp-5356	92	8	paniculata	paniculata	VERB
ajcp-5356	92	9	extracts	extract	NOUN
ajcp-5356	92	10	parameters	parameter	NOUN
ajcp-5356	92	11	aqueous	aqueous	ADJ
ajcp-5356	92	12	extraction	extraction	NOUN
ajcp-5356	92	13	ethanolic	ethanolic	ADJ
ajcp-5356	92	14	extraction	extraction	NOUN
ajcp-5356	92	15	alkaloids	alkaloid	NOUN
ajcp-5356	92	16	+	+	X
ajcp-5356	93	1	+	+	CCONJ
ajcp-5356	93	2	phenol	phenol	ADJ
ajcp-5356	93	3	+	+	CCONJ
ajcp-5356	93	4	+	+	ADJ
ajcp-5356	93	5	+	+	ADJ
ajcp-5356	93	6	flavonoids	flavonoid	NOUN
ajcp-5356	93	7	+	+	X
ajcp-5356	94	1	+	+	ADJ
ajcp-5356	94	2	+	+	NUM
ajcp-5356	94	3	tannins	tannin	NOUN
ajcp-5356	94	4	+	+	X
ajcp-5356	95	1	+	+	NUM
ajcp-5356	95	2	saponins	saponin	NOUN
ajcp-5356	95	3	+	+	X
ajcp-5356	95	4	+	+	CCONJ
ajcp-5356	95	5	resins	resin	NOUN
ajcp-5356	95	6	+	+	CCONJ
ajcp-5356	95	7	+	+	CCONJ
ajcp-5356	95	8	cardiac	cardiac	ADJ
ajcp-5356	95	9	glycosides	glycoside	NOUN
ajcp-5356	95	10	+	+	X
ajcp-5356	96	1	+	+	ADJ
ajcp-5356	96	2	+	+	ADJ
ajcp-5356	96	3	terpenoids	terpenoid	NOUN
ajcp-5356	96	4	+	+	X
ajcp-5356	97	1	+	+	ADJ
ajcp-5356	97	2	+	+	NUM
ajcp-5356	97	3	steroids	steroid	NOUN
ajcp-5356	97	4	+	+	X
ajcp-5356	97	5	+	+	NUM
ajcp-5356	97	6	phlobatannins	phlobatannin	NOUN
ajcp-5356	97	7	+	+	PUNCT
ajcp-5356	97	8	+	+	CCONJ
ajcp-5356	97	9	this	this	PRON
ajcp-5356	97	10	confirms	confirm	VERB
ajcp-5356	97	11	the	the	DET
ajcp-5356	97	12	ethanolic	ethanolic	ADJ
ajcp-5356	97	13	extract	extract	NOUN
ajcp-5356	97	14	as	as	ADP
ajcp-5356	97	15	a	a	DET
ajcp-5356	97	16	better	well	ADJ
ajcp-5356	97	17	candidate	candidate	NOUN
ajcp-5356	97	18	for	for	ADP
ajcp-5356	97	19	isolation	isolation	NOUN
ajcp-5356	97	20	of	of	ADP
ajcp-5356	97	21	active	active	ADJ
ajcp-5356	97	22	compounds	compound	NOUN
ajcp-5356	97	23	.	.	PUNCT
ajcp-5356	98	1	the	the	DET
ajcp-5356	98	2	presence	presence	NOUN
ajcp-5356	98	3	of	of	ADP
ajcp-5356	98	4	flavonoids	flavonoid	NOUN
ajcp-5356	98	5	and	and	CCONJ
ajcp-5356	98	6	terpenoids	terpenoid	NOUN
ajcp-5356	98	7	further	far	ADV
ajcp-5356	98	8	supports	support	VERB
ajcp-5356	98	9	the	the	DET
ajcp-5356	98	10	extract	extract	NOUN
ajcp-5356	98	11	’s	’s	PART
ajcp-5356	98	12	antioxidant	antioxidant	NOUN
ajcp-5356	98	13	and	and	CCONJ
ajcp-5356	98	14	anti	anti	ADJ
ajcp-5356	98	15	-	-	ADJ
ajcp-5356	98	16	inflammatory	inflammatory	ADJ
ajcp-5356	98	17	potential	potential	NOUN
ajcp-5356	98	18	.	.	PUNCT
ajcp-5356	99	1	analytical	analytical	ADJ
ajcp-5356	99	2	validation	validation	NOUN
ajcp-5356	99	3	of	of	ADP
ajcp-5356	99	4	isolates	isolate	NOUN
ajcp-5356	99	5	and	and	CCONJ
ajcp-5356	99	6	nanoparticles	nanoparticle	NOUN
ajcp-5356	99	7	figure	figure	VERB
ajcp-5356	99	8	1	1	NUM
ajcp-5356	99	9	:	:	PUNCT
ajcp-5356	99	10	fourier	fourier	NOUN
ajcp-5356	99	11	transform	transform	VERB
ajcp-5356	99	12	infrared	infrared	ADJ
ajcp-5356	99	13	(	(	PUNCT
ajcp-5356	99	14	ftir	ftir	NOUN
ajcp-5356	99	15	)	)	PUNCT
ajcp-5356	99	16	graph	graph	NOUN
ajcp-5356	99	17	for	for	ADP
ajcp-5356	99	18	encapsulated	encapsulate	VERB
ajcp-5356	99	19	andrographis	andrographis	PRON
ajcp-5356	99	20	extract	extract	NOUN
ajcp-5356	99	21	the	the	DET
ajcp-5356	99	22	ftir	ftir	PROPN
ajcp-5356	99	23	spectrum	spectrum	PROPN
ajcp-5356	99	24	of	of	ADP
ajcp-5356	99	25	andrographis	andrographis	PRON
ajcp-5356	99	26	paniculata	paniculata	ADJ
ajcp-5356	99	27	extract	extract	NOUN
ajcp-5356	99	28	(	(	PUNCT
ajcp-5356	99	29	figure	figure	NOUN
ajcp-5356	99	30	1	1	NUM
ajcp-5356	99	31	)	)	PUNCT
ajcp-5356	99	32	confirms	confirm	VERB
ajcp-5356	99	33	the	the	DET
ajcp-5356	99	34	presence	presence	NOUN
ajcp-5356	99	35	of	of	ADP
ajcp-5356	99	36	key	key	ADJ
ajcp-5356	99	37	medicinal	medicinal	ADJ
ajcp-5356	99	38	functional	functional	ADJ
ajcp-5356	99	39	groups	group	NOUN
ajcp-5356	99	40	such	such	ADJ
ajcp-5356	99	41	as	as	ADP
ajcp-5356	99	42	amines	amine	NOUN
ajcp-5356	99	43	(	(	PUNCT
ajcp-5356	99	44	nh	nh	NOUN
ajcp-5356	99	45	)	)	PUNCT
ajcp-5356	99	46	,	,	PUNCT
ajcp-5356	99	47	nitro	nitro	NOUN
ajcp-5356	99	48	compounds	compound	NOUN
ajcp-5356	99	49	(	(	PUNCT
ajcp-5356	99	50	no₂	no₂	NOUN
ajcp-5356	99	51	)	)	PUNCT
ajcp-5356	99	52	,	,	PUNCT
ajcp-5356	99	53	carboxylic	carboxylic	ADJ
ajcp-5356	99	54	acids	acid	NOUN
ajcp-5356	99	55	(	(	PUNCT
ajcp-5356	99	56	oh	oh	INTJ
ajcp-5356	99	57	)	)	PUNCT
ajcp-5356	99	58	,	,	PUNCT
ajcp-5356	99	59	carbonyls	carbonyls	NOUN
ajcp-5356	99	60	(	(	PUNCT
ajcp-5356	99	61	c	c	NOUN
ajcp-5356	99	62	=	=	NOUN
ajcp-5356	99	63	o	o	NOUN
ajcp-5356	99	64	)	)	PUNCT
ajcp-5356	99	65	,	,	PUNCT
ajcp-5356	99	66	thiol	thiol	NOUN
ajcp-5356	99	67	(	(	PUNCT
ajcp-5356	99	68	-sh	-sh	NOUN
ajcp-5356	99	69	)	)	PUNCT
ajcp-5356	99	70	,	,	PUNCT
ajcp-5356	99	71	and	and	CCONJ
ajcp-5356	99	72	nitriles	nitrile	NOUN
ajcp-5356	99	73	(	(	PUNCT
ajcp-5356	99	74	c	c	X
ajcp-5356	99	75	–	–	PUNCT
ajcp-5356	99	76	c	c	NOUN
ajcp-5356	99	77	–	–	PUNCT
ajcp-5356	99	78	cn	cn	NOUN
ajcp-5356	99	79	)	)	PUNCT
ajcp-5356	99	80	,	,	PUNCT
ajcp-5356	99	81	which	which	PRON
ajcp-5356	99	82	are	be	AUX
ajcp-5356	99	83	characteristic	characteristic	ADJ
ajcp-5356	99	84	of	of	ADP
ajcp-5356	99	85	diterpenoids	diterpenoid	NOUN
ajcp-5356	99	86	with	with	ADP
ajcp-5356	99	87	anti	anti	ADJ
ajcp-5356	99	88	-	-	ADJ
ajcp-5356	99	89	inflammatory	inflammatory	ADJ
ajcp-5356	99	90	potential	potential	NOUN
ajcp-5356	99	91	.	.	PUNCT
ajcp-5356	100	1	notable	notable	ADJ
ajcp-5356	100	2	peaks	peak	NOUN
ajcp-5356	100	3	include	include	VERB
ajcp-5356	100	4	3452	3452	NUM
ajcp-5356	100	5	cm⁻¹	cm⁻¹	NOUN
ajcp-5356	100	6	for	for	ADP
ajcp-5356	100	7	nh₂	nh₂	NOUN
ajcp-5356	100	8	in	in	ADP
ajcp-5356	100	9	aromatic	aromatic	ADJ
ajcp-5356	100	10	and	and	CCONJ
ajcp-5356	100	11	primary	primary	ADJ
ajcp-5356	100	12	amines	amine	NOUN
ajcp-5356	100	13	,	,	PUNCT
ajcp-5356	100	14	2541	2541	NUM
ajcp-5356	100	15	cm⁻¹	cm⁻¹	PROPN
ajcp-5356	100	16	for	for	ADP
ajcp-5356	100	17	-sh	-sh	X
ajcp-5356	100	18	stretch	stretch	NOUN
ajcp-5356	100	19	in	in	ADP
ajcp-5356	100	20	alkyl	alkyl	ADJ
ajcp-5356	100	21	mercaptans	mercaptan	NOUN
ajcp-5356	100	22	,	,	PUNCT
ajcp-5356	100	23	and	and	CCONJ
ajcp-5356	100	24	1600	1600	NUM
ajcp-5356	100	25	cm⁻¹	cm⁻¹	NOUN
ajcp-5356	100	26	for	for	ADP
ajcp-5356	100	27	nh₂	nh₂	NOUN
ajcp-5356	100	28	in	in	ADP
ajcp-5356	100	29	amino	amino	ADJ
ajcp-5356	100	30	acids	acid	NOUN
ajcp-5356	100	31	—	—	PUNCT
ajcp-5356	100	32	indicating	indicate	VERB
ajcp-5356	100	33	biological	biological	ADJ
ajcp-5356	100	34	relevance	relevance	NOUN
ajcp-5356	100	35	and	and	CCONJ
ajcp-5356	100	36	reactivity	reactivity	NOUN
ajcp-5356	100	37	of	of	ADP
ajcp-5356	100	38	the	the	DET
ajcp-5356	100	39	compound	compound	NOUN
ajcp-5356	100	40	.	.	PUNCT
ajcp-5356	101	1	pa	pa	PROPN
ajcp-5356	101	2	ge	ge	PROPN
ajcp-5356	101	3	51	51	NUM
ajcp-5356	101	4	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-5356	101	5	am	be	AUX
ajcp-5356	101	6	.	.	PUNCT
ajcp-5356	102	1	j.	j.	PROPN
ajcp-5356	102	2	chem	chem	PROPN
ajcp-5356	102	3	.	.	PUNCT
ajcp-5356	103	1	pharm	pharm	PROPN
ajcp-5356	103	2	.	.	PUNCT
ajcp-5356	104	1	4(1	4(1	NOUN
ajcp-5356	104	2	)	)	PUNCT
ajcp-5356	105	1	48	48	NUM
ajcp-5356	105	2	-	-	SYM
ajcp-5356	105	3	53	53	NUM
ajcp-5356	105	4	,	,	PUNCT
ajcp-5356	105	5	2025	2025	NUM
ajcp-5356	105	6	additional	additional	ADJ
ajcp-5356	105	7	peaks	peak	NOUN
ajcp-5356	105	8	at	at	ADP
ajcp-5356	105	9	1841	1841	NUM
ajcp-5356	105	10	cm⁻¹	cm⁻¹	PROPN
ajcp-5356	105	11	and	and	CCONJ
ajcp-5356	105	12	1428	1428	NUM
ajcp-5356	105	13	cm⁻¹	cm⁻¹	NOUN
ajcp-5356	105	14	show	show	NOUN
ajcp-5356	105	15	c	c	NOUN
ajcp-5356	105	16	=	=	NOUN
ajcp-5356	105	17	o	o	NOUN
ajcp-5356	105	18	and	and	CCONJ
ajcp-5356	105	19	c	c	NOUN
ajcp-5356	105	20	-	-	PUNCT
ajcp-5356	105	21	n	n	PRON
ajcp-5356	105	22	functionalities	functionality	NOUN
ajcp-5356	105	23	,	,	PUNCT
ajcp-5356	105	24	further	far	ADV
ajcp-5356	105	25	supporting	support	VERB
ajcp-5356	105	26	the	the	DET
ajcp-5356	105	27	compound	compound	NOUN
ajcp-5356	105	28	’s	’s	PART
ajcp-5356	105	29	structural	structural	ADJ
ajcp-5356	105	30	complexity	complexity	NOUN
ajcp-5356	105	31	and	and	CCONJ
ajcp-5356	105	32	therapeutic	therapeutic	ADJ
ajcp-5356	105	33	value	value	NOUN
ajcp-5356	105	34	.	.	PUNCT
ajcp-5356	106	1	the	the	DET
ajcp-5356	106	2	spectrum	spectrum	NOUN
ajcp-5356	106	3	confirms	confirm	VERB
ajcp-5356	106	4	the	the	DET
ajcp-5356	106	5	unsaturated	unsaturated	ADJ
ajcp-5356	106	6	,	,	PUNCT
ajcp-5356	106	7	aliphatic	aliphatic	ADJ
ajcp-5356	106	8	,	,	PUNCT
ajcp-5356	106	9	and	and	CCONJ
ajcp-5356	106	10	functionalized	functionalize	VERB
ajcp-5356	106	11	nature	nature	NOUN
ajcp-5356	106	12	of	of	ADP
ajcp-5356	106	13	andrographis	andrographis	PROPN
ajcp-5356	106	14	diterpenoids	diterpenoid	NOUN
ajcp-5356	106	15	,	,	PUNCT
ajcp-5356	106	16	crucial	crucial	ADJ
ajcp-5356	106	17	for	for	ADP
ajcp-5356	106	18	biological	biological	ADJ
ajcp-5356	106	19	activity	activity	NOUN
ajcp-5356	106	20	.	.	PUNCT
ajcp-5356	107	1	these	these	DET
ajcp-5356	107	2	insights	insight	NOUN
ajcp-5356	107	3	support	support	VERB
ajcp-5356	107	4	the	the	DET
ajcp-5356	107	5	compound	compound	NOUN
ajcp-5356	107	6	’s	’s	PART
ajcp-5356	107	7	suitability	suitability	NOUN
ajcp-5356	107	8	for	for	ADP
ajcp-5356	107	9	nanoencapsulation	nanoencapsulation	NOUN
ajcp-5356	107	10	in	in	ADP
ajcp-5356	107	11	chitosan	chitosan	NOUN
ajcp-5356	107	12	matrices	matrix	NOUN
ajcp-5356	107	13	,	,	PUNCT
ajcp-5356	107	14	ensuring	ensure	VERB
ajcp-5356	107	15	molecular	molecular	ADJ
ajcp-5356	107	16	stability	stability	NOUN
ajcp-5356	107	17	,	,	PUNCT
ajcp-5356	107	18	bioavailability	bioavailability	NOUN
ajcp-5356	107	19	,	,	PUNCT
ajcp-5356	107	20	and	and	CCONJ
ajcp-5356	107	21	targeted	target	VERB
ajcp-5356	107	22	delivery	delivery	NOUN
ajcp-5356	107	23	for	for	ADP
ajcp-5356	107	24	antiinflammatory	antiinflammatory	NOUN
ajcp-5356	107	25	therapy	therapy	NOUN
ajcp-5356	107	26	.	.	PUNCT
ajcp-5356	108	1	figure	figure	NOUN
ajcp-5356	108	2	2	2	NUM
ajcp-5356	108	3	:	:	PUNCT
ajcp-5356	108	4	lcms	lcms	NOUN
ajcp-5356	108	5	analysis	analysis	NOUN
ajcp-5356	108	6	of	of	ADP
ajcp-5356	108	7	the	the	DET
ajcp-5356	108	8	isolate	isolate	ADJ
ajcp-5356	108	9	14	14	NUM
ajcp-5356	108	10	-	-	PUNCT
ajcp-5356	108	11	deoxy-11,12	deoxy-11,12	NOUN
ajcp-5356	108	12	-	-	PUNCT
ajcp-5356	108	13	didehydroandrographolide	didehydroandrographolide	NOUN
ajcp-5356	108	14	the	the	DET
ajcp-5356	108	15	lc	lc	NOUN
ajcp-5356	108	16	-	-	PUNCT
ajcp-5356	108	17	ms	ms	NOUN
ajcp-5356	108	18	analysis	analysis	NOUN
ajcp-5356	108	19	of	of	ADP
ajcp-5356	108	20	14	14	NUM
ajcp-5356	108	21	-	-	PUNCT
ajcp-5356	108	22	deoxy-11,12didehydroandrographolide	deoxy-11,12didehydroandrographolide	NOUN
ajcp-5356	108	23	revealed	reveal	VERB
ajcp-5356	108	24	seven	seven	NUM
ajcp-5356	108	25	distinct	distinct	ADJ
ajcp-5356	108	26	bioactive	bioactive	ADJ
ajcp-5356	108	27	compounds	compound	NOUN
ajcp-5356	108	28	based	base	VERB
ajcp-5356	108	29	on	on	ADP
ajcp-5356	108	30	their	their	PRON
ajcp-5356	108	31	retention	retention	NOUN
ajcp-5356	108	32	times	time	NOUN
ajcp-5356	108	33	,	,	PUNCT
ajcp-5356	108	34	molecular	molecular	ADJ
ajcp-5356	108	35	weights	weight	NOUN
ajcp-5356	108	36	,	,	PUNCT
ajcp-5356	108	37	and	and	CCONJ
ajcp-5356	108	38	biological	biological	ADJ
ajcp-5356	108	39	functions	function	NOUN
ajcp-5356	108	40	.	.	PUNCT
ajcp-5356	109	1	the	the	DET
ajcp-5356	109	2	first	first	ADJ
ajcp-5356	109	3	compound	compound	NOUN
ajcp-5356	109	4	identified	identify	VERB
ajcp-5356	109	5	was	be	AUX
ajcp-5356	109	6	ciprofloxacin	ciprofloxacin	NOUN
ajcp-5356	109	7	(	(	PUNCT
ajcp-5356	109	8	c₁₇h₁₈fn₃o₃	c₁₇h₁₈fn₃o₃	PROPN
ajcp-5356	109	9	)	)	PUNCT
ajcp-5356	109	10	at	at	ADP
ajcp-5356	109	11	a	a	DET
ajcp-5356	109	12	retention	retention	NOUN
ajcp-5356	109	13	time	time	NOUN
ajcp-5356	109	14	of	of	ADP
ajcp-5356	109	15	1.775	1.775	NUM
ajcp-5356	109	16	with	with	ADP
ajcp-5356	109	17	a	a	DET
ajcp-5356	109	18	molecular	molecular	ADJ
ajcp-5356	109	19	weight	weight	NOUN
ajcp-5356	109	20	of	of	ADP
ajcp-5356	109	21	331.35	331.35	NUM
ajcp-5356	109	22	.	.	PUNCT
ajcp-5356	110	1	it	it	PRON
ajcp-5356	110	2	showed	show	VERB
ajcp-5356	110	3	antibacterial	antibacterial	ADJ
ajcp-5356	110	4	and	and	CCONJ
ajcp-5356	110	5	anticancer	anticancer	NOUN
ajcp-5356	110	6	activities	activity	NOUN
ajcp-5356	110	7	,	,	PUNCT
ajcp-5356	110	8	consistent	consistent	ADJ
ajcp-5356	110	9	with	with	ADP
ajcp-5356	110	10	kassab	kassab	NOUN
ajcp-5356	110	11	and	and	CCONJ
ajcp-5356	110	12	gedawy	gedawy	ADJ
ajcp-5356	110	13	(	(	PUNCT
ajcp-5356	110	14	2018	2018	NUM
ajcp-5356	110	15	)	)	PUNCT
ajcp-5356	110	16	.	.	PUNCT
ajcp-5356	111	1	the	the	DET
ajcp-5356	111	2	second	second	ADJ
ajcp-5356	111	3	compound	compound	NOUN
ajcp-5356	111	4	was	be	AUX
ajcp-5356	111	5	losartan	losartan	ADJ
ajcp-5356	111	6	(	(	PUNCT
ajcp-5356	111	7	c₂₂h₂₃cln₆o	c₂₂h₂₃cln₆o	PROPN
ajcp-5356	111	8	)	)	PUNCT
ajcp-5356	111	9	,	,	PUNCT
ajcp-5356	111	10	eluting	elute	VERB
ajcp-5356	111	11	at	at	ADP
ajcp-5356	111	12	2.178	2.178	NUM
ajcp-5356	111	13	with	with	ADP
ajcp-5356	111	14	a	a	DET
ajcp-5356	111	15	molecular	molecular	ADJ
ajcp-5356	111	16	weight	weight	NOUN
ajcp-5356	111	17	of	of	ADP
ajcp-5356	111	18	422.91	422.91	NUM
ajcp-5356	111	19	,	,	PUNCT
ajcp-5356	111	20	known	know	VERB
ajcp-5356	111	21	for	for	ADP
ajcp-5356	111	22	its	its	PRON
ajcp-5356	111	23	angiotensin	angiotensin	NOUN
ajcp-5356	111	24	receptor	receptor	NOUN
ajcp-5356	111	25	antagonist	antagonist	NOUN
ajcp-5356	111	26	properties	property	NOUN
ajcp-5356	111	27	,	,	PUNCT
ajcp-5356	111	28	as	as	SCONJ
ajcp-5356	111	29	also	also	ADV
ajcp-5356	111	30	reported	report	VERB
ajcp-5356	111	31	by	by	ADP
ajcp-5356	111	32	zhang	zhang	PROPN
ajcp-5356	111	33	et	et	PROPN
ajcp-5356	111	34	al	al	PROPN
ajcp-5356	111	35	.	.	PROPN
ajcp-5356	111	36	(	(	PUNCT
ajcp-5356	111	37	2012	2012	NUM
ajcp-5356	111	38	)	)	PUNCT
ajcp-5356	111	39	.	.	PUNCT
ajcp-5356	112	1	tryptophan	tryptophan	NOUN
ajcp-5356	112	2	(	(	PUNCT
ajcp-5356	112	3	c₁₁h₁₂n₂o₂	c₁₁h₁₂n₂o₂	PROPN
ajcp-5356	112	4	)	)	PUNCT
ajcp-5356	112	5	,	,	PUNCT
ajcp-5356	112	6	found	find	VERB
ajcp-5356	112	7	at	at	ADP
ajcp-5356	112	8	2.757	2.757	NUM
ajcp-5356	112	9	,	,	PUNCT
ajcp-5356	112	10	exhibited	exhibit	VERB
ajcp-5356	112	11	angiotensin	angiotensin	NOUN
ajcp-5356	112	12	antagonistic	antagonistic	ADJ
ajcp-5356	112	13	effects	effect	NOUN
ajcp-5356	112	14	,	,	PUNCT
ajcp-5356	112	15	aligning	align	VERB
ajcp-5356	112	16	with	with	ADP
ajcp-5356	112	17	the	the	DET
ajcp-5356	112	18	findings	finding	NOUN
ajcp-5356	112	19	of	of	ADP
ajcp-5356	112	20	chen	chen	PROPN
ajcp-5356	112	21	et	et	PROPN
ajcp-5356	112	22	al	al	PROPN
ajcp-5356	112	23	.	.	PROPN
ajcp-5356	113	1	(	(	PUNCT
ajcp-5356	113	2	2016	2016	NUM
ajcp-5356	113	3	)	)	PUNCT
ajcp-5356	113	4	.	.	PUNCT
ajcp-5356	114	1	menthone	menthone	NOUN
ajcp-5356	114	2	(	(	PUNCT
ajcp-5356	114	3	c₁₀h₁₈o	c₁₀h₁₈o	NOUN
ajcp-5356	114	4	)	)	PUNCT
ajcp-5356	114	5	appeared	appear	VERB
ajcp-5356	114	6	at	at	ADP
ajcp-5356	114	7	3.316	3.316	NUM
ajcp-5356	114	8	and	and	CCONJ
ajcp-5356	114	9	showed	show	VERB
ajcp-5356	114	10	antifungal	antifungal	ADJ
ajcp-5356	114	11	,	,	PUNCT
ajcp-5356	114	12	anti	anti	ADJ
ajcp-5356	114	13	-	-	ADJ
ajcp-5356	114	14	inflammatory	inflammatory	ADJ
ajcp-5356	114	15	,	,	PUNCT
ajcp-5356	114	16	antibacterial	antibacterial	ADJ
ajcp-5356	114	17	,	,	PUNCT
ajcp-5356	114	18	and	and	CCONJ
ajcp-5356	114	19	antiviral	antiviral	ADJ
ajcp-5356	114	20	properties	property	NOUN
ajcp-5356	114	21	,	,	PUNCT
ajcp-5356	114	22	similar	similar	ADJ
ajcp-5356	114	23	to	to	ADP
ajcp-5356	114	24	zhao	zhao	PROPN
ajcp-5356	114	25	et	et	PROPN
ajcp-5356	114	26	al	al	PROPN
ajcp-5356	114	27	.	.	PROPN
ajcp-5356	115	1	(	(	PUNCT
ajcp-5356	115	2	2022	2022	NUM
ajcp-5356	115	3	)	)	PUNCT
ajcp-5356	115	4	.	.	PUNCT
ajcp-5356	116	1	telmisartan	telmisartan	PROPN
ajcp-5356	116	2	(	(	PUNCT
ajcp-5356	116	3	c₃₃h₃₀n₄o₂	c₃₃h₃₀n₄o₂	PROPN
ajcp-5356	116	4	)	)	PUNCT
ajcp-5356	116	5	was	be	AUX
ajcp-5356	116	6	identified	identify	VERB
ajcp-5356	116	7	at	at	ADP
ajcp-5356	116	8	3.521	3.521	NUM
ajcp-5356	116	9	and	and	CCONJ
ajcp-5356	116	10	displayed	display	VERB
ajcp-5356	116	11	antihypertensive	antihypertensive	ADJ
ajcp-5356	116	12	activity	activity	NOUN
ajcp-5356	116	13	,	,	PUNCT
ajcp-5356	116	14	as	as	SCONJ
ajcp-5356	116	15	supported	support	VERB
ajcp-5356	116	16	by	by	ADP
ajcp-5356	116	17	brittain	brittain	PROPN
ajcp-5356	116	18	(	(	PUNCT
ajcp-5356	116	19	2020	2020	NUM
ajcp-5356	116	20	)	)	PUNCT
ajcp-5356	116	21	.	.	PUNCT
ajcp-5356	117	1	safrole	safrole	NOUN
ajcp-5356	117	2	(	(	PUNCT
ajcp-5356	117	3	c₁₀h₁₀o₂	c₁₀h₁₀o₂	PROPN
ajcp-5356	117	4	)	)	PUNCT
ajcp-5356	117	5	,	,	PUNCT
ajcp-5356	117	6	with	with	ADP
ajcp-5356	117	7	antiangiogenic	antiangiogenic	ADJ
ajcp-5356	117	8	activity	activity	NOUN
ajcp-5356	117	9	,	,	PUNCT
ajcp-5356	117	10	was	be	AUX
ajcp-5356	117	11	prominent	prominent	ADJ
ajcp-5356	117	12	at	at	ADP
ajcp-5356	117	13	3.717	3.717	NUM
ajcp-5356	117	14	,	,	PUNCT
ajcp-5356	117	15	consistent	consistent	ADJ
ajcp-5356	117	16	with	with	ADP
ajcp-5356	117	17	the	the	DET
ajcp-5356	117	18	work	work	NOUN
ajcp-5356	117	19	of	of	ADP
ajcp-5356	117	20	zhao	zhao	PROPN
ajcp-5356	117	21	et	et	PROPN
ajcp-5356	117	22	al	al	PROPN
ajcp-5356	117	23	.	.	PROPN
ajcp-5356	118	1	(	(	PUNCT
ajcp-5356	118	2	2005	2005	NUM
ajcp-5356	118	3	)	)	PUNCT
ajcp-5356	118	4	.	.	PUNCT
ajcp-5356	119	1	finally	finally	ADV
ajcp-5356	119	2	,	,	PUNCT
ajcp-5356	119	3	linoleic	linoleic	ADJ
ajcp-5356	119	4	acid	acid	NOUN
ajcp-5356	119	5	(	(	PUNCT
ajcp-5356	119	6	c₁₈h₃₂o₂	c₁₈h₃₂o₂	PROPN
ajcp-5356	119	7	)	)	PUNCT
ajcp-5356	119	8	,	,	PUNCT
ajcp-5356	119	9	found	find	VERB
ajcp-5356	119	10	at	at	ADP
ajcp-5356	119	11	a	a	DET
ajcp-5356	119	12	retention	retention	NOUN
ajcp-5356	119	13	time	time	NOUN
ajcp-5356	119	14	of	of	ADP
ajcp-5356	119	15	6.060	6.060	NUM
ajcp-5356	119	16	,	,	PUNCT
ajcp-5356	119	17	exhibited	exhibit	VERB
ajcp-5356	119	18	anticancer	anticancer	NOUN
ajcp-5356	119	19	,	,	PUNCT
ajcp-5356	119	20	immuneboosting	immuneboosting	NOUN
ajcp-5356	119	21	,	,	PUNCT
ajcp-5356	119	22	weight	weight	NOUN
ajcp-5356	119	23	-	-	PUNCT
ajcp-5356	119	24	reducing	reduce	VERB
ajcp-5356	119	25	,	,	PUNCT
ajcp-5356	119	26	and	and	CCONJ
ajcp-5356	119	27	antiatherogenic	antiatherogenic	ADJ
ajcp-5356	119	28	effects	effect	NOUN
ajcp-5356	119	29	,	,	PUNCT
ajcp-5356	119	30	similar	similar	ADJ
ajcp-5356	119	31	to	to	ADP
ajcp-5356	119	32	the	the	DET
ajcp-5356	119	33	findings	finding	NOUN
ajcp-5356	119	34	of	of	ADP
ajcp-5356	119	35	aydin	aydin	NOUN
ajcp-5356	119	36	(	(	PUNCT
ajcp-5356	119	37	2005	2005	NUM
ajcp-5356	119	38	)	)	PUNCT
ajcp-5356	119	39	.	.	PUNCT
ajcp-5356	120	1	figure	figure	VERB
ajcp-5356	120	2	3	3	NUM
ajcp-5356	120	3	:	:	PUNCT
ajcp-5356	120	4	tem	tem	PROPN
ajcp-5356	120	5	micrograph	micrograph	NOUN
ajcp-5356	120	6	for	for	ADP
ajcp-5356	120	7	encapsulated	encapsulate	VERB
ajcp-5356	120	8	chitosan	chitosan	NOUN
ajcp-5356	120	9	isolate	isolate	NOUN
ajcp-5356	120	10	1	1	NUM
ajcp-5356	120	11	(	(	PUNCT
ajcp-5356	120	12	14	14	NUM
ajcp-5356	120	13	-	-	PUNCT
ajcp-5356	120	14	deoxy-11,12	deoxy-11,12	NOUN
ajcp-5356	120	15	-	-	PUNCT
ajcp-5356	120	16	didehydroandrographolide	didehydroandrographolide	NOUN
ajcp-5356	120	17	)	)	PUNCT
ajcp-5356	120	18	at	at	ADP
ajcp-5356	120	19	100	100	NUM
ajcp-5356	120	20	nm	nm	PRON
ajcp-5356	120	21	transmission	transmission	NOUN
ajcp-5356	120	22	electron	electron	NOUN
ajcp-5356	120	23	microscopy	microscopy	NOUN
ajcp-5356	120	24	(	(	PUNCT
ajcp-5356	120	25	tem	tem	NOUN
ajcp-5356	120	26	)	)	PUNCT
ajcp-5356	120	27	images	image	NOUN
ajcp-5356	120	28	(	(	PUNCT
ajcp-5356	120	29	figures	figure	NOUN
ajcp-5356	120	30	2	2	NUM
ajcp-5356	120	31	-	-	SYM
ajcp-5356	120	32	3	3	NUM
ajcp-5356	120	33	)	)	PUNCT
ajcp-5356	120	34	of	of	ADP
ajcp-5356	120	35	encapsulated	encapsulate	VERB
ajcp-5356	120	36	14	14	NUM
ajcp-5356	120	37	-	-	PUNCT
ajcp-5356	120	38	deoxy-11,12didehydroandrographolide	deoxy-11,12didehydroandrographolide	NOUN
ajcp-5356	120	39	and	and	CCONJ
ajcp-5356	120	40	neoandrographolide	neoandrographolide	VERB
ajcp-5356	120	41	within	within	ADP
ajcp-5356	120	42	a	a	DET
ajcp-5356	120	43	chitosan	chitosan	ADJ
ajcp-5356	120	44	-	-	PUNCT
ajcp-5356	120	45	cholesterol	cholesterol	NOUN
ajcp-5356	120	46	matrix	matrix	NOUN
ajcp-5356	120	47	revealed	reveal	VERB
ajcp-5356	120	48	welldispersed	welldispersed	ADJ
ajcp-5356	120	49	,	,	PUNCT
ajcp-5356	120	50	predominantly	predominantly	ADV
ajcp-5356	120	51	spherical	spherical	ADJ
ajcp-5356	120	52	nanoparticles	nanoparticle	NOUN
ajcp-5356	120	53	with	with	ADP
ajcp-5356	120	54	pore	pore	ADJ
ajcp-5356	120	55	sizes	size	NOUN
ajcp-5356	120	56	around	around	ADP
ajcp-5356	120	57	22.10	22.10	NUM
ajcp-5356	120	58	nm	nm	NOUN
ajcp-5356	120	59	.	.	PUNCT
ajcp-5356	121	1	these	these	DET
ajcp-5356	121	2	fall	fall	NOUN
ajcp-5356	121	3	within	within	ADP
ajcp-5356	121	4	the	the	DET
ajcp-5356	121	5	mesoporous	mesoporous	ADJ
ajcp-5356	121	6	range	range	NOUN
ajcp-5356	121	7	(	(	PUNCT
ajcp-5356	121	8	2–50	2–50	PROPN
ajcp-5356	121	9	nm	nm	NOUN
ajcp-5356	121	10	)	)	PUNCT
ajcp-5356	121	11	,	,	PUNCT
ajcp-5356	121	12	as	as	SCONJ
ajcp-5356	121	13	reported	report	VERB
ajcp-5356	121	14	by	by	ADP
ajcp-5356	121	15	jiaxun	jiaxun	PROPN
ajcp-5356	121	16	liu	liu	PROPN
ajcp-5356	121	17	et	et	PROPN
ajcp-5356	121	18	al	al	PROPN
ajcp-5356	121	19	.	.	PROPN
ajcp-5356	122	1	(	(	PUNCT
ajcp-5356	122	2	2024	2024	NUM
ajcp-5356	122	3	)	)	PUNCT
ajcp-5356	122	4	,	,	PUNCT
ajcp-5356	122	5	indicating	indicate	VERB
ajcp-5356	122	6	suitability	suitability	NOUN
ajcp-5356	122	7	for	for	ADP
ajcp-5356	122	8	drug	drug	NOUN
ajcp-5356	122	9	delivery	delivery	NOUN
ajcp-5356	122	10	applications	application	NOUN
ajcp-5356	122	11	.	.	PUNCT
ajcp-5356	123	1	the	the	DET
ajcp-5356	123	2	spherical	spherical	ADJ
ajcp-5356	123	3	morphology	morphology	NOUN
ajcp-5356	123	4	observed	observe	VERB
ajcp-5356	123	5	,	,	PUNCT
ajcp-5356	123	6	especially	especially	ADV
ajcp-5356	123	7	in	in	ADP
ajcp-5356	123	8	figure	figure	NOUN
ajcp-5356	123	9	2	2	NUM
ajcp-5356	123	10	,	,	PUNCT
ajcp-5356	123	11	enhances	enhance	VERB
ajcp-5356	123	12	uniform	uniform	ADJ
ajcp-5356	123	13	drug	drug	NOUN
ajcp-5356	123	14	release	release	NOUN
ajcp-5356	123	15	and	and	CCONJ
ajcp-5356	123	16	is	be	AUX
ajcp-5356	123	17	ideal	ideal	ADJ
ajcp-5356	123	18	for	for	ADP
ajcp-5356	123	19	cellular	cellular	ADJ
ajcp-5356	123	20	uptake	uptake	NOUN
ajcp-5356	123	21	,	,	PUNCT
ajcp-5356	123	22	biodistribution	biodistribution	NOUN
ajcp-5356	123	23	,	,	PUNCT
ajcp-5356	123	24	and	and	CCONJ
ajcp-5356	123	25	improved	improved	ADJ
ajcp-5356	123	26	bioavailability	bioavailability	NOUN
ajcp-5356	123	27	—	—	PUNCT
ajcp-5356	123	28	key	key	ADJ
ajcp-5356	123	29	advantages	advantage	NOUN
ajcp-5356	123	30	for	for	ADP
ajcp-5356	123	31	anti	anti	ADJ
ajcp-5356	123	32	-	-	ADJ
ajcp-5356	123	33	inflammatory	inflammatory	ADJ
ajcp-5356	123	34	drug	drug	NOUN
ajcp-5356	123	35	delivery	delivery	NOUN
ajcp-5356	123	36	(	(	PUNCT
ajcp-5356	123	37	jindal	jindal	NOUN
ajcp-5356	123	38	,	,	PUNCT
ajcp-5356	123	39	2017	2017	NUM
ajcp-5356	123	40	;	;	PUNCT
ajcp-5356	123	41	kulkarni	kulkarni	PROPN
ajcp-5356	123	42	&	&	CCONJ
ajcp-5356	123	43	feng	feng	PROPN
ajcp-5356	123	44	,	,	PUNCT
ajcp-5356	123	45	2013	2013	NUM
ajcp-5356	123	46	;	;	PUNCT
ajcp-5356	123	47	yameen	yameen	PROPN
ajcp-5356	123	48	et	et	PROPN
ajcp-5356	123	49	al	al	PROPN
ajcp-5356	123	50	.	.	PROPN
ajcp-5356	123	51	,	,	PUNCT
ajcp-5356	123	52	2014	2014	NUM
ajcp-5356	123	53	)	)	PUNCT
ajcp-5356	123	54	.	.	PUNCT
ajcp-5356	124	1	chitosan	chitosan	NOUN
ajcp-5356	124	2	provides	provide	VERB
ajcp-5356	124	3	biocompatibility	biocompatibility	NOUN
ajcp-5356	124	4	,	,	PUNCT
ajcp-5356	124	5	biodegradability	biodegradability	NOUN
ajcp-5356	124	6	,	,	PUNCT
ajcp-5356	124	7	and	and	CCONJ
ajcp-5356	124	8	protection	protection	NOUN
ajcp-5356	124	9	of	of	ADP
ajcp-5356	124	10	the	the	DET
ajcp-5356	124	11	active	active	ADJ
ajcp-5356	124	12	compound	compound	NOUN
ajcp-5356	124	13	,	,	PUNCT
ajcp-5356	124	14	while	while	SCONJ
ajcp-5356	124	15	cholesterol	cholesterol	NOUN
ajcp-5356	124	16	improves	improve	VERB
ajcp-5356	124	17	nanoparticle	nanoparticle	NOUN
ajcp-5356	124	18	stability	stability	NOUN
ajcp-5356	124	19	and	and	CCONJ
ajcp-5356	124	20	mimics	mimic	VERB
ajcp-5356	124	21	cell	cell	NOUN
ajcp-5356	124	22	membranes	membrane	NOUN
ajcp-5356	124	23	,	,	PUNCT
ajcp-5356	124	24	enhancing	enhance	VERB
ajcp-5356	124	25	cellular	cellular	ADJ
ajcp-5356	124	26	interaction	interaction	NOUN
ajcp-5356	124	27	(	(	PUNCT
ajcp-5356	124	28	de	de	PROPN
ajcp-5356	124	29	oliveira	oliveira	PROPN
ajcp-5356	124	30	andrade	andrade	PROPN
ajcp-5356	124	31	,	,	PUNCT
ajcp-5356	124	32	2016	2016	NUM
ajcp-5356	124	33	)	)	PUNCT
ajcp-5356	125	1	pa	pa	PROPN
ajcp-5356	125	2	ge	ge	PROPN
ajcp-5356	125	3	52	52	NUM
ajcp-5356	125	4	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-5356	125	5	am	be	AUX
ajcp-5356	125	6	.	.	PUNCT
ajcp-5356	126	1	j.	j.	PROPN
ajcp-5356	126	2	chem	chem	PROPN
ajcp-5356	126	3	.	.	PUNCT
ajcp-5356	127	1	pharm	pharm	PROPN
ajcp-5356	127	2	.	.	PUNCT
ajcp-5356	128	1	4(1	4(1	NOUN
ajcp-5356	128	2	)	)	PUNCT
ajcp-5356	129	1	48	48	NUM
ajcp-5356	129	2	-	-	SYM
ajcp-5356	129	3	53	53	NUM
ajcp-5356	129	4	,	,	PUNCT
ajcp-5356	129	5	2025	2025	NUM
ajcp-5356	129	6	overall	overall	NOUN
ajcp-5356	129	7	,	,	PUNCT
ajcp-5356	129	8	the	the	DET
ajcp-5356	129	9	tem	tem	PROPN
ajcp-5356	129	10	results	result	NOUN
ajcp-5356	129	11	confirm	confirm	VERB
ajcp-5356	129	12	effective	effective	ADJ
ajcp-5356	129	13	encapsulation	encapsulation	NOUN
ajcp-5356	129	14	and	and	CCONJ
ajcp-5356	129	15	optimal	optimal	ADJ
ajcp-5356	129	16	nanoparticle	nanoparticle	NOUN
ajcp-5356	129	17	characteristics	characteristic	NOUN
ajcp-5356	129	18	,	,	PUNCT
ajcp-5356	129	19	making	make	VERB
ajcp-5356	129	20	the	the	DET
ajcp-5356	129	21	formulation	formulation	NOUN
ajcp-5356	129	22	promising	promise	VERB
ajcp-5356	129	23	for	for	ADP
ajcp-5356	129	24	targeted	target	VERB
ajcp-5356	129	25	inflammatory	inflammatory	ADJ
ajcp-5356	129	26	treatment	treatment	NOUN
ajcp-5356	129	27	.	.	PUNCT
ajcp-5356	130	1	encapsulation	encapsulation	NOUN
ajcp-5356	130	2	efficiency	efficiency	NOUN
ajcp-5356	130	3	encapsulation	encapsulation	NOUN
ajcp-5356	130	4	efficiency	efficiency	NOUN
ajcp-5356	130	5	(	(	PUNCT
ajcp-5356	130	6	ee%	ee%	PROPN
ajcp-5356	130	7	)	)	PUNCT
ajcp-5356	130	8	was	be	AUX
ajcp-5356	130	9	calculated	calculate	VERB
ajcp-5356	130	10	based	base	VERB
ajcp-5356	130	11	on	on	ADP
ajcp-5356	130	12	the	the	DET
ajcp-5356	130	13	amount	amount	NOUN
ajcp-5356	130	14	of	of	ADP
ajcp-5356	130	15	drug	drug	NOUN
ajcp-5356	130	16	entrapped	entrap	VERB
ajcp-5356	130	17	in	in	ADP
ajcp-5356	130	18	chitosan	chitosan	ADJ
ajcp-5356	130	19	nanoparticles	nanoparticle	NOUN
ajcp-5356	130	20	.	.	PUNCT
ajcp-5356	131	1	uv	uv	NOUN
ajcp-5356	131	2	-	-	PUNCT
ajcp-5356	131	3	vis	vis	X
ajcp-5356	131	4	analysis	analysis	NOUN
ajcp-5356	131	5	at	at	ADP
ajcp-5356	131	6	270	270	NUM
ajcp-5356	131	7	nm	nm	NOUN
ajcp-5356	131	8	showed	show	VERB
ajcp-5356	131	9	high	high	ADJ
ajcp-5356	131	10	efficiency	efficiency	NOUN
ajcp-5356	131	11	values	value	NOUN
ajcp-5356	131	12	:	:	PUNCT
ajcp-5356	131	13	•	•	NUM
ajcp-5356	131	14	14	14	NUM
ajcp-5356	131	15	-	-	PUNCT
ajcp-5356	131	16	deoxy-11,12	deoxy-11,12	NOUN
ajcp-5356	131	17	-	-	PUNCT
ajcp-5356	131	18	didehydroandrographolide	didehydroandrographolide	NOUN
ajcp-5356	131	19	:	:	PUNCT
ajcp-5356	131	20	82.5	82.5	NUM
ajcp-5356	131	21	%	%	NOUN
ajcp-5356	131	22	•	•	ADP
ajcp-5356	131	23	total	total	ADJ
ajcp-5356	131	24	extract	extract	NOUN
ajcp-5356	131	25	encapsulation	encapsulation	NOUN
ajcp-5356	131	26	:	:	PUNCT
ajcp-5356	131	27	71.8	71.8	NUM
ajcp-5356	131	28	%	%	NOUN
ajcp-5356	131	29	high	high	PROPN
ajcp-5356	131	30	ee	ee	PROPN
ajcp-5356	131	31	values	value	NOUN
ajcp-5356	131	32	reflect	reflect	VERB
ajcp-5356	131	33	the	the	DET
ajcp-5356	131	34	effectiveness	effectiveness	NOUN
ajcp-5356	131	35	of	of	ADP
ajcp-5356	131	36	the	the	DET
ajcp-5356	131	37	ionic	ionic	ADJ
ajcp-5356	131	38	gelation	gelation	NOUN
ajcp-5356	131	39	method	method	NOUN
ajcp-5356	131	40	and	and	CCONJ
ajcp-5356	131	41	compatibility	compatibility	NOUN
ajcp-5356	131	42	of	of	ADP
ajcp-5356	131	43	chitosan	chitosan	NOUN
ajcp-5356	131	44	with	with	ADP
ajcp-5356	131	45	diterpenoid	diterpenoid	ADJ
ajcp-5356	131	46	structures	structure	NOUN
ajcp-5356	131	47	.	.	PUNCT
ajcp-5356	132	1	the	the	DET
ajcp-5356	132	2	strong	strong	ADJ
ajcp-5356	132	3	electrostatic	electrostatic	ADJ
ajcp-5356	132	4	interactions	interaction	NOUN
ajcp-5356	132	5	between	between	ADP
ajcp-5356	132	6	protonated	protonated	ADJ
ajcp-5356	132	7	amine	amine	ADJ
ajcp-5356	132	8	groups	group	NOUN
ajcp-5356	132	9	of	of	ADP
ajcp-5356	132	10	chitosan	chitosan	NOUN
ajcp-5356	132	11	and	and	CCONJ
ajcp-5356	132	12	negatively	negatively	ADV
ajcp-5356	132	13	charged	charge	VERB
ajcp-5356	132	14	sulfate	sulfate	NOUN
ajcp-5356	132	15	groups	group	NOUN
ajcp-5356	132	16	ensured	ensure	VERB
ajcp-5356	132	17	optimal	optimal	ADJ
ajcp-5356	132	18	entrapment	entrapment	NOUN
ajcp-5356	132	19	.	.	PUNCT
ajcp-5356	133	1	this	this	DET
ajcp-5356	133	2	encapsulation	encapsulation	NOUN
ajcp-5356	133	3	is	be	AUX
ajcp-5356	133	4	critical	critical	ADJ
ajcp-5356	133	5	for	for	ADP
ajcp-5356	133	6	achieving	achieve	VERB
ajcp-5356	133	7	sustained	sustained	ADJ
ajcp-5356	133	8	release	release	NOUN
ajcp-5356	133	9	and	and	CCONJ
ajcp-5356	133	10	targeted	target	VERB
ajcp-5356	133	11	drug	drug	NOUN
ajcp-5356	133	12	delivery	delivery	NOUN
ajcp-5356	133	13	,	,	PUNCT
ajcp-5356	133	14	reducing	reduce	VERB
ajcp-5356	133	15	the	the	DET
ajcp-5356	133	16	frequency	frequency	NOUN
ajcp-5356	133	17	of	of	ADP
ajcp-5356	133	18	administration	administration	NOUN
ajcp-5356	133	19	and	and	CCONJ
ajcp-5356	133	20	minimizing	minimize	VERB
ajcp-5356	133	21	systemic	systemic	ADJ
ajcp-5356	133	22	side	side	NOUN
ajcp-5356	133	23	effects	effect	NOUN
ajcp-5356	133	24	.	.	PUNCT
ajcp-5356	134	1	in	in	ADP
ajcp-5356	134	2	vitro	vitro	X
ajcp-5356	134	3	release	release	NOUN
ajcp-5356	134	4	profile	profile	NOUN
ajcp-5356	134	5	the	the	DET
ajcp-5356	134	6	drug	drug	NOUN
ajcp-5356	134	7	release	release	NOUN
ajcp-5356	134	8	profile	profile	NOUN
ajcp-5356	134	9	,	,	PUNCT
ajcp-5356	134	10	measured	measure	VERB
ajcp-5356	134	11	using	use	VERB
ajcp-5356	134	12	a	a	DET
ajcp-5356	134	13	dialysis	dialysis	NOUN
ajcp-5356	134	14	membrane	membrane	NOUN
ajcp-5356	134	15	method	method	NOUN
ajcp-5356	134	16	in	in	ADP
ajcp-5356	134	17	pbs	pbs	PROPN
ajcp-5356	134	18	(	(	PUNCT
ajcp-5356	134	19	ph	ph	NOUN
ajcp-5356	134	20	7.4	7.4	NUM
ajcp-5356	134	21	)	)	PUNCT
ajcp-5356	134	22	,	,	PUNCT
ajcp-5356	134	23	was	be	AUX
ajcp-5356	134	24	plotted	plot	VERB
ajcp-5356	134	25	against	against	ADP
ajcp-5356	134	26	time	time	NOUN
ajcp-5356	134	27	.	.	PUNCT
ajcp-5356	135	1	uv	uv	NOUN
ajcp-5356	135	2	-	-	PUNCT
ajcp-5356	135	3	vis	vis	X
ajcp-5356	135	4	spectrophotometry	spectrophotometry	NOUN
ajcp-5356	135	5	revealed	reveal	VERB
ajcp-5356	135	6	a	a	DET
ajcp-5356	135	7	biphasic	biphasic	ADJ
ajcp-5356	135	8	release	release	NOUN
ajcp-5356	135	9	:	:	PUNCT
ajcp-5356	135	10	•	•	NUM
ajcp-5356	135	11	initial	initial	ADJ
ajcp-5356	135	12	burst	burst	NOUN
ajcp-5356	135	13	phase	phase	NOUN
ajcp-5356	135	14	(	(	PUNCT
ajcp-5356	135	15	0–1	0–1	NUM
ajcp-5356	135	16	hr	hr	NOUN
ajcp-5356	135	17	):	):	PUNCT
ajcp-5356	135	18	attributed	attribute	VERB
ajcp-5356	135	19	to	to	PART
ajcp-5356	135	20	surfacebound	surfacebound	VERB
ajcp-5356	135	21	drug	drug	NOUN
ajcp-5356	135	22	molecules	molecule	NOUN
ajcp-5356	135	23	.	.	PUNCT
ajcp-5356	136	1	•	•	NUM
ajcp-5356	136	2	sustained	sustain	VERB
ajcp-5356	136	3	release	release	NOUN
ajcp-5356	136	4	phase	phase	NOUN
ajcp-5356	136	5	(	(	PUNCT
ajcp-5356	136	6	1–4	1–4	NUM
ajcp-5356	136	7	hr	hr	NOUN
ajcp-5356	136	8	):	):	PUNCT
ajcp-5356	136	9	due	due	ADP
ajcp-5356	136	10	to	to	ADP
ajcp-5356	136	11	diffusion	diffusion	NOUN
ajcp-5356	136	12	from	from	ADP
ajcp-5356	136	13	the	the	DET
ajcp-5356	136	14	chitosan	chitosan	ADJ
ajcp-5356	136	15	matrix	matrix	NOUN
ajcp-5356	136	16	.	.	PUNCT
ajcp-5356	137	1	compared	compare	VERB
ajcp-5356	137	2	to	to	ADP
ajcp-5356	137	3	non	non	ADJ
ajcp-5356	137	4	-	-	ADJ
ajcp-5356	137	5	encapsulated	encapsulate	VERB
ajcp-5356	137	6	extract	extract	NOUN
ajcp-5356	137	7	,	,	PUNCT
ajcp-5356	137	8	which	which	PRON
ajcp-5356	137	9	showed	show	VERB
ajcp-5356	137	10	a	a	DET
ajcp-5356	137	11	rapid	rapid	ADJ
ajcp-5356	137	12	release	release	NOUN
ajcp-5356	137	13	within	within	ADP
ajcp-5356	137	14	30	30	NUM
ajcp-5356	137	15	minutes	minute	NOUN
ajcp-5356	137	16	,	,	PUNCT
ajcp-5356	137	17	the	the	DET
ajcp-5356	137	18	encapsulated	encapsulate	VERB
ajcp-5356	137	19	drug	drug	NOUN
ajcp-5356	137	20	extended	extend	VERB
ajcp-5356	137	21	release	release	NOUN
ajcp-5356	137	22	up	up	ADP
ajcp-5356	137	23	to	to	PART
ajcp-5356	137	24	4	4	NUM
ajcp-5356	137	25	hours	hour	NOUN
ajcp-5356	137	26	.	.	PUNCT
ajcp-5356	138	1	this	this	PRON
ajcp-5356	138	2	is	be	AUX
ajcp-5356	138	3	advantageous	advantageous	ADJ
ajcp-5356	138	4	for	for	ADP
ajcp-5356	138	5	anti	anti	ADJ
ajcp-5356	138	6	-	-	ADJ
ajcp-5356	138	7	inflammatory	inflammatory	ADJ
ajcp-5356	138	8	therapy	therapy	NOUN
ajcp-5356	138	9	requiring	require	VERB
ajcp-5356	138	10	prolonged	prolonged	ADJ
ajcp-5356	138	11	drug	drug	NOUN
ajcp-5356	138	12	presence	presence	NOUN
ajcp-5356	138	13	at	at	ADP
ajcp-5356	138	14	the	the	DET
ajcp-5356	138	15	inflammation	inflammation	NOUN
ajcp-5356	138	16	site	site	NOUN
ajcp-5356	138	17	.	.	PUNCT
ajcp-5356	139	1	the	the	DET
ajcp-5356	139	2	kinetics	kinetic	NOUN
ajcp-5356	139	3	followed	follow	VERB
ajcp-5356	139	4	a	a	DET
ajcp-5356	139	5	quasi	quasi	ADJ
ajcp-5356	139	6	-	-	ADJ
ajcp-5356	139	7	fickian	fickian	ADJ
ajcp-5356	139	8	diffusion	diffusion	NOUN
ajcp-5356	139	9	model	model	NOUN
ajcp-5356	139	10	,	,	PUNCT
ajcp-5356	139	11	suggesting	suggest	VERB
ajcp-5356	139	12	diffusion	diffusion	NOUN
ajcp-5356	139	13	as	as	ADP
ajcp-5356	139	14	the	the	DET
ajcp-5356	139	15	primary	primary	ADJ
ajcp-5356	139	16	release	release	NOUN
ajcp-5356	139	17	mechanism	mechanism	NOUN
ajcp-5356	139	18	.	.	PUNCT
ajcp-5356	140	1	sonographic	sonographic	ADJ
ajcp-5356	140	2	evidence	evidence	NOUN
ajcp-5356	140	3	of	of	ADP
ajcp-5356	140	4	inflammation	inflammation	ADJ
ajcp-5356	140	5	resolution	resolution	NOUN
ajcp-5356	140	6	sonographic	sonographic	ADJ
ajcp-5356	140	7	imaging	imaging	NOUN
ajcp-5356	140	8	played	play	VERB
ajcp-5356	140	9	a	a	DET
ajcp-5356	140	10	vital	vital	ADJ
ajcp-5356	140	11	role	role	NOUN
ajcp-5356	140	12	in	in	ADP
ajcp-5356	140	13	monitoring	monitor	VERB
ajcp-5356	140	14	the	the	DET
ajcp-5356	140	15	anti	anti	ADJ
ajcp-5356	140	16	-	-	ADJ
ajcp-5356	140	17	inflammatory	inflammatory	ADJ
ajcp-5356	140	18	effect	effect	NOUN
ajcp-5356	140	19	of	of	ADP
ajcp-5356	140	20	the	the	DET
ajcp-5356	140	21	formulation	formulation	NOUN
ajcp-5356	140	22	.	.	PUNCT
ajcp-5356	141	1	in	in	ADP
ajcp-5356	141	2	the	the	DET
ajcp-5356	141	3	carrageenan	carrageenan	NOUN
ajcp-5356	141	4	-	-	PUNCT
ajcp-5356	141	5	induced	induce	VERB
ajcp-5356	141	6	rat	rat	NOUN
ajcp-5356	141	7	paw	paw	PROPN
ajcp-5356	141	8	edema	edema	PROPN
ajcp-5356	141	9	model	model	NOUN
ajcp-5356	141	10	:	:	PUNCT
ajcp-5356	141	11	•	•	NUM
ajcp-5356	141	12	b	b	X
ajcp-5356	141	13	-	-	PUNCT
ajcp-5356	141	14	mode	mode	NOUN
ajcp-5356	141	15	ultrasound	ultrasound	NOUN
ajcp-5356	141	16	showed	show	VERB
ajcp-5356	141	17	reduced	reduce	VERB
ajcp-5356	141	18	paw	paw	NOUN
ajcp-5356	141	19	thickness	thickness	NOUN
ajcp-5356	141	20	and	and	CCONJ
ajcp-5356	141	21	improved	improved	ADJ
ajcp-5356	141	22	tissue	tissue	NOUN
ajcp-5356	141	23	echotexture	echotexture	NOUN
ajcp-5356	141	24	after	after	ADP
ajcp-5356	141	25	24–48	24–48	NUM
ajcp-5356	141	26	hours	hour	NOUN
ajcp-5356	141	27	of	of	ADP
ajcp-5356	141	28	treatment	treatment	NOUN
ajcp-5356	141	29	.	.	PUNCT
ajcp-5356	142	1	•	•	NOUN
ajcp-5356	142	2	color	color	NOUN
ajcp-5356	142	3	doppler	doppler	NOUN
ajcp-5356	142	4	imaging	imaging	NOUN
ajcp-5356	142	5	revealed	reveal	VERB
ajcp-5356	142	6	decreased	decrease	VERB
ajcp-5356	142	7	vascular	vascular	ADJ
ajcp-5356	142	8	perfusion	perfusion	NOUN
ajcp-5356	142	9	in	in	ADP
ajcp-5356	142	10	the	the	DET
ajcp-5356	142	11	inflamed	inflamed	ADJ
ajcp-5356	142	12	area	area	NOUN
ajcp-5356	142	13	,	,	PUNCT
ajcp-5356	142	14	indicating	indicate	VERB
ajcp-5356	142	15	reduced	reduced	ADJ
ajcp-5356	142	16	inflammation	inflammation	NOUN
ajcp-5356	142	17	.	.	PUNCT
ajcp-5356	143	1	compared	compare	VERB
ajcp-5356	143	2	to	to	ADP
ajcp-5356	143	3	diclofenac	diclofenac	NOUN
ajcp-5356	143	4	-	-	PUNCT
ajcp-5356	143	5	treated	treat	VERB
ajcp-5356	143	6	groups	group	NOUN
ajcp-5356	143	7	,	,	PUNCT
ajcp-5356	143	8	the	the	DET
ajcp-5356	143	9	chitosanencapsulated	chitosanencapsulate	VERB
ajcp-5356	143	10	diterpenoids	diterpenoid	NOUN
ajcp-5356	143	11	showed	show	VERB
ajcp-5356	143	12	equivalent	equivalent	ADJ
ajcp-5356	143	13	or	or	CCONJ
ajcp-5356	143	14	superior	superior	ADJ
ajcp-5356	143	15	reduction	reduction	NOUN
ajcp-5356	143	16	in	in	ADP
ajcp-5356	143	17	vascular	vascular	ADJ
ajcp-5356	143	18	signal	signal	NOUN
ajcp-5356	143	19	intensity	intensity	NOUN
ajcp-5356	143	20	and	and	CCONJ
ajcp-5356	143	21	paw	paw	NOUN
ajcp-5356	143	22	volume	volume	NOUN
ajcp-5356	143	23	.	.	PUNCT
ajcp-5356	144	1	these	these	DET
ajcp-5356	144	2	results	result	NOUN
ajcp-5356	144	3	were	be	AUX
ajcp-5356	144	4	quantified	quantify	VERB
ajcp-5356	144	5	using	use	VERB
ajcp-5356	144	6	standardized	standardized	ADJ
ajcp-5356	144	7	imaging	imaging	NOUN
ajcp-5356	144	8	scales	scale	NOUN
ajcp-5356	144	9	and	and	CCONJ
ajcp-5356	144	10	validated	validate	VERB
ajcp-5356	144	11	against	against	ADP
ajcp-5356	144	12	histopathological	histopathological	ADJ
ajcp-5356	144	13	findings	finding	NOUN
ajcp-5356	144	14	.	.	PUNCT
ajcp-5356	145	1	thus	thus	ADV
ajcp-5356	145	2	,	,	PUNCT
ajcp-5356	145	3	sonography	sonography	NOUN
ajcp-5356	145	4	offered	offer	VERB
ajcp-5356	145	5	a	a	DET
ajcp-5356	145	6	real	real	ADJ
ajcp-5356	145	7	-	-	PUNCT
ajcp-5356	145	8	time	time	NOUN
ajcp-5356	145	9	,	,	PUNCT
ajcp-5356	145	10	non	non	ADJ
ajcp-5356	145	11	-	-	ADJ
ajcp-5356	145	12	invasive	invasive	ADJ
ajcp-5356	145	13	assessment	assessment	NOUN
ajcp-5356	145	14	of	of	ADP
ajcp-5356	145	15	drug	drug	NOUN
ajcp-5356	145	16	efficacy	efficacy	NOUN
ajcp-5356	145	17	and	and	CCONJ
ajcp-5356	145	18	biodistribution	biodistribution	NOUN
ajcp-5356	145	19	,	,	PUNCT
ajcp-5356	145	20	demonstrating	demonstrate	VERB
ajcp-5356	145	21	the	the	DET
ajcp-5356	145	22	formulation	formulation	NOUN
ajcp-5356	145	23	’s	’s	PART
ajcp-5356	145	24	clinical	clinical	ADJ
ajcp-5356	145	25	applicability	applicability	NOUN
ajcp-5356	145	26	.	.	PUNCT
ajcp-5356	146	1	biochemical	biochemical	ADJ
ajcp-5356	146	2	and	and	CCONJ
ajcp-5356	146	3	clinical	clinical	ADJ
ajcp-5356	146	4	observations	observation	NOUN
ajcp-5356	146	5	the	the	DET
ajcp-5356	146	6	anti	anti	ADJ
ajcp-5356	146	7	-	-	ADJ
ajcp-5356	146	8	inflammatory	inflammatory	ADJ
ajcp-5356	146	9	effect	effect	NOUN
ajcp-5356	146	10	was	be	AUX
ajcp-5356	146	11	further	far	ADV
ajcp-5356	146	12	confirmed	confirm	VERB
ajcp-5356	146	13	by	by	ADP
ajcp-5356	146	14	measuring	measure	VERB
ajcp-5356	146	15	serum	serum	NOUN
ajcp-5356	146	16	levels	level	NOUN
ajcp-5356	146	17	of	of	ADP
ajcp-5356	146	18	inflammatory	inflammatory	ADJ
ajcp-5356	146	19	biomarkers	biomarker	NOUN
ajcp-5356	146	20	:	:	PUNCT
ajcp-5356	146	21	•	•	NUM
ajcp-5356	146	22	tnf	tnf	PROPN
ajcp-5356	146	23	-	-	PUNCT
ajcp-5356	146	24	α	α	PROPN
ajcp-5356	146	25	,	,	PUNCT
ajcp-5356	146	26	il-6	il-6	NOUN
ajcp-5356	146	27	,	,	PUNCT
ajcp-5356	146	28	and	and	CCONJ
ajcp-5356	146	29	c	c	X
ajcp-5356	146	30	-	-	PUNCT
ajcp-5356	146	31	reactive	reactive	ADJ
ajcp-5356	146	32	protein	protein	NOUN
ajcp-5356	146	33	(	(	PUNCT
ajcp-5356	146	34	crp	crp	NOUN
ajcp-5356	146	35	)	)	PUNCT
ajcp-5356	146	36	levels	level	NOUN
ajcp-5356	146	37	significantly	significantly	ADV
ajcp-5356	146	38	decreased	decrease	VERB
ajcp-5356	146	39	in	in	ADP
ajcp-5356	146	40	the	the	DET
ajcp-5356	146	41	treatment	treatment	NOUN
ajcp-5356	146	42	group	group	NOUN
ajcp-5356	146	43	(	(	PUNCT
ajcp-5356	146	44	p	p	X
ajcp-5356	146	45	<	<	X
ajcp-5356	146	46	0.01	0.01	NUM
ajcp-5356	146	47	)	)	PUNCT
ajcp-5356	146	48	.	.	PUNCT
ajcp-5356	147	1	•	•	NOUN
ajcp-5356	147	2	liver	liver	NOUN
ajcp-5356	147	3	and	and	CCONJ
ajcp-5356	147	4	kidney	kidney	NOUN
ajcp-5356	147	5	function	function	NOUN
ajcp-5356	147	6	parameters	parameter	NOUN
ajcp-5356	147	7	(	(	PUNCT
ajcp-5356	147	8	alt	alt	ADJ
ajcp-5356	147	9	,	,	PUNCT
ajcp-5356	147	10	ast	ast	NOUN
ajcp-5356	147	11	,	,	PUNCT
ajcp-5356	147	12	creatinine	creatinine	NOUN
ajcp-5356	147	13	,	,	PUNCT
ajcp-5356	147	14	urea	urea	NOUN
ajcp-5356	147	15	)	)	PUNCT
ajcp-5356	147	16	remained	remain	VERB
ajcp-5356	147	17	within	within	ADP
ajcp-5356	147	18	physiological	physiological	ADJ
ajcp-5356	147	19	limits	limit	NOUN
ajcp-5356	147	20	,	,	PUNCT
ajcp-5356	147	21	confirming	confirm	VERB
ajcp-5356	147	22	safety	safety	NOUN
ajcp-5356	147	23	.	.	PUNCT
ajcp-5356	148	1	these	these	DET
ajcp-5356	148	2	results	result	NOUN
ajcp-5356	148	3	corroborate	corroborate	VERB
ajcp-5356	148	4	the	the	DET
ajcp-5356	148	5	findings	finding	NOUN
ajcp-5356	148	6	from	from	ADP
ajcp-5356	148	7	sonographic	sonographic	ADJ
ajcp-5356	148	8	and	and	CCONJ
ajcp-5356	148	9	histological	histological	ADJ
ajcp-5356	148	10	assessments	assessment	NOUN
ajcp-5356	148	11	.	.	PUNCT
ajcp-5356	149	1	additionally	additionally	ADV
ajcp-5356	149	2	,	,	PUNCT
ajcp-5356	149	3	white	white	ADJ
ajcp-5356	149	4	blood	blood	NOUN
ajcp-5356	149	5	cell	cell	NOUN
ajcp-5356	149	6	(	(	PUNCT
ajcp-5356	149	7	wbc	wbc	NOUN
ajcp-5356	149	8	)	)	PUNCT
ajcp-5356	149	9	count	count	NOUN
ajcp-5356	149	10	and	and	CCONJ
ajcp-5356	149	11	neutrophil	neutrophil	ADJ
ajcp-5356	149	12	/	/	SYM
ajcp-5356	149	13	lymphocyte	lymphocyte	ADJ
ajcp-5356	149	14	ratios	ratio	NOUN
ajcp-5356	149	15	normalized	normalize	VERB
ajcp-5356	149	16	after	after	ADP
ajcp-5356	149	17	treatment	treatment	NOUN
ajcp-5356	149	18	,	,	PUNCT
ajcp-5356	149	19	supporting	support	VERB
ajcp-5356	149	20	systemic	systemic	ADJ
ajcp-5356	149	21	antiinflammatory	antiinflammatory	NOUN
ajcp-5356	149	22	action	action	NOUN
ajcp-5356	149	23	.	.	PUNCT
ajcp-5356	150	1	this	this	DET
ajcp-5356	150	2	multidisciplinary	multidisciplinary	ADJ
ajcp-5356	150	3	validation	validation	NOUN
ajcp-5356	150	4	confirms	confirm	VERB
ajcp-5356	150	5	both	both	CCONJ
ajcp-5356	150	6	the	the	DET
ajcp-5356	150	7	safety	safety	NOUN
ajcp-5356	150	8	and	and	CCONJ
ajcp-5356	150	9	therapeutic	therapeutic	ADJ
ajcp-5356	150	10	efficacy	efficacy	NOUN
ajcp-5356	150	11	of	of	ADP
ajcp-5356	150	12	the	the	DET
ajcp-5356	150	13	nanoformulated	nanoformulate	VERB
ajcp-5356	150	14	drug	drug	NOUN
ajcp-5356	150	15	.	.	PUNCT
ajcp-5356	151	1	comparative	comparative	ADJ
ajcp-5356	151	2	assessment	assessment	NOUN
ajcp-5356	151	3	with	with	ADP
ajcp-5356	151	4	standard	standard	ADJ
ajcp-5356	151	5	drugs	drug	NOUN
ajcp-5356	151	6	comparative	comparative	ADJ
ajcp-5356	151	7	studies	study	NOUN
ajcp-5356	151	8	were	be	AUX
ajcp-5356	151	9	conducted	conduct	VERB
ajcp-5356	151	10	with	with	ADP
ajcp-5356	151	11	standard	standard	ADJ
ajcp-5356	151	12	antiinflammatory	antiinflammatory	NOUN
ajcp-5356	151	13	drugs	drug	NOUN
ajcp-5356	151	14	—	—	PUNCT
ajcp-5356	151	15	chymoral	chymoral	ADJ
ajcp-5356	151	16	and	and	CCONJ
ajcp-5356	151	17	diclofenac	diclofenac	ADJ
ajcp-5356	151	18	sodium	sodium	NOUN
ajcp-5356	151	19	.	.	PUNCT
ajcp-5356	152	1	results	result	NOUN
ajcp-5356	152	2	indicate	indicate	VERB
ajcp-5356	152	3	:	:	PUNCT
ajcp-5356	152	4	•	•	ADP
ajcp-5356	152	5	the	the	DET
ajcp-5356	152	6	encapsulated	encapsulate	VERB
ajcp-5356	152	7	a.	a.	NOUN
ajcp-5356	152	8	paniculata	paniculata	VERB
ajcp-5356	152	9	isolates	isolate	NOUN
ajcp-5356	152	10	produced	produce	VERB
ajcp-5356	152	11	comparable	comparable	ADJ
ajcp-5356	152	12	or	or	CCONJ
ajcp-5356	152	13	superior	superior	ADJ
ajcp-5356	152	14	edema	edema	NOUN
ajcp-5356	152	15	reduction	reduction	NOUN
ajcp-5356	152	16	.	.	PUNCT
ajcp-5356	153	1	•	•	NUM
ajcp-5356	153	2	lower	low	ADJ
ajcp-5356	153	3	hepatotoxicity	hepatotoxicity	NOUN
ajcp-5356	153	4	and	and	CCONJ
ajcp-5356	153	5	longer	long	ADJ
ajcp-5356	153	6	duration	duration	NOUN
ajcp-5356	153	7	of	of	ADP
ajcp-5356	153	8	effect	effect	NOUN
ajcp-5356	153	9	were	be	AUX
ajcp-5356	153	10	observed	observe	VERB
ajcp-5356	153	11	.	.	PUNCT
ajcp-5356	154	1	•	•	NUM
ajcp-5356	154	2	sonographic	sonographic	ADJ
ajcp-5356	154	3	profiles	profile	NOUN
ajcp-5356	154	4	were	be	AUX
ajcp-5356	154	5	more	more	ADV
ajcp-5356	154	6	stable	stable	ADJ
ajcp-5356	154	7	over	over	ADP
ajcp-5356	154	8	time	time	NOUN
ajcp-5356	154	9	,	,	PUNCT
ajcp-5356	154	10	and	and	CCONJ
ajcp-5356	154	11	doppler	doppler	NOUN
ajcp-5356	154	12	indices	index	NOUN
ajcp-5356	154	13	showed	show	VERB
ajcp-5356	154	14	consistent	consistent	ADJ
ajcp-5356	154	15	vascular	vascular	ADJ
ajcp-5356	154	16	improvement	improvement	NOUN
ajcp-5356	154	17	.	.	PUNCT
ajcp-5356	155	1	histological	histological	ADJ
ajcp-5356	155	2	examination	examination	NOUN
ajcp-5356	155	3	of	of	ADP
ajcp-5356	155	4	paw	paw	PROPN
ajcp-5356	155	5	tissues	tissue	NOUN
ajcp-5356	155	6	confirmed	confirm	VERB
ajcp-5356	155	7	reduced	reduce	VERB
ajcp-5356	155	8	neutrophil	neutrophil	ADJ
ajcp-5356	155	9	infiltration	infiltration	NOUN
ajcp-5356	155	10	and	and	CCONJ
ajcp-5356	155	11	minimal	minimal	ADJ
ajcp-5356	155	12	fibrosis	fibrosis	NOUN
ajcp-5356	155	13	,	,	PUNCT
ajcp-5356	155	14	aligning	align	VERB
ajcp-5356	155	15	with	with	ADP
ajcp-5356	155	16	biochemical	biochemical	ADJ
ajcp-5356	155	17	and	and	CCONJ
ajcp-5356	155	18	imaging	imaging	NOUN
ajcp-5356	155	19	data	datum	NOUN
ajcp-5356	155	20	.	.	PUNCT
ajcp-5356	156	1	thus	thus	ADV
ajcp-5356	156	2	,	,	PUNCT
ajcp-5356	156	3	this	this	DET
ajcp-5356	156	4	formulation	formulation	NOUN
ajcp-5356	156	5	holds	hold	VERB
ajcp-5356	156	6	promise	promise	NOUN
ajcp-5356	156	7	as	as	ADP
ajcp-5356	156	8	a	a	DET
ajcp-5356	156	9	plant	plant	NOUN
ajcp-5356	156	10	-	-	PUNCT
ajcp-5356	156	11	based	base	VERB
ajcp-5356	156	12	alternative	alternative	NOUN
ajcp-5356	156	13	to	to	ADP
ajcp-5356	156	14	synthetic	synthetic	ADJ
ajcp-5356	156	15	anti	anti	ADJ
ajcp-5356	156	16	-	-	NOUN
ajcp-5356	156	17	inflammatories	inflammatorie	NOUN
ajcp-5356	156	18	,	,	PUNCT
ajcp-5356	156	19	particularly	particularly	ADV
ajcp-5356	156	20	suitable	suitable	ADJ
ajcp-5356	156	21	for	for	ADP
ajcp-5356	156	22	chronic	chronic	ADJ
ajcp-5356	156	23	conditions	condition	NOUN
ajcp-5356	156	24	requiring	require	VERB
ajcp-5356	156	25	long	long	ADJ
ajcp-5356	156	26	-	-	PUNCT
ajcp-5356	156	27	term	term	NOUN
ajcp-5356	156	28	treatment	treatment	NOUN
ajcp-5356	156	29	.	.	PUNCT
ajcp-5356	157	1	conclusion	conclusion	NOUN
ajcp-5356	157	2	this	this	DET
ajcp-5356	157	3	work	work	NOUN
ajcp-5356	157	4	effectively	effectively	ADV
ajcp-5356	157	5	illustrates	illustrate	VERB
ajcp-5356	157	6	how	how	SCONJ
ajcp-5356	157	7	the	the	DET
ajcp-5356	157	8	transport	transport	NOUN
ajcp-5356	157	9	,	,	PUNCT
ajcp-5356	157	10	stability	stability	NOUN
ajcp-5356	157	11	,	,	PUNCT
ajcp-5356	157	12	and	and	CCONJ
ajcp-5356	157	13	anti	anti	ADJ
ajcp-5356	157	14	-	-	ADJ
ajcp-5356	157	15	inflammatory	inflammatory	ADJ
ajcp-5356	157	16	effectiveness	effectiveness	NOUN
ajcp-5356	157	17	of	of	ADP
ajcp-5356	157	18	the	the	DET
ajcp-5356	157	19	bioactive	bioactive	PROPN
ajcp-5356	157	20	chemicals	chemical	NOUN
ajcp-5356	157	21	are	be	AUX
ajcp-5356	157	22	much	much	ADV
ajcp-5356	157	23	improved	improve	VERB
ajcp-5356	157	24	when	when	SCONJ
ajcp-5356	157	25	andrographis	andrographis	PRON
ajcp-5356	157	26	paniculata	paniculata	ADJ
ajcp-5356	157	27	diterpenoids	diterpenoid	NOUN
ajcp-5356	157	28	are	be	AUX
ajcp-5356	157	29	nanoencapsulated	nanoencapsulate	VERB
ajcp-5356	157	30	utilizing	utilize	VERB
ajcp-5356	157	31	a	a	DET
ajcp-5356	157	32	chitosan	chitosan	ADJ
ajcp-5356	157	33	matrix	matrix	NOUN
ajcp-5356	157	34	.	.	PUNCT
ajcp-5356	158	1	the	the	DET
ajcp-5356	158	2	sustained	sustained	ADJ
ajcp-5356	158	3	drug	drug	NOUN
ajcp-5356	158	4	release	release	NOUN
ajcp-5356	158	5	and	and	CCONJ
ajcp-5356	158	6	high	high	ADJ
ajcp-5356	158	7	encapsulation	encapsulation	NOUN
ajcp-5356	158	8	efficiency	efficiency	NOUN
ajcp-5356	158	9	of	of	ADP
ajcp-5356	158	10	the	the	DET
ajcp-5356	158	11	chitosan	chitosan	NOUN
ajcp-5356	158	12	-	-	PUNCT
ajcp-5356	158	13	based	base	VERB
ajcp-5356	158	14	nanoformulation	nanoformulation	NOUN
ajcp-5356	158	15	decreased	decrease	VERB
ajcp-5356	158	16	the	the	DET
ajcp-5356	158	17	frequency	frequency	NOUN
ajcp-5356	158	18	of	of	ADP
ajcp-5356	158	19	administration	administration	NOUN
ajcp-5356	158	20	and	and	CCONJ
ajcp-5356	158	21	enhanced	enhance	VERB
ajcp-5356	158	22	treatment	treatment	NOUN
ajcp-5356	158	23	compliance	compliance	NOUN
ajcp-5356	158	24	.	.	PUNCT
ajcp-5356	159	1	analytical	analytical	ADJ
ajcp-5356	159	2	validation	validation	NOUN
ajcp-5356	159	3	using	use	VERB
ajcp-5356	159	4	ftir	ftir	PROPN
ajcp-5356	159	5	,	,	PUNCT
ajcp-5356	159	6	sem	sem	PROPN
ajcp-5356	159	7	/	/	SYM
ajcp-5356	159	8	tem	tem	PROPN
ajcp-5356	159	9	,	,	PUNCT
ajcp-5356	159	10	xrd	xrd	NOUN
ajcp-5356	159	11	,	,	PUNCT
ajcp-5356	159	12	and	and	CCONJ
ajcp-5356	159	13	uv	uv	NOUN
ajcp-5356	159	14	-	-	PUNCT
ajcp-5356	159	15	vis	vis	X
ajcp-5356	159	16	verified	verify	VERB
ajcp-5356	159	17	the	the	DET
ajcp-5356	159	18	nanoparticles	nanoparticle	NOUN
ajcp-5356	159	19	’	'	PUNCT
ajcp-5356	159	20	morphological	morphological	ADJ
ajcp-5356	159	21	and	and	CCONJ
ajcp-5356	159	22	structural	structural	ADJ
ajcp-5356	159	23	integrity	integrity	NOUN
ajcp-5356	159	24	.	.	PUNCT
ajcp-5356	160	1	the	the	DET
ajcp-5356	160	2	in	in	ADP
ajcp-5356	160	3	vivo	vivo	ADJ
ajcp-5356	160	4	anti	anti	ADJ
ajcp-5356	160	5	-	-	ADJ
ajcp-5356	160	6	inflammatory	inflammatory	ADJ
ajcp-5356	160	7	impact	impact	NOUN
ajcp-5356	160	8	was	be	AUX
ajcp-5356	160	9	demonstrated	demonstrate	VERB
ajcp-5356	160	10	by	by	ADP
ajcp-5356	160	11	better	well	ADJ
ajcp-5356	160	12	histological	histological	ADJ
ajcp-5356	160	13	architecture	architecture	NOUN
ajcp-5356	160	14	,	,	PUNCT
ajcp-5356	160	15	normalized	normalize	VERB
ajcp-5356	160	16	organ	organ	NOUN
ajcp-5356	160	17	function	function	NOUN
ajcp-5356	160	18	measures	measure	NOUN
ajcp-5356	160	19	,	,	PUNCT
ajcp-5356	160	20	and	and	CCONJ
ajcp-5356	160	21	decreased	decrease	VERB
ajcp-5356	160	22	blood	blood	NOUN
ajcp-5356	160	23	levels	level	NOUN
ajcp-5356	160	24	of	of	ADP
ajcp-5356	160	25	inflammatory	inflammatory	ADJ
ajcp-5356	160	26	biomarkers	biomarker	NOUN
ajcp-5356	160	27	(	(	PUNCT
ajcp-5356	160	28	tnf	tnf	PROPN
ajcp-5356	160	29	-	-	PUNCT
ajcp-5356	160	30	α	α	PROPN
ajcp-5356	160	31	,	,	PUNCT
ajcp-5356	160	32	il-6	il-6	NOUN
ajcp-5356	160	33	,	,	PUNCT
ajcp-5356	160	34	and	and	CCONJ
ajcp-5356	160	35	crp	crp	PROPN
ajcp-5356	160	36	)	)	PUNCT
ajcp-5356	160	37	.	.	PUNCT
ajcp-5356	161	1	sonographic	sonographic	ADJ
ajcp-5356	161	2	imaging	imaging	NOUN
ajcp-5356	161	3	supported	support	VERB
ajcp-5356	161	4	the	the	DET
ajcp-5356	161	5	incorporation	incorporation	NOUN
ajcp-5356	161	6	of	of	ADP
ajcp-5356	161	7	radiological	radiological	ADJ
ajcp-5356	161	8	assessment	assessment	NOUN
ajcp-5356	161	9	in	in	ADP
ajcp-5356	161	10	preclinical	preclinical	ADJ
ajcp-5356	161	11	investigations	investigation	NOUN
ajcp-5356	161	12	by	by	ADP
ajcp-5356	161	13	providing	provide	VERB
ajcp-5356	161	14	a	a	DET
ajcp-5356	161	15	new	new	ADJ
ajcp-5356	161	16	and	and	CCONJ
ajcp-5356	161	17	real	real	ADJ
ajcp-5356	161	18	-	-	PUNCT
ajcp-5356	161	19	time	time	NOUN
ajcp-5356	161	20	way	way	NOUN
ajcp-5356	161	21	to	to	PART
ajcp-5356	161	22	evaluate	evaluate	VERB
ajcp-5356	161	23	inflammation	inflammation	NOUN
ajcp-5356	161	24	.	.	PUNCT
ajcp-5356	162	1	the	the	DET
ajcp-5356	162	2	nanoformulation	nanoformulation	NOUN
ajcp-5356	162	3	not	not	PART
ajcp-5356	162	4	only	only	ADV
ajcp-5356	162	5	matches	match	NOUN
ajcp-5356	162	6	but	but	CCONJ
ajcp-5356	162	7	may	may	AUX
ajcp-5356	162	8	surpass	surpass	VERB
ajcp-5356	162	9	traditional	traditional	ADJ
ajcp-5356	162	10	treatments	treatment	NOUN
ajcp-5356	162	11	in	in	ADP
ajcp-5356	162	12	terms	term	NOUN
ajcp-5356	162	13	of	of	ADP
ajcp-5356	162	14	efficacy	efficacy	NOUN
ajcp-5356	162	15	and	and	CCONJ
ajcp-5356	162	16	safety	safety	NOUN
ajcp-5356	162	17	,	,	PUNCT
ajcp-5356	162	18	according	accord	VERB
ajcp-5356	162	19	to	to	ADP
ajcp-5356	162	20	comparative	comparative	ADJ
ajcp-5356	162	21	data	datum	NOUN
ajcp-5356	162	22	with	with	ADP
ajcp-5356	162	23	pa	pa	PROPN
ajcp-5356	162	24	ge	ge	PROPN
ajcp-5356	162	25	53	53	NUM
ajcp-5356	162	26	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-5356	162	27	am	be	AUX
ajcp-5356	162	28	.	.	PUNCT
ajcp-5356	163	1	j.	j.	PROPN
ajcp-5356	163	2	chem	chem	PROPN
ajcp-5356	163	3	.	.	PUNCT
ajcp-5356	164	1	pharm	pharm	PROPN
ajcp-5356	164	2	.	.	PUNCT
ajcp-5356	165	1	4(1	4(1	NOUN
ajcp-5356	165	2	)	)	PUNCT
ajcp-5356	166	1	48	48	NUM
ajcp-5356	166	2	-	-	SYM
ajcp-5356	166	3	53	53	NUM
ajcp-5356	166	4	,	,	PUNCT
ajcp-5356	166	5	2025	2025	NUM
ajcp-5356	166	6	standard	standard	ADJ
ajcp-5356	166	7	medications	medication	NOUN
ajcp-5356	166	8	.	.	PUNCT
ajcp-5356	167	1	the	the	DET
ajcp-5356	167	2	importance	importance	NOUN
ajcp-5356	167	3	of	of	ADP
ajcp-5356	167	4	integrating	integrate	VERB
ajcp-5356	167	5	imaging	imaging	NOUN
ajcp-5356	167	6	,	,	PUNCT
ajcp-5356	167	7	clinical	clinical	ADJ
ajcp-5356	167	8	science	science	NOUN
ajcp-5356	167	9	,	,	PUNCT
ajcp-5356	167	10	nanotechnology	nanotechnology	NOUN
ajcp-5356	167	11	,	,	PUNCT
ajcp-5356	167	12	and	and	CCONJ
ajcp-5356	167	13	phytochemistry	phytochemistry	NOUN
ajcp-5356	167	14	in	in	ADP
ajcp-5356	167	15	medication	medication	NOUN
ajcp-5356	167	16	development	development	NOUN
ajcp-5356	167	17	is	be	AUX
ajcp-5356	167	18	highlighted	highlight	VERB
ajcp-5356	167	19	by	by	ADP
ajcp-5356	167	20	this	this	DET
ajcp-5356	167	21	interdisciplinary	interdisciplinary	ADJ
ajcp-5356	167	22	work	work	NOUN
ajcp-5356	167	23	.	.	PUNCT
ajcp-5356	168	1	clinical	clinical	ADJ
ajcp-5356	168	2	trials	trial	NOUN
ajcp-5356	168	3	,	,	PUNCT
ajcp-5356	168	4	large	large	ADJ
ajcp-5356	168	5	-	-	PUNCT
ajcp-5356	168	6	scale	scale	NOUN
ajcp-5356	168	7	formulation	formulation	NOUN
ajcp-5356	168	8	,	,	PUNCT
ajcp-5356	168	9	and	and	CCONJ
ajcp-5356	168	10	prolonged	prolong	VERB
ajcp-5356	168	11	pharmacokinetics	pharmacokinetic	NOUN
ajcp-5356	168	12	in	in	ADP
ajcp-5356	168	13	human	human	ADJ
ajcp-5356	168	14	models	model	NOUN
ajcp-5356	168	15	should	should	AUX
ajcp-5356	168	16	all	all	PRON
ajcp-5356	168	17	be	be	AUX
ajcp-5356	168	18	investigated	investigate	VERB
ajcp-5356	168	19	in	in	ADP
ajcp-5356	168	20	future	future	ADJ
ajcp-5356	168	21	research	research	NOUN
ajcp-5356	168	22	.	.	PUNCT
ajcp-5356	169	1	references	reference	NOUN
ajcp-5356	169	2	akbar	akbar	NOUN
ajcp-5356	169	3	,	,	PUNCT
ajcp-5356	169	4	s.	s.	PROPN
ajcp-5356	169	5	(	(	PUNCT
ajcp-5356	169	6	2011	2011	NUM
ajcp-5356	169	7	)	)	PUNCT
ajcp-5356	169	8	.	.	PUNCT
ajcp-5356	170	1	andrographis	andrographis	PROPN
ajcp-5356	170	2	paniculata	paniculata	ADJ
ajcp-5356	170	3	:	:	PUNCT
ajcp-5356	170	4	a	a	DET
ajcp-5356	170	5	review	review	NOUN
ajcp-5356	170	6	of	of	ADP
ajcp-5356	170	7	pharmacological	pharmacological	ADJ
ajcp-5356	170	8	activities	activity	NOUN
ajcp-5356	170	9	and	and	CCONJ
ajcp-5356	170	10	clinical	clinical	ADJ
ajcp-5356	170	11	effects	effect	NOUN
ajcp-5356	170	12	.	.	PUNCT
ajcp-5356	171	1	alternative	alternative	ADJ
ajcp-5356	171	2	medicine	medicine	PROPN
ajcp-5356	171	3	review	review	PROPN
ajcp-5356	171	4	,	,	PUNCT
ajcp-5356	171	5	16(1	16(1	NUM
ajcp-5356	171	6	)	)	PUNCT
ajcp-5356	171	7	,	,	PUNCT
ajcp-5356	171	8	66–77	66–77	NUM
ajcp-5356	171	9	.	.	PUNCT
ajcp-5356	172	1	https://	https://	PROPN
ajcp-5356	172	2	pubmed.ncbi.nlm.nih.gov/21438646	pubmed.ncbi.nlm.nih.gov/21438646	PUNCT
ajcp-5356	173	1	beg	beg	NOUN
ajcp-5356	173	2	,	,	PUNCT
ajcp-5356	173	3	s.	s.	PROPN
ajcp-5356	173	4	,	,	PUNCT
ajcp-5356	173	5	javed	javed	PROPN
ajcp-5356	173	6	,	,	PUNCT
ajcp-5356	173	7	s.	s.	PROPN
ajcp-5356	173	8	,	,	PUNCT
ajcp-5356	173	9	kohli	kohli	PROPN
ajcp-5356	173	10	,	,	PUNCT
ajcp-5356	173	11	k.	k.	PROPN
ajcp-5356	173	12	,	,	PUNCT
ajcp-5356	173	13	ahmad	ahmad	PROPN
ajcp-5356	173	14	,	,	PUNCT
ajcp-5356	173	15	f.	f.	PROPN
ajcp-5356	173	16	j.	j.	PROPN
ajcp-5356	173	17	,	,	PUNCT
ajcp-5356	173	18	&	&	CCONJ
ajcp-5356	173	19	aqil	aqil	PROPN
ajcp-5356	173	20	,	,	PUNCT
ajcp-5356	173	21	m.	m.	NOUN
ajcp-5356	173	22	(	(	PUNCT
ajcp-5356	173	23	2010	2010	NUM
ajcp-5356	173	24	)	)	PUNCT
ajcp-5356	173	25	.	.	PUNCT
ajcp-5356	174	1	nanotechnology	nanotechnology	NOUN
ajcp-5356	174	2	-	-	PUNCT
ajcp-5356	174	3	based	base	VERB
ajcp-5356	174	4	approaches	approach	NOUN
ajcp-5356	174	5	for	for	ADP
ajcp-5356	174	6	the	the	DET
ajcp-5356	174	7	delivery	delivery	NOUN
ajcp-5356	174	8	of	of	ADP
ajcp-5356	174	9	bioactive	bioactive	ADJ
ajcp-5356	174	10	compounds	compound	NOUN
ajcp-5356	174	11	in	in	ADP
ajcp-5356	174	12	cardiovascular	cardiovascular	ADJ
ajcp-5356	174	13	disorders	disorder	NOUN
ajcp-5356	174	14	.	.	PUNCT
ajcp-5356	175	1	current	current	ADJ
ajcp-5356	175	2	vascular	vascular	ADJ
ajcp-5356	175	3	pharmacology	pharmacology	NOUN
ajcp-5356	175	4	,	,	PUNCT
ajcp-5356	175	5	8(2	8(2	NUM
ajcp-5356	175	6	)	)	PUNCT
ajcp-5356	175	7	,	,	PUNCT
ajcp-5356	175	8	168–179	168–179	NUM
ajcp-5356	175	9	.	.	PUNCT
ajcp-5356	176	1	https://doi.org/10.2174/157016110790226645	https://doi.org/10.2174/157016110790226645	PROPN
ajcp-5356	176	2	choudhury	choudhury	PROPN
ajcp-5356	176	3	,	,	PUNCT
ajcp-5356	176	4	h.	h.	PROPN
ajcp-5356	176	5	,	,	PUNCT
ajcp-5356	176	6	pandey	pandey	PROPN
ajcp-5356	176	7	,	,	PUNCT
ajcp-5356	176	8	m.	m.	NOUN
ajcp-5356	176	9	,	,	PUNCT
ajcp-5356	176	10	hua	hua	PROPN
ajcp-5356	176	11	,	,	PUNCT
ajcp-5356	176	12	c.	c.	PROPN
ajcp-5356	176	13	k.	k.	PROPN
ajcp-5356	176	14	,	,	PUNCT
ajcp-5356	176	15	mun	mun	PROPN
ajcp-5356	176	16	,	,	PUNCT
ajcp-5356	176	17	c.	c.	PROPN
ajcp-5356	176	18	s.	s.	PROPN
ajcp-5356	176	19	,	,	PUNCT
ajcp-5356	176	20	jing	jing	PROPN
ajcp-5356	176	21	,	,	PUNCT
ajcp-5356	176	22	j.	j.	PROPN
ajcp-5356	176	23	k.	k.	PROPN
ajcp-5356	176	24	,	,	PUNCT
ajcp-5356	176	25	kong	kong	PROPN
ajcp-5356	176	26	,	,	PUNCT
ajcp-5356	176	27	l.	l.	PROPN
ajcp-5356	176	28	,	,	PUNCT
ajcp-5356	176	29	…	…	PUNCT
ajcp-5356	176	30	&	&	CCONJ
ajcp-5356	176	31	sisinthy	sisinthy	ADJ
ajcp-5356	176	32	,	,	PUNCT
ajcp-5356	176	33	s.	s.	PROPN
ajcp-5356	176	34	p.	p.	PROPN
ajcp-5356	176	35	(	(	PUNCT
ajcp-5356	176	36	2021	2021	NUM
ajcp-5356	176	37	)	)	PUNCT
ajcp-5356	176	38	.	.	PUNCT
ajcp-5356	177	1	an	an	DET
ajcp-5356	177	2	update	update	NOUN
ajcp-5356	177	3	on	on	ADP
ajcp-5356	177	4	natural	natural	ADJ
ajcp-5356	177	5	compounds	compound	NOUN
ajcp-5356	177	6	in	in	ADP
ajcp-5356	177	7	the	the	DET
ajcp-5356	177	8	remedy	remedy	NOUN
ajcp-5356	177	9	of	of	ADP
ajcp-5356	177	10	diabetes	diabetes	NOUN
ajcp-5356	177	11	mellitus	mellitus	NOUN
ajcp-5356	177	12	:	:	PUNCT
ajcp-5356	177	13	a	a	DET
ajcp-5356	177	14	systematic	systematic	ADJ
ajcp-5356	177	15	review	review	NOUN
ajcp-5356	177	16	.	.	PUNCT
ajcp-5356	178	1	journal	journal	NOUN
ajcp-5356	178	2	of	of	ADP
ajcp-5356	178	3	traditional	traditional	ADJ
ajcp-5356	178	4	and	and	CCONJ
ajcp-5356	178	5	complementary	complementary	ADJ
ajcp-5356	178	6	medicine	medicine	NOUN
ajcp-5356	178	7	,	,	PUNCT
ajcp-5356	178	8	11(2	11(2	NOUN
ajcp-5356	178	9	)	)	PUNCT
ajcp-5356	178	10	,	,	PUNCT
ajcp-5356	178	11	204–229	204–229	NUM
ajcp-5356	178	12	.	.	PUNCT
ajcp-5356	179	1	https://doi	https://doi	X
ajcp-5356	179	2	.	.	PUNCT
ajcp-5356	179	3	org/10.1016	org/10.1016	PROPN
ajcp-5356	179	4	/	/	SYM
ajcp-5356	179	5	j.jtcme.2020.10.004	j.jtcme.2020.10.004	NOUN
ajcp-5356	179	6	hancke	hancke	NOUN
ajcp-5356	179	7	,	,	PUNCT
ajcp-5356	179	8	j.	j.	PROPN
ajcp-5356	179	9	l.	l.	PROPN
ajcp-5356	179	10	,	,	PUNCT
ajcp-5356	179	11	burgos	burgos	PROPN
ajcp-5356	179	12	,	,	PUNCT
ajcp-5356	179	13	r.	r.	PROPN
ajcp-5356	179	14	a.	a.	PROPN
ajcp-5356	179	15	,	,	PUNCT
ajcp-5356	179	16	&	&	CCONJ
ajcp-5356	179	17	ahumada	ahumada	PROPN
ajcp-5356	179	18	,	,	PUNCT
ajcp-5356	179	19	f.	f.	PROPN
ajcp-5356	179	20	(	(	PUNCT
ajcp-5356	179	21	1995	1995	NUM
ajcp-5356	179	22	)	)	PUNCT
ajcp-5356	179	23	.	.	PUNCT
ajcp-5356	180	1	activity	activity	NOUN
ajcp-5356	180	2	of	of	ADP
ajcp-5356	180	3	andrographis	andrographis	PRON
ajcp-5356	180	4	paniculata	paniculata	NOUN
ajcp-5356	180	5	in	in	ADP
ajcp-5356	180	6	the	the	DET
ajcp-5356	180	7	treatment	treatment	NOUN
ajcp-5356	180	8	of	of	ADP
ajcp-5356	180	9	upper	upper	ADJ
ajcp-5356	180	10	respiratory	respiratory	ADJ
ajcp-5356	180	11	tract	tract	NOUN
ajcp-5356	180	12	infections	infection	NOUN
ajcp-5356	180	13	.	.	PUNCT
ajcp-5356	181	1	phytomedicine	phytomedicine	NOUN
ajcp-5356	181	2	,	,	PUNCT
ajcp-5356	181	3	2(4	2(4	NUM
ajcp-5356	181	4	)	)	PUNCT
ajcp-5356	181	5	,	,	PUNCT
ajcp-5356	181	6	293–298	293–298	NUM
ajcp-5356	181	7	.	.	PUNCT
ajcp-5356	182	1	https://doi.org/10.1016/s09447113(11)80052-1	https://doi.org/10.1016/s09447113(11)80052-1	PROPN
ajcp-5356	182	2	jin	jin	PROPN
ajcp-5356	182	3	,	,	PUNCT
ajcp-5356	182	4	l.	l.	PROPN
ajcp-5356	182	5	,	,	PUNCT
ajcp-5356	182	6	quan	quan	PROPN
ajcp-5356	182	7	,	,	PUNCT
ajcp-5356	182	8	c.	c.	PROPN
ajcp-5356	182	9	,	,	PUNCT
ajcp-5356	182	10	hou	hou	PROPN
ajcp-5356	182	11	,	,	PUNCT
ajcp-5356	182	12	x.	x.	NOUN
ajcp-5356	182	13	,	,	PUNCT
ajcp-5356	182	14	&	&	CCONJ
ajcp-5356	182	15	fan	fan	PROPN
ajcp-5356	182	16	,	,	PUNCT
ajcp-5356	182	17	s.	s.	PROPN
ajcp-5356	182	18	(	(	PUNCT
ajcp-5356	182	19	2016	2016	NUM
ajcp-5356	182	20	)	)	PUNCT
ajcp-5356	182	21	.	.	PUNCT
ajcp-5356	183	1	potential	potential	ADJ
ajcp-5356	183	2	pharmacological	pharmacological	ADJ
ajcp-5356	183	3	resources	resource	NOUN
ajcp-5356	183	4	:	:	PUNCT
ajcp-5356	183	5	natural	natural	ADJ
ajcp-5356	183	6	bioactive	bioactive	ADJ
ajcp-5356	183	7	compounds	compound	NOUN
ajcp-5356	183	8	from	from	ADP
ajcp-5356	183	9	marine	marine	ADJ
ajcp-5356	183	10	-	-	PUNCT
ajcp-5356	183	11	derived	derive	VERB
ajcp-5356	183	12	fungi	fungus	NOUN
ajcp-5356	183	13	.	.	PUNCT
ajcp-5356	184	1	marine	marine	PROPN
ajcp-5356	184	2	drugs	drug	NOUN
ajcp-5356	184	3	,	,	PUNCT
ajcp-5356	184	4	14(4	14(4	NUM
ajcp-5356	184	5	)	)	PUNCT
ajcp-5356	184	6	,	,	PUNCT
ajcp-5356	184	7	76	76	NUM
ajcp-5356	184	8	.	.	PUNCT
ajcp-5356	185	1	https://doi.org/10.3390/md14040076	https://doi.org/10.3390/md14040076	PROPN
ajcp-5356	185	2	kayser	kayser	PROPN
ajcp-5356	185	3	,	,	PUNCT
ajcp-5356	185	4	o.	o.	PROPN
ajcp-5356	185	5	,	,	PUNCT
ajcp-5356	185	6	lemke	lemke	PROPN
ajcp-5356	185	7	,	,	PUNCT
ajcp-5356	185	8	a.	a.	PROPN
ajcp-5356	185	9	,	,	PUNCT
ajcp-5356	185	10	&	&	CCONJ
ajcp-5356	185	11	hernandez	hernandez	PROPN
ajcp-5356	185	12	-	-	PUNCT
ajcp-5356	185	13	trejo	trejo	PROPN
ajcp-5356	185	14	,	,	PUNCT
ajcp-5356	185	15	n.	n.	PROPN
ajcp-5356	185	16	(	(	PUNCT
ajcp-5356	185	17	2005	2005	NUM
ajcp-5356	185	18	)	)	PUNCT
ajcp-5356	185	19	.	.	PUNCT
ajcp-5356	186	1	the	the	DET
ajcp-5356	186	2	impact	impact	NOUN
ajcp-5356	186	3	of	of	ADP
ajcp-5356	186	4	nanobiotechnology	nanobiotechnology	NOUN
ajcp-5356	186	5	on	on	ADP
ajcp-5356	186	6	the	the	DET
ajcp-5356	186	7	development	development	NOUN
ajcp-5356	186	8	of	of	ADP
ajcp-5356	186	9	new	new	ADJ
ajcp-5356	186	10	drug	drug	NOUN
ajcp-5356	186	11	delivery	delivery	NOUN
ajcp-5356	186	12	systems	system	NOUN
ajcp-5356	186	13	.	.	PUNCT
ajcp-5356	187	1	current	current	ADJ
ajcp-5356	187	2	pharmaceutical	pharmaceutical	NOUN
ajcp-5356	187	3	biotechnology	biotechnology	NOUN
ajcp-5356	187	4	,	,	PUNCT
ajcp-5356	187	5	6(1	6(1	NUM
ajcp-5356	187	6	)	)	PUNCT
ajcp-5356	187	7	,	,	PUNCT
ajcp-5356	187	8	3–5	3–5	X
ajcp-5356	187	9	.	.	PUNCT
ajcp-5356	188	1	https://doi	https://doi	X
ajcp-5356	188	2	.	.	PUNCT
ajcp-5356	189	1	org/10.2174/1389201053167148	org/10.2174/1389201053167148	PROPN
ajcp-5356	189	2	kwon	kwon	PROPN
ajcp-5356	189	3	,	,	PUNCT
ajcp-5356	189	4	h.	h.	PROPN
ajcp-5356	189	5	c.	c.	PROPN
ajcp-5356	189	6	,	,	PUNCT
ajcp-5356	189	7	kauffman	kauffman	PROPN
ajcp-5356	189	8	,	,	PUNCT
ajcp-5356	189	9	c.	c.	PROPN
ajcp-5356	189	10	a.	a.	PROPN
ajcp-5356	189	11	,	,	PUNCT
ajcp-5356	189	12	jensen	jensen	PROPN
ajcp-5356	189	13	,	,	PUNCT
ajcp-5356	189	14	p.	p.	PROPN
ajcp-5356	189	15	r.	r.	PROPN
ajcp-5356	189	16	,	,	PUNCT
ajcp-5356	189	17	&	&	CCONJ
ajcp-5356	189	18	fenical	fenical	PROPN
ajcp-5356	189	19	,	,	PUNCT
ajcp-5356	189	20	w.	w.	PROPN
ajcp-5356	189	21	(	(	PUNCT
ajcp-5356	189	22	2006	2006	NUM
ajcp-5356	189	23	)	)	PUNCT
ajcp-5356	189	24	.	.	PUNCT
ajcp-5356	190	1	marinopyrrole	marinopyrrole	PROPN
ajcp-5356	190	2	a	a	PRON
ajcp-5356	190	3	:	:	PUNCT
ajcp-5356	190	4	a	a	DET
ajcp-5356	190	5	cytotoxic	cytotoxic	ADJ
ajcp-5356	190	6	and	and	CCONJ
ajcp-5356	190	7	antibiotic	antibiotic	ADJ
ajcp-5356	190	8	compound	compound	NOUN
ajcp-5356	190	9	from	from	ADP
ajcp-5356	190	10	a	a	DET
ajcp-5356	190	11	marine	marine	ADJ
ajcp-5356	190	12	streptomycete	streptomycete	NOUN
ajcp-5356	190	13	.	.	PUNCT
ajcp-5356	191	1	journal	journal	NOUN
ajcp-5356	191	2	of	of	ADP
ajcp-5356	191	3	the	the	DET
ajcp-5356	191	4	american	american	PROPN
ajcp-5356	191	5	chemical	chemical	PROPN
ajcp-5356	191	6	society	society	PROPN
ajcp-5356	191	7	,	,	PUNCT
ajcp-5356	191	8	128(5	128(5	NUM
ajcp-5356	191	9	)	)	PUNCT
ajcp-5356	191	10	,	,	PUNCT
ajcp-5356	191	11	1622–1632	1622–1632	NUM
ajcp-5356	191	12	.	.	PUNCT
ajcp-5356	192	1	https://	https://	PROPN
ajcp-5356	192	2	doi.org/10.1021/ja057153z	doi.org/10.1021/ja057153z	PROPN
ajcp-5356	192	3	lim	lim	PROPN
ajcp-5356	192	4	,	,	PUNCT
ajcp-5356	192	5	j.	j.	PROPN
ajcp-5356	192	6	c.	c.	PROPN
ajcp-5356	192	7	,	,	PUNCT
ajcp-5356	192	8	chan	chan	PROPN
ajcp-5356	192	9	,	,	PUNCT
ajcp-5356	192	10	t.	t.	PROPN
ajcp-5356	192	11	k.	k.	PROPN
ajcp-5356	192	12	,	,	PUNCT
ajcp-5356	192	13	ng	ng	PROPN
ajcp-5356	192	14	,	,	PUNCT
ajcp-5356	192	15	d.	d.	PROPN
ajcp-5356	192	16	s.	s.	PROPN
ajcp-5356	192	17	,	,	PUNCT
ajcp-5356	192	18	sagineedu	sagineedu	PROPN
ajcp-5356	192	19	,	,	PUNCT
ajcp-5356	192	20	s.	s.	PROPN
ajcp-5356	192	21	r.	r.	PROPN
ajcp-5356	192	22	,	,	PUNCT
ajcp-5356	192	23	stanslas	stanslas	PROPN
ajcp-5356	192	24	,	,	PUNCT
ajcp-5356	192	25	j.	j.	PROPN
ajcp-5356	192	26	,	,	PUNCT
ajcp-5356	192	27	&	&	CCONJ
ajcp-5356	192	28	wong	wong	PROPN
ajcp-5356	192	29	,	,	PUNCT
ajcp-5356	192	30	w.	w.	PROPN
ajcp-5356	192	31	s.	s.	PROPN
ajcp-5356	192	32	(	(	PUNCT
ajcp-5356	192	33	2012	2012	NUM
ajcp-5356	192	34	)	)	PUNCT
ajcp-5356	192	35	.	.	PUNCT
ajcp-5356	193	1	andrographolide	andrographolide	ADJ
ajcp-5356	193	2	and	and	CCONJ
ajcp-5356	193	3	its	its	PRON
ajcp-5356	193	4	analogues	analogue	NOUN
ajcp-5356	193	5	:	:	PUNCT
ajcp-5356	193	6	versatile	versatile	ADJ
ajcp-5356	193	7	bioactive	bioactive	ADJ
ajcp-5356	193	8	molecules	molecule	NOUN
ajcp-5356	193	9	for	for	ADP
ajcp-5356	193	10	combating	combat	VERB
ajcp-5356	193	11	inflammation	inflammation	NOUN
ajcp-5356	193	12	and	and	CCONJ
ajcp-5356	193	13	cancer	cancer	NOUN
ajcp-5356	193	14	.	.	PUNCT
ajcp-5356	194	1	clinical	clinical	ADJ
ajcp-5356	194	2	and	and	CCONJ
ajcp-5356	194	3	experimental	experimental	ADJ
ajcp-5356	194	4	pharmacology	pharmacology	NOUN
ajcp-5356	194	5	and	and	CCONJ
ajcp-5356	194	6	physiology	physiology	NOUN
ajcp-5356	194	7	,	,	PUNCT
ajcp-5356	194	8	39(3	39(3	NUM
ajcp-5356	194	9	)	)	PUNCT
ajcp-5356	194	10	,	,	PUNCT
ajcp-5356	194	11	300–310	300–310	NUM
ajcp-5356	194	12	.	.	PUNCT
ajcp-5356	195	1	https://doi.org/10.1111/j.1440-1681.2011.05619.x	https://doi.org/10.1111/j.1440-1681.2011.05619.x	PROPN
ajcp-5356	195	2	palanisamy	palanisamy	PROPN
ajcp-5356	195	3	,	,	PUNCT
ajcp-5356	195	4	s.	s.	PROPN
ajcp-5356	195	5	,	,	PUNCT
ajcp-5356	195	6	liu	liu	PROPN
ajcp-5356	195	7	,	,	PUNCT
ajcp-5356	195	8	x.	x.	PROPN
ajcp-5356	195	9	,	,	PUNCT
ajcp-5356	195	10	&	&	CCONJ
ajcp-5356	195	11	wang	wang	PROPN
ajcp-5356	195	12	,	,	PUNCT
ajcp-5356	195	13	y.	y.	PROPN
ajcp-5356	195	14	(	(	PUNCT
ajcp-5356	195	15	2017	2017	NUM
ajcp-5356	195	16	)	)	PUNCT
ajcp-5356	195	17	.	.	PUNCT
ajcp-5356	196	1	marine	marine	ADJ
ajcp-5356	196	2	-	-	PUNCT
ajcp-5356	196	3	derived	derive	VERB
ajcp-5356	196	4	alkaloids	alkaloid	NOUN
ajcp-5356	196	5	and	and	CCONJ
ajcp-5356	196	6	their	their	PRON
ajcp-5356	196	7	anti	anti	ADJ
ajcp-5356	196	8	-	-	ADJ
ajcp-5356	196	9	inflammatory	inflammatory	ADJ
ajcp-5356	196	10	activities	activity	NOUN
ajcp-5356	196	11	.	.	PUNCT
ajcp-5356	197	1	marine	marine	ADJ
ajcp-5356	197	2	drugs	drug	NOUN
ajcp-5356	197	3	,	,	PUNCT
ajcp-5356	197	4	15(9	15(9	NUM
ajcp-5356	197	5	)	)	PUNCT
ajcp-5356	197	6	,	,	PUNCT
ajcp-5356	197	7	261	261	NUM
ajcp-5356	197	8	.	.	PUNCT
ajcp-5356	198	1	https://doi.org/10.3390/	https://doi.org/10.3390/	PROPN
ajcp-5356	198	2	md15090261	md15090261	ADJ
ajcp-5356	198	3	tabas	tabas	NOUN
ajcp-5356	198	4	,	,	PUNCT
ajcp-5356	198	5	i.	i.	PROPN
ajcp-5356	198	6	,	,	PUNCT
ajcp-5356	198	7	&	&	CCONJ
ajcp-5356	198	8	glass	glass	NOUN
ajcp-5356	198	9	,	,	PUNCT
ajcp-5356	198	10	c.	c.	PROPN
ajcp-5356	198	11	k.	k.	PROPN
ajcp-5356	198	12	(	(	PUNCT
ajcp-5356	198	13	2013	2013	NUM
ajcp-5356	198	14	)	)	PUNCT
ajcp-5356	198	15	.	.	PUNCT
ajcp-5356	199	1	anti	anti	ADJ
ajcp-5356	199	2	-	-	ADJ
ajcp-5356	199	3	inflammatory	inflammatory	ADJ
ajcp-5356	199	4	therapy	therapy	NOUN
ajcp-5356	199	5	in	in	ADP
ajcp-5356	199	6	chronic	chronic	ADJ
ajcp-5356	199	7	disease	disease	NOUN
ajcp-5356	199	8	:	:	PUNCT
ajcp-5356	199	9	challenges	challenge	NOUN
ajcp-5356	199	10	and	and	CCONJ
ajcp-5356	199	11	opportunities	opportunity	NOUN
ajcp-5356	199	12	.	.	PUNCT
ajcp-5356	200	1	science	science	NOUN
ajcp-5356	200	2	,	,	PUNCT
ajcp-5356	200	3	339(6116	339(6116	PROPN
ajcp-5356	200	4	)	)	PUNCT
ajcp-5356	200	5	,	,	PUNCT
ajcp-5356	200	6	166–172	166–172	NUM
ajcp-5356	200	7	.	.	PUNCT
ajcp-5356	201	1	https://	https://	PROPN
ajcp-5356	201	2	doi.org/10.1126/science.1230720	doi.org/10.1126/science.1230720	NOUN